0001157523-17-001278.txt : 20170428 0001157523-17-001278.hdr.sgml : 20170428 20170428075823 ACCESSION NUMBER: 0001157523-17-001278 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170428 DATE AS OF CHANGE: 20170428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMED CORP CENTRAL INDEX KEY: 0000019584 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 310791746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08351 FILM NUMBER: 17791703 BUSINESS ADDRESS: STREET 1: SUITE 2600 STREET 2: 255 E FIFTH ST CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: (513)762-6690 MAIL ADDRESS: STREET 1: SUITE 2600 STREET 2: 255 E FIFTH STREET CITY: CINCINNATI STATE: OH ZIP: 45202-4726 FORMER COMPANY: FORMER CONFORMED NAME: ROTO-ROOTER INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: CHEMED CORP DATE OF NAME CHANGE: 19920703 10-Q 1 a51546341.htm CHEMED CORP. 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ Quarterly Report Under Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2017

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 1-8351

CHEMED CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		31-0791746
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

255 E. Fifth Street, Suite 2600, Cincinnati, Ohio		45202
(Address of principal executive offices)		(Zip code)

(513) 762-6690

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes

☒

☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes

☒

☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Large accelerated filer	☒	Accelerated filer	☐	Non-accelerated filer	☐	Smaller reporting company	☐

Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended the extended transition period for complying with a new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes

☐

☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

Class	Amount	Date

Capital Stock $1 Par Value	16,082,181 Shares	March 31, 2017

-1-

CHEMED CORPORATION AND

SUBSIDIARY COMPANIES

Index

			Page No.
PART I. FINANCIAL INFORMATION:
	Item 1. Financial Statements
		Unaudited Consolidated Balance Sheets -
		March 31, 2017 and December 31, 2016	3

		Unaudited Consolidated Statements of Income -
		Three months ended March 31, 2017 and 2016	4

		Unaudited Consolidated Statements of Cash Flows -
		Three months ended March 31, 2017 and 2016	5

		Notes to Unaudited Consolidated Financial Statements	6

	Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations		14

	Item 3. Quantitative and Qualitative Disclosures about Market Risk		25

	Item 4. Controls and Procedures		25

PART II. OTHER INFORMATION
	Item 1. Legal Proceedings		25

	Item 1A. Risk Factors		25

	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		26

	Item 3. Defaults Upon Senior Securities		26

	Item 4. Mine Safety Disclosures		26

	Item 5. Other Information		26

	Item 6. Exhibits		27
		EX – 31.1
		EX – 31.2
		EX – 31.3
		EX – 32.1
		EX – 32.2
		EX – 32.3
		EX – 101.INS
		EX – 101.SCH
		EX – 101.CAL
		EX – 101.DEF
		EX – 101.LAB
		EX – 101.PRE

-2-

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
CHEMED CORPORATION AND SUBSIDIARY COMPANIES
UNAUDITED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)



	March 31, 2017			December 31, 2016
ASSETS
Current assets
Cash and cash equivalents	$	47,049		$	15,310
Accounts receivable less allowances of $15,908 (2016 - $14,236)		109,726			132,021
Inventories		5,433			5,755
Prepaid income taxes		1,663			3,709
Prepaid expenses		12,102			13,105
Total current assets		175,973			169,900
Investments of deferred compensation plans		56,596			54,389
Properties and equipment, at cost, less accumulated depreciation of $216,423 (2016 - $211,290)		119,394			121,302
Identifiable intangible assets less accumulated amortization of $32,794 (2016 - $33,225)		54,976			55,065
Goodwill		472,391			472,366
Other assets		6,901			7,037
Total Assets	$	886,231		$	880,059

LIABILITIES
Current liabilities
Accounts payable	$	29,341		$	39,586
Current portion of long-term debt		9,375			8,750
Income taxes		12,614			-
Accrued insurance		54,150			47,960
Accrued compensation		37,382			53,979
Accrued legal		2,471			1,805
Other current liabilities		19,050			19,752
Total current liabilities		164,383			171,832
Deferred income taxes		11,875			14,291
Long-term debt		137,500			100,000
Deferred compensation liabilities		56,024			54,288
Other liabilities		15,805			15,549
Total Liabilities		385,587			355,960
Commitments and contingencies (Note 11)
STOCKHOLDERS' EQUITY
Capital stock - authorized 80,000,000 shares $1 par; issued 34,404,220 shares (2016 - 34,270,104 shares)		34,404			34,270
Paid-in capital		651,269			639,703
Retained earnings		983,742			958,149
Treasury stock - 18,407,027 shares (2016 - 18,083,527)		(1,170,933	)		(1,110,536	)
Deferred compensation payable in Company stock		2,162			2,513
Total Stockholders' Equity		500,644			524,099
Total Liabilities and Stockholders' Equity	$	886,231		$	880,059


See accompanying notes to unaudited consolidated financial statements.

-3-

CHEMED CORPORATION AND SUBSIDIARY COMPANIES
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share data)



	Three Months Ended March 31,
	2017			2016
Service revenues and sales	$	405,864		$	390,389
Cost of services provided and goods sold (excluding depreciation)		285,140			278,435
Selling, general and administrative expenses		69,458			59,045
Depreciation		8,893			8,424
Amortization		46			92
Other operating expenses		873			-
Total costs and expenses		364,410			345,996
Income from operations		41,454			44,393
Interest expense		(995	)		(842	)
Other income/(expense) - net		2,463			(2,924	)
Income before income taxes		42,922			40,627
Income taxes		(13,078	)		(15,787	)
Net income	$	29,844		$	24,840

Earnings Per Share
Net income	$	1.84		$	1.49
Average number of shares outstanding		16,219			16,720

Diluted Earnings Per Share
Net income	$	1.78		$	1.45
Average number of shares outstanding		16,801			17,170

Cash Dividends Per Share	$	0.26		$	0.24

See accompanying notes to unaudited consolidated financial statements.

-4-

CHEMED CORPORATION AND SUBSIDIARY COMPANIES
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

	Three Months Ended March 31,
	2017			2016
Cash Flows from Operating Activities
Net income	$	29,844		$	24,840
Adjustments to reconcile net income to net cash provided
by operating activities:
Depreciation and amortization		8,939			8,516
Provision for uncollectible accounts receivable		4,249			4,242
Stock option expense		3,001			2,563
Benefit for deferred income taxes		(2,415	)		(4,202	)
Noncash long-term incentive compensation		827			(305	)
Amortization of restricted stock awards		336			539
Amortization of debt issuance costs		129			130
Changes in operating assets and liabilities:
Decrease/(increase) in accounts receivable		17,972			(41,050	)
Decrease in inventories		322			212
Decrease in prepaid expenses		1,003			546
Decrease in accounts payable and other current liabilities		(10,766	)		(7,567	)
Increase in income taxes		14,655			19,448
Increase/(decrease) in other assets		(2,140	)		410
Increase/(decrease) in other liabilities		1,992			(140	)
Excess tax benefit on share-based compensation		-			(900	)
Other sources/(uses)		838			(59	)
Net cash provided by operating activities		68,786			7,223
Cash Flows from Investing Activities
Capital expenditures		(9,020	)		(11,473	)
Other sources/(uses)		(70	)		153
Net cash used by investing activities		(9,090	)		(11,320	)
Cash Flows from Financing Activities
Proceeds from revolving line of credit		116,000			59,000
Payments on revolving line of credit		(76,000	)		(3,500	)
Purchases of treasury stock		(54,262	)		(52,460	)
Change in cash overdrafts payable		(8,607	)		7,061
Proceeds from exercise of stock options		5,635			2,887
Capital stock surrendered to pay taxes on stock-based compensation		(4,744	)		(4,020	)
Dividends paid		(4,251	)		(4,081	)
Payments on other long-term debt		(1,875	)		(1,875	)
Excess tax benefit on share-based compensation		-			900
Other sources		147			693
Net cash (used)/provided by financing activities		(27,957	)		4,605
Increase in Cash and Cash Equivalents		31,739			508
Cash and cash equivalents at beginning of year		15,310			14,727
Cash and cash equivalents at end of period	$	47,049		$	15,235

See accompanying notes to unaudited consolidated financial statements.

-5-

CHEMED CORPORATION AND SUBSIDIARY COMPANIES

Notes to Unaudited Consolidated Financial Statements

1. Basis of Presentation

As used herein, the terms "We," "Company" and "Chemed" refer to Chemed Corporation or Chemed Corporation and its consolidated subsidiaries.

We have prepared the accompanying unaudited consolidated financial statements of Chemed in accordance with Rule 10-01 of SEC Regulation S-X. Consequently, we have omitted certain disclosures required under generally accepted accounting principles in the United States (“GAAP”) for complete financial statements. The December 31, 2016 balance sheet data were derived from audited financial statements but do not include all disclosures required by GAAP. However, in our opinion, the financial statements presented herein contain all adjustments, consisting only of normal recurring adjustments, necessary to state fairly our financial position, results of operations and cash flows. These financial statements are prepared on the same basis as and should be read in conjunction with the audited Consolidated Financial Statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2016.

EARNINGS PER SHARE

In March 2016, the FASB issued Accounting Standards Update “ASU No. 2016-09 - Compensation – Stock Compensation” which is part of the FASB’s Simplification Initiative. The object of this initiative is to identify, evaluate, and improve areas of GAAP. The areas of simplification in this initiative involve several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The guidance was effective for fiscal years beginning after December 15, 2016. We adopted the applicable provisions of ASU 2016-09 on a prospective basis. The impact of this ASU on our financial statements for the quarter ended March 31, 2017 was to decrease our income tax expense by $3.7 million as the result of excess tax benefits on stock based compensation being recorded on the statements of income. The decrease in income tax expense reduced our effective tax rate to 30.5% in the first quarter of 2017 as compared to 38.9% in the first quarter of 2016. This, combined with the required change in diluted share count, resulted in an increase to basic earnings per share by $0.23 and an increase to diluted earnings per share by $0.22.

2. Revenue Recognition

Both the VITAS segment and the Roto-Rooter segment recognize service revenues and sales when the earnings process has been completed. Generally, this occurs when services are provided or products are shipped. VITAS recognizes revenue at the estimated realizable amount due from third-party payers. Medicare payments are subject to certain limitations, as described below.

We actively monitor each of our hospice programs, by provider number, as to their specific admission, discharge rate and median length of stay data in an attempt to determine whether they are likely to exceed the annual per-beneficiary Medicare cap (“Medicare cap”). Should we determine that revenues for a program are likely to exceed the Medicare cap based on projected trends, we attempt to institute corrective action to influence the patient mix or to increase patient admissions. However, should we project our corrective action will not prevent that program from exceeding its Medicare cap, we estimate the amount of revenue recognized during the period that will require repayment to the Federal government under the Medicare cap and record the amount as a reduction to patient revenue.

In 2013, the U.S. government implemented automatic budget reductions of 2.0% for all government payees, including hospice benefits paid under the Medicare program. In 2015, CMS determined that the Medicare cap should be calculated “as if” sequestration did not occur. As a result of this decision, VITAS has received notification from our third party intermediary that an additional $2.1 million is owed for Medicare cap in three programs arising during the 2013, 2014 and 2015 measurement periods. The amounts were automatically deducted from our semi-monthly PIP payments. We do not believe that CMS is authorized under the sequestration authority or the statutory methodology for establishing the Medicare cap to demand the $2.1 million under their “as if” methodology. We have not recorded a reserve as of March 31, 2017 for $1.9 million of the potential exposure. We have appealed CMS’s methodology change with the appropriate regulatory appeal board.

During the three months ended March 31, 2017 and 2016, respectively, no Medicare cap was recorded.

-6-

Shown below is the Medicare cap liability activity for the fiscal periods ended (in thousands):

	March 31,
		2017	2016
Beginning balance January 1,	$	235	$	1,165
Payments		-		(618	)
Ending balance March 31,	$	235	$	547

Vitas provides charity care, in certain circumstances, to patients without charge when management of the hospice program determines, at the time services are performed, that the patient cannot afford payment. There is no revenue or associated accounts receivable in the accompanying consolidated financial statements related to charity care. The cost of charity care is calculated by taking the ratio of charity care days to total days of care and multiplying by total cost of care. The cost of charity care is as follows (in thousands):

Three months ended March 31,
	2017		2016
	$	1,937	$	1,806

3. Segments

Service revenues and sales and after-tax earnings by business segment are as follows (in thousands):

	Three months ended March 31,
	2017			2016
Service Revenues and Sales
VITAS	$	282,316		$	277,528
Roto-Rooter		123,548			112,861
Total	$	405,864		$	390,389

After-tax Earnings
VITAS	$	20,597		$	19,087
Roto-Rooter		14,624			13,020
Total		35,221			32,107
Corporate		(5,377	)		(7,267	)
Net income	$	29,844		$	24,840

We report corporate administrative expenses and unallocated investing and financing income and expense not directly related to either segment as “Corporate”.

-7-

4. Earnings per Share

Earnings per share (“EPS”) are computed using the weighted average number of shares of capital stock outstanding. Earnings and diluted earnings per share are computed as follows (in thousands, except per share data):

	Net Income
For the Three Months Ended March 31,	Income		Shares		Earnings per Share
2017
Earnings	$	29,844		16,219	$	1.84
Dilutive stock options		-		490
Nonvested stock awards		-		92
Diluted earnings	$	29,844		16,801	$	1.78

2016
Earnings	$	24,840		16,720	$	1.49
Dilutive stock options		-		305
Nonvested stock awards		-		145
Diluted earnings	$	24,840		17,170	$	1.45

For the three month periods ended March 31, 2017 and 2016, respectively, 402,000 and 421,000 stock options were excluded from the computation of diluted earnings per share because they would have been anti-dilutive.

5. Long-Term Debt

On June 30, 2014, we replaced our existing credit agreement with the Third Amended and Restated Credit Agreement (“2014 Credit Agreement”). Terms of the 2014 Credit Agreement consist of a five-year, $350 million revolving credit facility and a $100 million term loan. The 2014 Credit Agreement has a floating interest rate that is generally LIBOR plus a tiered additional rate which varies based on our current leverage ratio. The interest rate is LIBOR plus 113 basis points as of March 31, 2017.

The debt outstanding as of March 31, 2017 consists of the following:

Revolver	$	65,000
Term loan		81,875
Total		146,875
Current portion of long-term debt		(9,375	)
Long-term debt	$	137,500

Scheduled principal payments of the term loan are as follows:

2017	$	6,875
2018		10,000
2019		65,000
	$	81,875

The 2014 Credit Agreement contains the following quarterly financial covenants:

Description		Requirement

Leverage Ratio (Consolidated Indebtedness/Consolidated Adj. EBITDA)		< 3.50 to 1.00

Fixed Charge Coverage Ratio (Consolidated Free Cash Flow/Consolidated Fixed Charges)		> 1.50 to 1.00

Annual Operating Lease Commitment		< $50.0 million

-8-

We are in compliance with all debt covenants as of March 31, 2017. We have issued $38.7 million in standby letters of credit as of March 31, 2017 mainly for insurance purposes. Issued letters of credit reduce our available credit under the 2014 Credit Agreement. As of March 31, 2017, we have approximately $246.3 million of unused lines of credit available and eligible to be drawn down under our revolving credit facility.

6. Other Operating Expenses

During the three months ended March 31, 2017, the Company recorded $873,000 in expenses related to the closure of three Alabama programs at Vitas. The expenses mainly include employee severance and the write-off of leasehold improvements for one in-patient unit.

7. Other Income/(Expense) – Net

Other income/(expense) -- net comprises the following (in thousands):

	Three months ended March 31,
	2017			2016
Market value adjustment on assets held in
deferred compensation trust	$	2,615		$	(2,987	)
Loss on disposal of property and equipment		(236	)		(33	)
Interest income		85			97
Other - net		(1	)		(1	)
Total other income/(expense) - net	$	2,463		$	(2,924	)

8. Stock-Based Compensation Plans

On February 17, 2017, the Compensation/Incentive Committee of the Board of Directors (“CIC”) granted 7,304 Performance Stock Units (“PSUs”) contingent upon the achievement of certain total shareholders return (“TSR”) targets as compared to the TSR of a group of peer companies for the three-year period ending December 31, 2019, the date at which such awards vest. The cumulative compensation cost of the TSR-based PSU award to be recorded over the three year service period is $1.7 million.

On February 17, 2017, the CIC also granted 7,304 PSUs contingent upon the achievement of certain earnings per share (“EPS”) targets for the three-year period ending December 31, 2019. At the end of each reporting period, the Company estimates the number of shares that it believes will ultimately be earned and records that expense over the service period of the award. We currently estimate the cumulative compensation cost of the EPS-based PSUs to be recorded over the three year service period is $1.3 million.

9. Independent Contractor Operations

The Roto-Rooter segment sublicenses with 69 independent contractors to operate certain plumbing repair, excavation, water restoration and drain cleaning businesses in lesser-populated areas of the United States and Canada. We had notes receivable from our independent contractors as of March 31, 2017 totaling $1.5 million (December 31, 2016 - $1.7 million). In most cases these loans are fully or partially secured by equipment owned by the contractor. The interest rates on the loans range from 0% to 7% per annum and the remaining terms of the loans range from 2.5 months to 5.4 years at March 31, 2017. We recorded the following from our independent contractors (in thousands):

	Three months ended March 31,
	2017		2016
Revenues	$	11,025	$	9,858
Pretax profits		6,689		6,155

-9-

10. Retirement Plans

All of the Company’s plans that provide retirement and similar benefits are defined contribution plans. These expenses include the impact of market gains and losses on assets held in deferred compensation plans. Expenses for the Company’s retirement and profit-sharing plans, excess benefit plans and other similar plans are as follows (in thousands):

Three months ended March 31,
	2017		2016
	$	6,157	$	526

11. Legal and Regulatory Matters

The VITAS segment of the Company’s business operates in a heavily-regulated industry. As a result, the Company is subjected to inquiries and investigations by various government agencies, as well as to lawsuits, including qui tam actions. The following sections describe the various ongoing material lawsuits and investigations of which the Company is currently aware. It is not possible at this time for us to estimate either the timing or outcome of any of those matters, or whether any potential loss, or range of potential losses, is probable or reasonably estimable.

Regulatory Matters and Litigation

On May 2, 2013, the government filed a False Claims Act complaint against the Company and certain of its hospice-related subsidiaries in the U.S. District Court for the Western District of Missouri, United States v. VITAS Hospice Services, LLC, et al., No. 4:13-cv-00449-BCW (the “2013 Action”). Prior to that date, the Company received various qui tam lawsuits and subpoenas from the U.S. Department of Justice and OIG that have been previously disclosed. The 2013 Action alleges that, since at least 2002, VITAS, and since 2004, the Company, submitted or caused the submission of false claims to the Medicare program by (a) billing Medicare for continuous home care services when the patients were not eligible, the services were not provided, or the medical care was inappropriate, and (b) billing Medicare for patients who were not eligible for the Medicare hospice benefit because they did not have a life expectancy of six months or less if their illnesses ran their normal course. This complaint seeks treble damages, statutory penalties, and the costs of the action, plus interest. The defendants filed a motion to dismiss on September 24, 2013. On September 30, 2014, the Court denied the motion, except to the extent that claims were filed before July 24, 2002. On November 13, 2014, the government filed a Second Amended Complaint. The Second Amended Complaint changed and supplemented some of the allegations, but did not otherwise expand the causes of action or the nature of the relief sought against VITAS. VITAS filed its Answer to the Second Amended Complaint on August 11, 2015. This case is in the discovery phase. The Company is not able to reasonably estimate the probability of loss or range of loss at this time. For additional procedural history of this litigation, please refer to our prior quarterly and annual filings. The net costs incurred related to U.S. v. Vitas and related regulatory matters were $2.2 million and $2.3 million for March 31, 2017 and 2016, respectively.

The Company and certain current and former directors and officers are defendants in a case captioned In re Chemed Corp. Shareholder and Derivative Litigation, No. 13 Civ. 1854 (LPS) (CJB) (D. Del.), which was consolidated on February 2, 2015 and is covered by the Company’s commercial insurance.

On February 2, 2015, the Court appointed KBC Asset Management NV the sole lead plaintiff and its counsel, the sole lead and liaison counsel. On March 3, 2015, Lead Plaintiff KBC designated its Complaint as the operative complaint in the consolidated proceedings and defendants renewed a previously filed motion to dismiss those claims and allegations. The consolidated Complaint named fourteen individual defendants, together with the Company as nominal defendant. The Complaint alleges a claim for breach of fiduciary duty against the individual defendants for allegedly permitting the Company to submit false claims to the U.S. government. The Complaint seeks (a) a declaration that the individual defendants breached their fiduciary duties to the Company; (b) an order requiring those defendants to pay compensatory damages, restitution and exemplary damages, in unspecified amounts, to the Company; (c) an order directing the Company to implement new policies and procedures; and (d) costs and disbursements incurred in bringing the action, including attorneys’ fees. On May 12, 2016, the court issued a Memorandum Order granting Chemed’s motion to dismiss, and dismissing Lead Plaintiff KBC’s Complaint without prejudice to KBC’s opportunity to file within 30 days of the date of the court’s Order (June 13, 2016) an amended Complaint addressing the deficiencies in its duty of loyalty claim. Lead Plaintiff KBC did not file an amended Complaint within the time specified by the court.

-10-

However, on June 13, 2016, counsel for Chemed shareholder Michael Kvint filed a letter with the court requesting a two-week extension to file a motion to substitute Mr. Kvint as Lead Plaintiff, in place of Lead Plaintiff KBC and to file an amended Complaint. Alternatively, counsel for Mr. Kvint requested that any dismissal of the action be with prejudice to KBC only. On June 14, 2016, Chemed filed a reply letter with the court, reserving its rights to oppose any motion filed by Mr. Kvint and, if warranted, to oppose any other actions taken by Mr. Kvint to proceed with the action (including by filing an untimely amended Complaint). On June 21, 2016, the court entered an Oral Order providing Mr. Kvint until June 30, 2016 to file a Motion to Substitute and Motion for Leave to File an Amended Complaint. On that date, Mr. Kvint filed, under seal, a Motion to Substitute Plaintiff and File Amended Complaint, and attached a Proposed Amended Complaint. Mr. Kvint’s motion was fully briefed by the parties. The Court heard oral argument on Mr. Kvint’s motion on January 24, 2017. On January 25, 2017, Magistrate Judge Burke entered an Order requesting additional letter briefing on issues arising from Mr. Kvint’s motion. Pursuant to that Order, the parties have each submitted opening and reply letter briefing. Magistrate Judge Burke has not yet issued a recommendation or report on Mr. Kvint’s motion. For additional procedural history of this litigation, please refer to our prior quarterly and annual filings.

Jordan Seper, (“Seper”) a Registered Nurse at VITAS' Inland Empire program from May 12, 2014 to March 21, 2015, filed a lawsuit in San Francisco Superior Court on September 26, 2016. She alleged VITAS Healthcare Corp of CA (“VITAS CA”) (1) failed to provide minimum wage for all hours worked; (2) failed to provide overtime for all hours worked; (3) failed to provide a second meal period; (4) failed to provide rest breaks; (5) failed to indemnify for necessary expenditures; (6) failed to timely pay wages due at time of separation; and (7) engaged in unfair business practices. Seper seeks a state-wide class action of current and former non-exempt employees employed with VITAS in California within the four years preceding the filing of the lawsuit. She seeks court determination that this action may be maintained as a class action for the entire California class and subclasses, designation as class representative, declaratory relief, injunctive relief, damages (including wages for regular or overtime hours allegedly worked but not paid, premium payments for missed meal or rest periods, and unreimbursed expenses), all applicable penalties associated with each claim, pre and post-judgment interest, and attorneys' fees and costs. Seper served VITAS CA with the lawsuit, Jordan A. Seper on behalf of herself and others similarly situated v. VITAS Healthcare Corporation of California, a Delaware corporation; VITAS Healthcare Corp of CA, a business entity unknown; and DOES 1 to 100, inclusive; Los Angeles Superior Court Case Number BC 642857 on October 13, 2016.

On November 14, 2016, the Parties filed a Stipulation to transfer the venue of the lawsuit from San Francisco to Los Angeles. The Los Angeles Superior Court accepted transfer of the case on December 6, 2016. On December 16, 2016, VITAS CA filed its Answer and served written discovery on Seper.

Jiwan Chhina ("Chhina"), hired by VITAS as a Home Health Aide on February 5, 2002, is currently a Licensed Vocational Nurse for VITAS' San Diego program. On September 27, 2016, Chhina filed a lawsuit in San Diego Superior Court, alleging (1) failure to pay minimum wage for all hours worked; (2) failure to provide overtime for all hours worked; (3) failure to pay wages for all hours at the regular rate; (4) failure to provide meal periods; (5) failure to provide rest breaks; (6) failure to provide complete and accurate wage statements; (7) failure to pay for all reimbursement expenses; (8) unfair business practices; and (9) violation of the California Private Attorneys General Act. Chhina seeks to pursue these claims in the form of a state-wide class action of current and former non-exempt employees employed with VITAS in California within the four years preceding the filing of the lawsuit. He seeks court determination that this action may be maintained as a class action for the entire California class and subclasses, designation as class representative, declaratory relief, injunctive relief, damages (including wages for regular or overtime hours allegedly worked but not paid, premium payments for missed meal or rest periods, and unreimbursed expenses), all applicable penalties associated with each claim, pre-judgment interest, and attorneys' fees and costs. Chhina served VITAS CA with the lawsuit, Jiwann Chhina v. VITAS Health Services of California, Inc., a California corporation; VITAS Healthcare Corporation of California, a Delaware corporation; VITAS Healthcare Corporation of California, a Delaware corporation dba VITAS Healthcare, Inc.; and DOES 1 to 100, inclusive; San Diego Superior Court Case Number 37-2015-00033978-CU-OE-CTL on November 3, 2016. On December 1, 2016, VITAS filed its Answer and served written discovery on Chhina.

The Company is not able to reasonably estimate the probability of loss or range of loss for either of these lawsuits at this time.

The Company intends to defend vigorously against the allegations in each of the above lawsuits. Regardless of the outcome of any of the preceding matters, responding to the subpoenas and dealing with the various regulatory agencies and opposing parties can adversely affect us through defense costs, potential payments, diversion of management time, and related publicity. Although the Company intends to defend them vigorously, there can be no assurance that those suits will not have a material adverse effect on the Company.

12. Concentration of Risk

During the quarter VITAS had pharmacy services agreements with one service provider to provide specified pharmacy services for VITAS and its hospice patients. VITAS made purchases from this provider of $8.9 million for the first quarter of 2017. Vitas made purchases from two providers of $8.9 million for the first quarter of 2016. Purchases from these providers were approximately 90% of all pharmacy services used by VITAS during each quarter presented.

-11-

13. Cash Overdrafts and Cash Equivalents

There are no cash overdrafts payable included in accounts payable at March 31, 2017 (December 31, 2016 - $8.6 million).

From time to time throughout the year, we invest excess cash in money market funds with major commercial banks. We closely monitor the creditworthiness of the institutions with which we invest our overnight funds. We had $30,000 in cash equivalents as of March 31, 2017. There was $72,000 in cash equivalents as of December 31, 2016.

14. Financial Instruments

FASB’s authoritative guidance on fair value measurements defines a hierarchy which prioritizes the inputs in fair value measurements. Level 1 measurements are measurements using quoted prices in active markets for identical assets or liabilities. Level 2 measurements use significant other observable inputs. Level 3 measurements are measurements using significant unobservable inputs which require a company to develop its own assumptions. In recording the fair value of assets and liabilities, companies must use the most reliable measurement available. For cash and cash equivalents, accounts receivable and accounts payable, the carrying amount is a reasonable estimate of fair value because of the liquidity and short-term nature of these instruments.

The following shows the carrying value, fair value and the hierarchy for our financial instruments as of March 31, 2017 (in thousands):

			Fair Value Measure
	Carrying Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Mutual fund investments of deferred
compensation plans held in trust	$	56,596	$	56,596	$	-	$	-
Long-term debt		146,875		-		146,875		-

The following shows the carrying value, fair value and the hierarchy for our financial instruments as of December 31, 2016 (in thousands):

			Fair Value Measure
	Carrying Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Mutual fund investments of deferred
compensation plans held in trust	$	54,389	$	54,389	$	-	$	-
Long-term debt		108,750		-		108,750		-

For cash and cash equivalents, accounts receivable and accounts payable, the carrying amount is a reasonable estimate of fair value because of the liquidity and short-term nature of these instruments. As further described in Footnote 5, our outstanding long-term debt and current portion of long-term debt have floating interest rates that are reset at short-term intervals, generally 30 or 60 days. The interest rate we pay also includes an additional amount based on our current leverage ratio. As such, we believe our borrowings reflect significant nonperformance risks, mainly credit risk. Based on these factors, we believe the fair value of our long-term debt and current portion of long-term debt approximate the carrying value.

-12-

15. Capital Stock Repurchase Plan Transactions

We repurchased the following capital stock for the three months ended March 31, 2017 and 2016:

	Three months ended March 31,
	2017		2016

Total cost of repurchased shares (in thousands):	$	54,262	$	52,460
Shares repurchased		300,000		400,000
Weighted average price per share	$	180.87	$	131.15

In March 2017, the Board of Directors authorized an additional $100.0 million for stock repurchase under Chemed’s existing share repurchase program. We currently have $95.9 million of authorization remaining under this share repurchase plan.

16. Recent Accounting Statements

In May 2014, the FASB issued Accounting Standards Update “ASU No. 2014-09 – Revenue from Contracts with Customers” which provides additional guidance to clarify the principles for recognizing revenue. The standard and subsequent amendments are intended to develop a common revenue standard for removing inconsistencies and weaknesses, improve comparability, provide more useful information to users through improved disclosure requirements, and simplify the preparation of financial statements. This guidance and subsequent amendments are effective for fiscal years beginning after December 15, 2017. We are in the process of analyzing various contractual arrangements with customers at each subsidiary. We believe that it is likely, as a result of adopting the ASU that certain expenses currently included in bad debt expense will be shown as contractual allowances (i.e. net revenue). We currently do not have an estimate of the magnitude of this potential impact. We anticipate a modified retrospective adoption of the ASU.

In February 2016, the FASB issued Accounting Standards Update “ASU No. 2016-02 – Leases” which introduces a lessee model that brings most leases on to the balance sheets and updates lessor accounting to align with changes in the lessee model and the revenue recognition standard. The guidance is effective for fiscal years beginning after December 15, 2018. We are currently evaluating the impact of this ASU on our financial statements, existing lease recognition policies and disclosures.

In August 2016, the FASB issued Accounting Standards Update “ASU No. 2016-15 – Cash Flow Classification” which amends guidance on the classification of certain cash receipts and payments in the statement of cash flows. The primary purpose of ASU 2016-15 is to reduce diversity in practice related to eight specific cash flow issues. The guidance in this ASU is effective for fiscal years beginning after December 15, 2017. We have analyzed the impact of ASU 2016-15 on our statement of cash flows and do not expect it to have a material effect.

In January 2017, the FASB issued Accounting Standards Update “ASU No. 2017-4 – Intangibles – Goodwill and Other”. To simplify the subsequent measurement of goodwill, the FASB eliminated Step 2 from the goodwill impairment test. The guidance in the ASU is effective for the Company in fiscal years beginning after December 15, 2019. Early adoption is permitted. We anticipate adoption of this standard will have no impact on our consolidated financial statements.

17. Goodwill

Shown below is movement in Goodwill (in thousands):

	Vitas		Roto-Rooter		Total
Balance at December 31, 2016	$	328,301	$	144,065	$	472,366
Foreign currency adjustments		-		25		25
Balance at March 31, 2017	$	328,301	$	144,090	$	472,391

-13-

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Executive Summary

We operate through our two wholly-owned subsidiaries, VITAS Healthcare Corporation and Roto-Rooter Group, Inc. VITAS focuses on hospice care that helps make terminally ill patients’ final days as comfortable as possible. Through its teams of doctors, nurses, home health aides, social workers, clergy and volunteers, VITAS provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Roto-Rooter’s services are focused on providing plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers. Through its network of company-owned branches, independent contractors and franchisees, Roto-Rooter offers plumbing and drain cleaning service to over 90% of the U.S. population.

The following is a summary of the key operating results (in thousands except per share amounts):

	Three months ended March 31,
	2017			2016
Service revenues and sales	$	405,864		$	390,389
Net income	$	29,844		$	24,840
Diluted EPS	$	1.78		$	1.45
Adjusted net income	$	30,495		$	27,754
Adjusted diluted EPS	$	1.82		$	1.62
Adjusted EBITDA	$	59,818		$	54,480
Adjusted EBITDA as a % of revenue		14.7	%		14.0	%

Adjusted net income, adjusted diluted EPS, earnings before interest, taxes and depreciation and amortization (“EBITDA”) and Adjusted EBITDA are not measures derived in accordance with GAAP. We provide non-GAAP measures to help readers evaluate our operating results and to compare our operating performance with that of similar companies that have different capital structures. Our non-GAAP measures should not be considered in isolation or as a substitute for comparable measures presented in accordance with GAAP. A reconciliation of our non-GAAP measures is presented on pages 22-23.

For the three months ended March 31, 2017, the increase in consolidated service revenues and sales was driven by a 9.5% increase at Roto-Rooter and a 1.7% increase at VITAS. The increase in service revenues at Roto-Rooter was driven by an increase in all major service lines. The increase in service revenues at VITAS was primarily a result of Medicare reimbursement rates increasing 1.6%, a 3.6% increase in average daily census, offset by acuity mix shift which negatively impacted revenue 2.4% and the 1.1% negative impact from having one less day in the quarter when compared to the prior year period. Consolidated net income increased 20.1% mainly due to increased revenue and gross profit margin at both VITAS and Roto-Rooter combined with a lower effective tax rate as a result of the adoption of ASU No. 2016-09. Diluted EPS increased 22.8% as a result of the increase in net income as well as a lower number of shares outstanding. Adjusted EBITDA as a percent of revenue increased 70 basis points when compared to the prior year quarter mainly as a result of the increase in net income. See page 24 for additional VITAS operating metrics.

VITAS expects its full-year 2017 revenue growth, prior to Medicare cap, to be in the range of 4.0% to 5.0%. Admissions and Average Daily Census in 2017 is estimated to expand approximately 3.0% to 4.0%. Adjusted EBITDA margin, prior to Medicare cap, is estimated to be 14.5% to 15.0%. This guidance includes $3.75 million for Medicare cap billing limitations. Roto-Rooter expects full-year 2017 revenue growth of 3.0% to 4.0%. The revenue estimate is a based upon increased job pricing of approximately 2.0% and continued growth in water restoration services. Adjusted EBITDA margin for 2017 is estimated in the range of 21.5% to 22.0%. We anticipate that our operating income and cash flows will be sufficient to operate our businesses and meet any commitments for the foreseeable future.

-14-

Financial Condition

Liquidity and Capital Resources

Material changes in the balance sheet accounts from December 31, 2016 to March 31, 2017 include the following:

•	A $22.3 million decrease in accounts receivable due mainly to timing of Medicare and Medicaid payments.

•	We received a $41.7 million Medicare payment on March 31, 2017.

•	A $10.2 million decrease in accounts payable due to timing of payments.

•	A $12.6 million increase in income taxes payable due to timing of payments.

•	A $6.2 million increase in accrued insurance primarily due to the change in stop loss receivable for the quarter.

•	A $16.6 million decrease in accrued compensation due to the payments of cash bonuses accrued in 2016.

•	A $38.1 million increase in long-term debt due to borrowings on our revolving line of credit mainly to fund stock repurchases.

Net cash provided by operating activities increased $61.6 million mainly as a result of a decrease in accounts receivable (causing an increase in cash) due to the timing of payments. We received a $41.7 million Medicare payment on March 31, 2017. Significant changes in our accounts receivable balances are typically driven mainly by the timing of payments received from the Federal government at our VITAS subsidiary. We typically receive a payment in excess of $40.0 million from the Federal government from hospice services every other Friday. The timing of period end will have a significant impact on the accounts receivable at VITAS. These changes generally normalize over a two year period, as cash flow variations in one year are offset in the following year.

Management continually evaluates cash utilization alternatives, including share repurchase, debt repurchase, acquisitions and increased dividends to determine the most beneficial use of available capital resources.

We have issued $38.7 million in standby letters of credit as of March 31, 2017, mainly for insurance purposes. Issued letters of credit reduce our available credit under the revolving credit agreement. As of March 31, 2017, we have approximately $246.3 million of unused lines of credit available and eligible to be drawn down under our revolving credit facility. Management believes its liquidity and sources of capital are satisfactory for the Company’s needs in the foreseeable future.

Commitments and Contingencies

Collectively, the terms of our credit agreements require us to meet various financial covenants, to be tested quarterly. We are in compliance with all financial and other debt covenants as of March 31, 2017 and anticipate remaining in compliance throughout the foreseeable future.

-15-

-16-

The Company is not able to reasonably estimate the probability of loss or range of loss for either of these lawsuits at this time.

Results of Operations

Three months ended March 31, 2017 versus 2016 - Consolidated Results

Our service revenues and sales for the first quarter of 2017 increased 4.0% versus services and sales revenues for the first quarter of 2016. Of this increase, a $4.8 million increase was attributable to VITAS and $10.7 million increase was attributable to Roto-Rooter. The following chart shows the components of those changes (in thousands):

	Increase/(Decrease)
	Amount			Percent
VITAS
Routine homecare	$	10,686			5.0
Continuous care		(4,304	)		(11.6	)
General inpatient		(1,594	)		(6.2	)
Roto-Rooter
Plumbing		3,122			6.4
Drain cleaning		412			1.1
Water restoration		5,625			45.1
Contractor operations		1,167			11.8
Other		361			6.9
Total	$	15,475			4.0

The increase in VITAS’ revenues for the first quarter of 2017 versus the first quarter of 2016 was comprised of an average net Medicare reimbursement rate increasing approximately 1.6%, a 2.5% increase in days of care offset by acuity mix shift which negatively impacted revenue 2.4% as well as the 1.1% negative impact from having one less day in the quarter when compared to the prior year period.

Days of care during the quarter ended March 31 were as follows:

	Days of Care				Increase/(Decrease)
	2017		2016		Percent

Routine homecare		1,380,548		1,335,617		3.4
Continuous care		45,417		50,970		(10.9	)
General inpatient		33,985		38,249		(11.1	)
Total days of care		1,459,950		1,424,836		2.5

Over 90% of VITAS’ service revenues for the period were from Medicare and Medicaid.

The increase in plumbing revenues for the first quarter of 2017 versus 2016 is attributable to an 8.3% increase in price and service mix shift offset by a 1.9% decrease in job count. Drain cleaning revenues for the first quarter of 2017 versus 2016 reflect a 6.1% increase in price and service mix shift offset by a 5.0% decrease in job count. Water restoration for the first quarter of 2017 versus 2016 increased 45.1% as a result of continued expansion of this service offering in all Roto-Rooter locations. Contractor operations increased 11.8% mainly due to their expansion into water restoration and other Roto-Rooter revenue increased 6.9%.

-17-

The consolidated gross margin was 29.7% in the first quarter of 2017 as compared with 28.7% in the first quarter of 2016. On a segment basis, VITAS’ gross margin was 21.5% in the first quarter of 2017 as compared with 21.0%, in the first quarter of 2016. The Roto-Rooter segment’s gross margin was 48.6% for the first quarter of 2017 compared with 47.6% in the first quarter of 2016.

Selling, general and administrative expenses (“SG&A”) comprise (in thousands):

	Three months ended March 31,
	2017		2016
SG&A expenses before market value adjustments of deferred compensation
plans, long-term incentive compensation, and OIG investigation expenses	$	63,732	$	59,937
Long-term incentive compensation		961		(241	)
Expenses related to OIG investigation		2,150		2,336
Impact of market value adjustments related to assets held in deferred
compensation trusts		2,615		(2,987	)
Total SG&A expenses	$	69,458	$	59,045

SG&A expenses before long-term incentive compensation, expenses related to OIG investigation and the impact of market value adjustments related to assets held in deferred compensation trusts for the first quarter of 2017 were up 6.3% when compared to the first quarter of 2016. This increase was mainly a result of the increase in variable expenses caused by increased revenue as well as normal salary increases in 2017.

Other operating expenses increased $873,000 in the first quarter of 2017 related to the closure of the programs in one state at Vitas. The expenses mainly include employee severance and the write-off of leasehold improvements for one in-patient unit. There were no other operating expenses in the first quarter of 2016.

Other income/(expense) - net comprise (in thousands):

	Three months ended March 31,
	2017			2016
Market value adjustment on assets held in
deferred compensation trusts	$	2,615		$	(2,987	)
Loss on disposal of property and equipment		(236	)		(33	)
Interest income		85			97
Other		(1	)		(1	)
Total other income/(expense) - net	$	2,463		$	(2,924	)

Our effective income tax rate was 30.5% in the first quarter of 2017 compared to 38.9% during the first quarter of 2016. The change in the effective income tax rate is a result of the adoption of ASU No. 2016-09 – Compensation – Stock Compensation which requires that the excess tax benefits from stock based compensation now be recorded in the income tax provision on the statements of income.

-18-

Net income for both periods included the following after-tax items/adjustments that (reduced) or increased after-tax earnings (in thousands):

	Three months ended March 31,
	2017			2016
VITAS
Expenses related to OIG investigation	$	(1,328	)	$	(1,443	)
Program closure expenses		(513	)		-
Corporate
Excess tax benefits on stock compensation		3,695			-
Stock option expense		(1,897	)		(1,621	)
Long-term incentive compensation		(608	)		152
Expenses related to securities litigation		-			(2	)
Total	$	(651	)	$	(2,914	)

Three months ended March 31, 2017 versus 2016 - Segment Results

The change in after-tax earnings for the first quarter of 2017 versus the first quarter of 2016 is due to (in thousands):

	Increase/(Decrease)
	Amount		Percent
VITAS	$	1,510		7.9
Roto-Rooter		1,604		12.3
Corporate		1,890		26.0
	$	5,004		20.1

VITAS’ after-tax earnings were positively impacted in 2017 compared to 2016 by a $4.8 million increase in revenue, offset by a $2.4 million increase in cost of services provided and goods sold. After-tax earnings as a percent of revenue in the first quarter of 2017 were 7.3%, an increase of 0.4% over the first quarter of 2016.

Roto-Rooter’s after-tax earnings were positively impacted in 2017 compared to 2016 primarily by a $5.6 million revenue increase in Roto-Rooter’s water restoration line of business, a $3.1 million increase in plumbing revenue and a $2.0 million increase in all other revenue types. After-tax earnings as a percent of revenue at Roto-Rooter in 2017 were 11.8% as compared to 11.5% in 2016.

The improvement at Corporate is due mainly to the impact of the adoption of ASU 2016-09 which positively impacted the Company’s tax provision by approximately $3.7 million.

-19-

CHEMED CORPORATION AND SUBSIDIARY COMPANIES
CONSOLIDATING STATEMENT OF INCOME
FOR THE THREE MONTHS ENDED MARCH 31, 2017
(in thousands)(unaudited)

										Chemed
	VITAS			Roto-Rooter			Corporate			Consolidated
2017 (a)
Service revenues and sales	$	282,316		$	123,548		$	-		$	405,864
Cost of services provided and goods sold		221,678			63,462			-			285,140
Selling, general and administrative expenses		24,294			33,460			11,704			69,458
Depreciation		4,778			3,984			131			8,893
Amortization		14			32			-			46
Other operating expenses		873			-			-			873
Total costs and expenses		251,637			100,938			11,835			364,410
Income/(loss) from operations		30,679			22,610			(11,835	)		41,454
Interest expense		(55	)		(99	)		(841	)		(995	)
Intercompany interest income/(expense)		2,702			1,310			(4,012	)		-
Other income/(expense)—net		(80	)		(72	)		2,615			2,463
Income/(expense) before income taxes		33,246			23,749			(14,073	)		42,922
Income taxes		(12,649	)		(9,125	)		8,696			(13,078	)
Net income/(loss)	$	20,597		$	14,624		$	(5,377	)	$	29,844

(a) The following amounts are included in net income (in thousands):
										Chemed
	VITAS			Roto-Rooter			Corporate			Consolidated
Pretax benefit/(cost):
Stock option expense	$	-		$	-		$	(3,001	)	$	(3,001	)
Long-term incentive compensation		-			-			(961	)		(961	)
Program closure expenses		(873	)		-			-			(873	)
Expenses related to OIG investigation		(2,150	)		-			-			(2,150	)
Total	$	(3,023	)	$	-		$	(3,962	)	$	(6,985	)

										Chemed
	VITAS			Roto-Rooter			Corporate			Consolidated
After-tax benefit/(cost):
Stock option expense	$	-		$	-		$	(1,897	)	$	(1,897	)
Long-term incentive compensation		-			-			(608	)		(608	)
Excess tax benefits on stock compensation		-			-			3,695			3,695
Program closure expenses		(513	)		-			-			(513	)
Expenses related to OIG investigation		(1,328	)		-			-			(1,328	)
Total	$	(1,841	)	$	-		$	1,190		$	(651	)

-20-

CHEMED CORPORATION AND SUBSIDIARY COMPANIES
CONSOLIDATING STATEMENT OF INCOME
FOR THE THREE MONTHS ENDED MARCH 31, 2016
(in thousands)(unaudited)

										Chemed
	VITAS			Roto-Rooter			Corporate			Consolidated
2016 (a)
Service revenues and sales	$	277,528		$	112,861		$	-		$	390,389
Cost of services provided and goods sold		219,266			59,169			-			278,435
Selling, general and administrative expenses		24,783			29,807			4,455			59,045
Depreciation		4,781			3,501			142			8,424
Amortization		14			78			-			92
Total costs and expenses		248,844			92,555			4,597			345,996
Income/(loss) from operations		28,684			20,306			(4,597	)		44,393
Interest expense		(59	)		(93	)		(690	)		(842	)
Intercompany interest income/(expense)		2,103			948			(3,051	)		-
Other income/(expense)—net		41			23			(2,988	)		(2,924	)
Income/(expense) before income taxes		30,769			21,184			(11,326	)		40,627
Income taxes		(11,682	)		(8,164	)		4,059			(15,787	)
Net income/(loss)	$	19,087		$	13,020		$	(7,267	)	$	24,840

(a) The following amounts are included in net income (in thousands):
										Chemed
	VITAS			Roto-Rooter			Corporate			Consolidated
Pretax benefit/(cost):
Stock option expense	$	-		$	-		$	(2,563	)	$	(2,563	)
Long-term incentive compensation		-			-			241			241
Expenses related to securities litigation		-			-			(3	)		(3	)
Expenses related to OIG investigation		(2,336	)		-			-			(2,336	)
Total	$	(2,336	)	$	-		$	(2,325	)	$	(4,661	)

										Chemed
	VITAS			Roto-Rooter			Corporate			Consolidated
After-tax benefit/(cost):
Stock option expense	$	-		$	-		$	(1,621	)	$	(1,621	)
Long-term incentive compensation		-			-			152			152
Expenses related to securities litigation		-			-			(2	)		(2	)
Expenses related to OIG investigation		(1,443	)		-			-			(1,443	)
Total	$	(1,443	)	$	-		$	(1,471	)	$	(2,914	)

-21-

Unaudited Consolidating Summary and Reconciliation of Adjusted EBITDA

Chemed Corporation and Subsidiary Companies
(in thousands)										Chemed
For the three months ended March 31, 2017	VITAS			Roto-Rooter			Corporate			Consolidated

Net income/(loss)	$	20,597		$	14,624		$	(5,377	)	$	29,844
Add/(deduct):
Interest expense		55			99			841			995
Income taxes		12,649			9,125			(8,696	)		13,078
Depreciation		4,778			3,984			131			8,893
Amortization		14			32			-			46
EBITDA		38,093			27,864			(13,101	)		52,856
Add/(deduct):
Intercompany interest expense/(income)		(2,702	)		(1,310	)		4,012			-
Interest income		(70	)		(15	)		-			(85	)
Program closure expenses		873			-			-			873
Expenses related to OIG investigation		2,150			-			-			2,150
Amortization of stock awards		78			70			188			336
Advertising cost adjustment		-			(274	)		-			(274	)
Stock option expense		-			-			3,001			3,001
Long-term incentive compensation		-			-			961			961
Adjusted EBITDA	$	38,422		$	26,335		$	(4,939	)	$	59,818

										Chemed
For the three months ended March 31, 2016	VITAS			Roto-Rooter			Corporate			Consolidated

Net income/(loss)	$	19,087		$	13,020		$	(7,267	)	$	24,840
Add/(deduct):
Interest expense		59			93			690			842
Income taxes		11,682			8,164			(4,059	)		15,787
Depreciation		4,781			3,501			142			8,424
Amortization		14			78			-			92
EBITDA		35,623			24,856			(10,494	)		49,985
Add/(deduct):
Intercompany interest expense/(income)		(2,103	)		(948	)		3,051			-
Interest income		(79	)		(17	)		(1	)		(97	)
Expenses related to OIG investigation		2,336			-			-			2,336
Amortization of stock awards		131			81			327			539
Expenses related to securities litigation		-			-			3			3
Advertising cost adjustment		-			(608	)		-			(608	)
Stock option expense		-			-			2,563			2,563
Long-term incentive compensation		-			-			(241	)		(241	)
Adjusted EBITDA	$	35,908		$	23,364		$	(4,792	)	$	54,480

-22-

RECONCILIATION OF ADJUSTED NET INCOME
(in thousands, except per share data)(unaudited)

	Three Months Ended March 31,
	2017			2016
Net income as reported	$	29,844		$	24,840

Add/(deduct) after-tax cost of:
Excess tax benefits on stock compensation		(3,695	)		-
Stock option expense		1,897			1,621
Expenses of OIG investigation		1,328			1,443
Long-term incentive compensation		608			(152	)
Program closure expenses		513			-
Expenses related to securities settlements		-			2
Adjusted net income	$	30,495		$	27,754

Diluted Earnings Per Share As Reported
Net income	$	1.78		$	1.45
Average number of shares outstanding		16,801			17,170

Adjusted Diluted Earnings Per Share
Adjusted net income	$	1.82		$	1.62
Adjusted average number of shares outstanding		16,801			17,170

-23-

CHEMED CORPORATION AND SUBSIDIARY COMPANIES
OPERATING STATISTICS FOR VITAS SEGMENT
(unaudited)
	Three Months Ended March 31,
OPERATING STATISTICS	2017			2016
Net revenue ($000)
Homecare	$	225,536		$	214,850
Inpatient		23,923			25,517
Continuous care		32,857			37,161
Total	$	282,316		$	277,528
Net revenue as a percent of total before Medicare cap allowances
Homecare		79.9	%		77.4	%
Inpatient		8.5			9.2
Continuous care		11.6			13.4
Total		100.0	%		100.0	%
Average daily census (days)
Homecare		12,287			11,681
Nursing home		3,052			2,991
Routine homecare		15,339			14,672
Inpatient		378			421
Continuous care		505			560
Total		16,222			15,653
Total Admissions		17,563			16,868
Total Discharges		17,213			16,743
Average length of stay (days)		88.7			83.7
Median length of stay (days)		15.0			15.0
ADC by major diagnosis
Cerebro		19.7	%		22.1	%
Neurological		34.4			31.2
Cancer		15.1			15.3
Cardio		16.6			17.3
Respiratory		7.9			7.9
Other		6.3			6.2
Total		100.0	%		100.0	%
Admissions by major diagnosis
Cerebro		10.9			11.3	%
Neurological		22.1			20.9
Cancer		29.5			30.5
Cardio		15.1			15.5
Respiratory		11.7			10.9
Other		10.7			10.9
Total		100.0	%		100.0	%
Direct patient care margins
Routine homecare		51.3	%		52.1	%
Inpatient		5.9			5.7
Continuous care		15.6			15.1
Homecare margin drivers (dollars per patient day)
Labor costs	$	58.64		$	56.72
Combined drug, HME and medical supplies		15.14			15.46
Inpatient margin drivers (dollars per patient day)
Labor costs	$	369.99		$	338.73
Continuous care margin drivers (dollars per patient day)
Labor costs	$	590.73		$	599.38
Bad debt expense as a percent of revenues		1.2	%		1.3	%
Accounts receivable -- Days of revenue outstanding- excluding unapplied Medicare payments		35.9			38.3
Accounts receivable -- Days of revenue outstanding- including unapplied Medicare payments		24.9			36.8

-24-

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 Regarding Forward-Looking Information

Certain statements contained in this report are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe”, “expect”, “hope”, “anticipate”, “plan” and similar expressions identify forward-looking statements, which speak only as of the date the statement was made. These forward-looking statements are based on current expectations and assumptions and involve various known and unknown risks, uncertainties, contingencies and other factors, which could cause Chemed’s actual results to differ from those expressed in such forward-looking statements. Variances in any or all of the risks, uncertainties, contingencies, and other factors from our assumptions could cause actual results to differ materially from these forward-looking statements and trends. In addition, our ability to deal with the unknown outcomes of these events, many of which are beyond our control, may affect the reliability of projections and other financial matters. Investors are cautioned that such forward-looking statements are subject to inherent risk and there are no assurances that the matters contained in such statements will be achieved. Chemed does not undertake and specifically disclaims any obligation to publicly update or revise any forward-looking statements, whether as a result of a new information, future events or otherwise.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

The Company’s primary market risk exposure relates to interest rate risk exposure through its variable interest line of credit. At March 31, 2017, the Company had $146.9 million of variable rate debt outstanding. For each $10 million dollars borrowed under the credit facility, an increase or decrease of 100 basis points (1% point), increases or decreases the Company’s annual interest expense by $100,000.

The Company continually evaluates this interest rate exposure and periodically weighs the cost versus the benefit of fixing the variable interest rates through a variety of hedging techniques.

Item 4. Controls and Procedures

We carried out an evaluation, under the supervision of our President and Chief Executive Officer and with the participation of the Executive Vice President and Chief Financial Officer and the Vice President and Controller, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on that evaluation, the President and Chief Executive Officer, Executive Vice President and Chief Financial Officer and Vice President and Controller have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report. There has been no change in our internal control over financial reporting that occurred during the quarter covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

For information regarding the Company’s legal proceedings, see note 10, Legal and Regulatory Matters, under Part I, Item I of this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors

There have been no material changes from the risk factors previously disclosed in the Company’s most recent Annual Report on Form 10-K.

-25-

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Item 2(c). Purchases of Equity Securities by Issuer and Affiliated Purchasers

The following table shows the activity related to our share repurchase program for the first three months of 2017:

	Total Number		Weighted Average		Cumulative Shares		Dollar Amount
	of Shares		Price Paid Per		Repurchased Under		Remaining Under
	Repurchased		Share		the Program		The Program

February 2011 Program
January 1 through January 31, 2017		-	$	-		7,315,718	$	50,173,009
February 1 through February 28, 2017		104,358		178.39		7,420,076		31,556,555
March 1 through March 31, 2017		195,642		182.20		7,615,718	$	95,910,768

First Quarter Total		300,000	$	180.87

On March 13, 2017 our Board of Directors authorized an additional $100 million under the February 2011 Repurchase Program.

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

None

Item 5. Other Information

-26-

Item 6. Exhibits

Exhibit No.		Description

31.1		Certification by Kevin J. McNamara pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act of 1934.

31.2		Certification by David P. Williams pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act of 1934.

31.3		Certification by Arthur V. Tucker, Jr. pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act of 1934.

32.1		Certification by Kevin J. McNamara pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification by David P. Williams pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.3		Certification by Arthur V. Tucker, Jr. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema

101.CAL		XBRL Taxonomy Extension Calculation Linkbase

101.DEF		XBRL Taxonomy Extension Definition Linkbase

101.LAB		XBRL Taxonomy Extension Label Linkbase

101.PRE		XBRL Taxonomy Extension Presentation Linkbase

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			Chemed Corporation
			(Registrant)


Dated:	April 28, 2017	By:	/s/ Kevin J. McNamara
			Kevin J. McNamara
			(President and Chief Executive Officer)


Dated:	April 28, 2017	By:	/s/ David P. Williams
			David P. Williams
			(Executive Vice President and Chief Financial Officer)


Dated:	April 28, 2017	By:	/s/ Michael D. Witzeman
			Michael D. Witzeman
			(Vice President and Controller)

-27-

EX-31.1 2 a51546341ex31_1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULES 13a-14(a)/15d-14(a) OF THE EXCHANGE ACT OF 1934

I, Kevin J. McNamara, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Chemed Corporation (“registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors or persons performing the equivalent function:

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	April 28, 2017	/s/ Kevin J. McNamara
		Kevin J. McNamara
		(President and Chief
		Executive Officer)

E-1

EX-31.2 3 a51546341ex31_2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULES 13a-14(a)/15d-14(a) OF THE EXCHANGE ACT OF 1934

I, David P. Williams, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Chemed Corporation (“registrant”);

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	April 28, 2017	/s/ David P. Williams
		David P. Williams
		(Executive Vice President
		and Chief Financial Officer)

E-2

EX-31.3 4 a51546341ex31_3.htm EXHIBIT 31.3

EXHIBIT 31.3

CERTIFICATION PURSUANT TO RULES 13a-14(a)/15d-14(a) OF THE EXCHANGE ACT OF 1934

I, Arthur V. Tucker, Jr., certify that:

1. I have reviewed this quarterly report on Form 10-Q of Chemed Corporation (“registrant”);

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	April 28, 2017	/s/ Michael D. Witzeman
		Michael D. Witzeman
		(Vice President and
		Controller)

E-3

EX-32.1 5 a51546341ex32_1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION BY KEVIN J. MCNAMARA

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as President and Chief Executive Officer of Chemed Corporation (“Company”), does hereby certify that:

the Company’s Quarterly Report on Form 10-Q for the quarter ending March 31, 2017 (“Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	April 28, 2017	/s/ Kevin J. McNamara
		Kevin J. McNamara
		(President and Chief
		Executive Officer)

E-4

EX-32.2 6 a51543641ex32_2.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION BY DAVID P. WILLIAMS

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Executive Vice President and Chief Financial Officer of Chemed Corporation (“Company”), does hereby certify that:

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	April 28, 2017	/s/ David P. Williams
		David P. Williams
		(Executive Vice President
		and Chief Financial Officer)

E-5

EX-32.3 7 a51543641ex32_3.htm EXHIBIT 32.3

EXHIBIT 32.3

CERTIFICATION BY ARTHUR V. TUCKER, JR.

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Vice President and Controller of Chemed Corporation (“Company”), does hereby certify that:

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:	April 28, 2017	/s/ Michael D. Witzeman
		Michael D. Witzeman
		(Vice President and
		Controller)

E-6

EX-101.INS 8 che-20170331.xml XBRL INSTANCE DOCUMENT 0000019584 che:PerformanceBasedTotalShareholderReturnTargetsMember 2017-02-17 2017-02-17 0000019584 che:PerformanceBasedEarningsPerShareTargetsMember 2017-02-17 2017-02-17 0000019584 che:PerformanceBasedTotalShareholderReturnTargetsMember 2017-01-01 2017-03-31 0000019584 che:PerformanceBasedEarningsPerShareTargetsMember 2017-01-01 2017-03-31 0000019584 us-gaap:OperatingSegmentsMember che:SegmentVitasMember 2017-01-01 2017-03-31 0000019584 us-gaap:OperatingSegmentsMember che:SegmentRotoRooterMember 2017-01-01 2017-03-31 0000019584 us-gaap:OperatingSegmentsMember 2017-01-01 2017-03-31 0000019584 us-gaap:CorporateMember 2017-01-01 2017-03-31 0000019584 us-gaap:OperatingSegmentsMember che:SegmentVitasMember 2016-01-01 2016-03-31 0000019584 us-gaap:OperatingSegmentsMember che:SegmentRotoRooterMember 2016-01-01 2016-03-31 0000019584 us-gaap:OperatingSegmentsMember 2016-01-01 2016-03-31 0000019584 us-gaap:CorporateMember 2016-01-01 2016-03-31 0000019584 us-gaap:MediumTermNotesMember 2017-03-31 0000019584 che:USVVitasMember 2017-01-01 2017-03-31 0000019584 che:USVVitasMember 2016-01-01 2016-03-31 0000019584 us-gaap:RevolvingCreditFacilityMember 2017-03-31 0000019584 che:TwoThousandFourteenCreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2017-03-31 0000019584 che:TwoThousandFourteenCreditAgreementMember us-gaap:MediumTermNotesMember 2017-03-31 0000019584 che:TwoThousandFourteenCreditAgreementMember 2017-01-01 2017-03-31 0000019584 us-gaap:FairValueInputsLevel1Member 2017-03-31 0000019584 us-gaap:FairValueInputsLevel1Member 2016-12-31 0000019584 che:RotoRooterMember 2017-01-01 2017-03-31 0000019584 che:SegmentVitasMember 2017-03-31 0000019584 che:SegmentVitasMember 2016-12-31 0000019584 che:RotoRooterMember 2016-12-31 0000019584 che:PerformanceBasedTotalShareholderReturnTargetsMember 2017-02-17 0000019584 che:PerformanceBasedEarningsPerShareTargetsMember 2017-02-17 0000019584 che:AccountingStandardsUpdate201609Member 2016-01-01 2016-03-31 0000019584 che:AccountingStandardsUpdate201609Member 2017-01-01 2017-03-31 0000019584 us-gaap:FairValueInputsLevel3Member 2017-03-31 0000019584 us-gaap:FairValueInputsLevel2Member 2017-03-31 0000019584 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-03-31 0000019584 us-gaap:FairValueInputsLevel3Member 2016-12-31 0000019584 us-gaap:FairValueInputsLevel2Member 2016-12-31 0000019584 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-12-31 0000019584 che:TwoThousandFourteenCreditAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-01-01 2017-03-31 0000019584 us-gaap:SalesRevenueNetMember che:SegmentVitasMember 2017-01-01 2017-03-31 0000019584 us-gaap:SalesRevenueNetMember che:SegmentVitasMember 2016-01-01 2016-03-31 0000019584 2013-01-01 2013-12-31 0000019584 che:SegmentVitasMember 2016-01-01 2016-03-31 0000019584 che:SegmentVitasMember 2017-01-01 2017-03-31 0000019584 2016-03-31 0000019584 2015-12-31 0000019584 che:RotoRooterMember 2017-03-31 0000019584 us-gaap:MinimumMember 2017-01-01 2017-03-31 0000019584 us-gaap:MaximumMember 2017-01-01 2017-03-31 0000019584 2017-03-31 0000019584 2016-12-31 0000019584 2017-01-01 2017-03-31 0000019584 2016-01-01 2016-03-31 0000019584 che:TwoProgramProjectedMeasurmentPeriodLiabilityMember 2015-01-01 2015-12-31 0000019584 che:TwoProgramProjectedMeasurmentPeriodLiabilityMember 2014-01-01 2014-12-31 0000019584 che:TwoProgramProjectedMeasurmentPeriodLiabilityMember 2013-01-01 2013-12-31 iso4217:USD xbrli:shares xbrli:shares che:item xbrli:pure iso4217:USD 2100000 2100000 2100000 539000 336000 50000000 8600000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Description </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Requirement </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Leverage Ratio (Consolidated Indebtedness/Consolidated  Adj. EBITDA) </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <  3.50 to 1.00 </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Fixed Charge Coverage Ratio (Consolidated Free Cash Flow/Consolidated Fixed Charges) </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> >  1.50 to 1.00 </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Annual Operating Lease Commitment </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <  $50.0 million </td> </tr> </table></div> </div> </div> 2513000 2162000 P14D P30D 1.50 1.00 0 0 69 0.07 0.00 3.50 1.00 P6M -2987000 2615000 1165000 547000 235000 235000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:04.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> March 31, </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:04.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Beginning balance January 1, </td> <td valign="bottom" style="width:04.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">235  </td> <td valign="bottom" style="width:04.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,165  </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Payments </td> <td valign="bottom" style="width:04.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:04.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(618) </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Ending balance March 31, </td> <td valign="bottom" style="width:04.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">235  </td> <td valign="bottom" style="width:04.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">547  </td> </tr> </table></div> </div> </div> -305000 827000 1700000 1500000 3 2 1 618000 0.0200 P60D P30D 6155000 6689000 P4Y 8900000 8900000 <div> <div style="margin-left:0pt;margin-right:0pt;"> 2.   Revenue Recognition Both the VITAS segment and the Roto-Rooter segment recognize service revenues and sales when the earnings process has been completed.  Generally, this occurs when services are provided or products are shipped.  VITAS recognizes revenue at the estimated realizable amount due from third-party payers.  Medicare payments are subject to certain limitations, as described below. We actively monitor each of our hospice programs, by provider number, as to their specific admission, discharge rate and median length of stay data in an attempt to determine whether they are likely to exceed the annual per-beneficiary Medicare cap (“Medicare cap”).  Should we determine that revenues for a program are likely to exceed the Medicare cap based on projected trends, we attempt to institute corrective action to influence the patient mix or to increase patient admissions.  However, should we project our corrective action will not prevent that program from exceeding its Medicare cap, we estimate the amount of revenue recognized during the period that will require repayment to the Federal government under the Medicare cap and record the amount as a reduction to patient revenue.  In 2013, the U.S. government implemented automatic budget reductions of 2.0% for all government payees, including hospice benefits paid under the Medicare program.  In 2015, CMS determined that the Medicare cap should be calculated “as if” sequestration did not occur.  As a result of this decision, VITAS has received notification from our third party intermediary that an additional $2.1 million is owed for Medicare cap in three programs arising during the 2013, 2014 and 2015 measurement periods.  The amounts were automatically deducted from our semi-monthly PIP payments.  We do not believe that CMS is authorized under the sequestration authority or the statutory methodology for establishing the Medicare cap to demand the $2.1 million under their “as if” methodology.  We have not recorded a reserve as of March 31, 2017 for $1.9 million of the potential exposure.  We have appealed CMS’s methodology change with the appropriate regulatory appeal board. During the three months ended March 31, 2017 and 2016,  respectively, no Medicare cap was recorded. Shown below is the Medicare cap liability activity for the fiscal periods ended (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:04.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> March 31, </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:04.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Beginning balance January 1, </td> <td valign="bottom" style="width:04.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">235  </td> <td valign="bottom" style="width:04.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,165  </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Payments </td> <td valign="bottom" style="width:04.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:04.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(618) </td> </tr> <tr> <td valign="bottom" style="width:57.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Ending balance March 31, </td> <td valign="bottom" style="width:04.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">235  </td> <td valign="bottom" style="width:04.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">547  </td> </tr> </table></div> Vitas provides charity care, in certain circumstances, to patients without charge when management of the hospice program determines, at the time services are performed, that the patient cannot afford payment.  There is no revenue or associated accounts receivable in the accompanying consolidated financial statements related to charity care.  The cost of charity care is calculated by taking the ratio of charity care days to total days of care and multiplying by total cost of care.  The cost of charity care is as follows (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="top" style="width:36.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:36.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> </tr> <tr> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Three months ended March 31, </td> </tr> <tr> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:08.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:36.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> </tr> <tr> <td valign="bottom" style="width:08.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:36.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,937  </td> <td valign="top" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:36.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,806  </td> </tr> </table></div> </div> </div> 9858000 11025000 <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="top" style="width:36.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:36.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> </tr> <tr> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Three months ended March 31, </td> </tr> <tr> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:08.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:36.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> </tr> <tr> <td valign="bottom" style="width:08.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:36.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,937  </td> <td valign="top" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:36.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1,806  </td> </tr> </table></div> </div> </div> <div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.25pt;padding:0pt;"> </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.25pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.25pt;padding:0pt;"> Three months ended March 31, </td> </tr> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:05.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> </tr> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Revenues </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:27.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">11,025  </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:27.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">9,858  </td> </tr> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Pretax profits </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,689  </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,155  </td> </tr> </table></div> </div> </div> P5Y4M24D P2M15D false --12-31 Q1 2017 2017-03-31 10-Q 0000019584 16082181 Large Accelerated Filer CHEMED CORP CHE

39586000

29341000

132021000

109726000

12614000

47960000

54150000

211290000

216423000

639703000

651269000

92000

46000

14236000

15908000

130000

129000

421000

402000

880059000

886231000

169900000

175973000

14727000

15235000

15310000

47049000

508000

31739000

72000

30000

1806000

1937000

0.24

0.26

80000000

34270104

34404220

34270000

34404000

<div> <div style="margin-left:0pt;margin-right:0pt;"> 12.   Concentration of Risk During the quarter VITAS had pharmacy services agreements with one service provider to provide specified pharmacy services for VITAS and its hospice patients.  VITAS made purchases from this provider of $8.9 million for the first quarter of 2017.  Vitas made purchases from two providers of $8.9 million for the first quarter of 2016.     Purchases from these providers were approximately 90% of all pharmacy services used by VITAS during each quarter presented. </div> </div>

0.90

278435000

285140000

345996000

364410000

0.0113

108750000

146875000

54288000

56024000

54389000

56596000

-4202000

-2415000

14291000

11875000

526000

6157000

8424000

8893000

8516000

8939000

1.49

1.84

0.23

1.45

1.78

0.22

<div> <div style="margin-left:0pt;margin-right:0pt;"> 4.  Earnings per Share Earnings per share (“EPS”) are computed using the weighted average number of shares of capital stock outstanding.  Earnings and diluted earnings per share are computed as follows (in thousands, except per share data): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="6" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Net Income </td> </tr> <tr> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> For the Three Months Ended March 31, </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> Income </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> Shares </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> Earnings per Share </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:47.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Earnings </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">29,844  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,219  </td> <td valign="top" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.84  </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Dilutive stock options </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">490  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Nonvested stock awards </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">92  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Diluted earnings </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">29,844  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,801  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.78  </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Earnings </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">24,840  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,720  </td> <td valign="top" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.49  </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Dilutive stock options </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">305  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Nonvested stock awards </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">145  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Diluted earnings </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">24,840  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,170  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.45  </td> </tr> </table></div>   For the three month periods ended March 31, 2017 and 2016, respectively, 402,000 and 421,000 stock options were excluded from the computation of diluted earnings per share because they would have been anti-dilutive.  </div> </div>

0.3890

0.3050

53979000

37382000

1300000

1700000

900000

<div> <div style="margin-left:0pt;margin-right:0pt;"> The following shows the carrying value, fair value and the hierarchy for our financial instruments as of           March 31, 2017 (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="7" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Fair Value Measure </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;"> Carrying Value </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;"> Quoted Prices in Active Markets for Identical Assets (Level 1) </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Mutual fund investments of deferred </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> compensation plans held in trust </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">56,596  </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">56,596  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Long-term debt </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">146,875  </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">146,875  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> </tr> </table></div> The following shows the carrying value, fair value and the hierarchy for our financial instruments as of            December 31, 2016 (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="7" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Fair Value Measure </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;"> Carrying Value </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;"> Quoted Prices in Active Markets for Identical Assets (Level 1) </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Mutual fund investments of deferred </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> compensation plans held in trust </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">54,389  </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">54,389  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Long-term debt </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">108,750  </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">108,750  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> </tr> </table></div> </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> 14.   Financial Instruments FASB’s authoritative guidance on fair value measurements defines a hierarchy which prioritizes the inputs in fair value measurements.  Level 1 measurements are measurements using quoted prices in active markets for identical assets or liabilities.  Level 2 measurements use significant other observable inputs.  Level 3 measurements are measurements using significant unobservable inputs which require a company to develop its own assumptions.  In recording the fair value of assets and liabilities, companies must use the most reliable measurement available.  For cash and cash equivalents, accounts receivable and accounts payable, the carrying amount is a reasonable estimate of fair value because of the liquidity and short-term nature of these instruments.  The following shows the carrying value, fair value and the hierarchy for our financial instruments as of           March 31, 2017 (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="7" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Fair Value Measure </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;"> Carrying Value </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;"> Quoted Prices in Active Markets for Identical Assets (Level 1) </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:53.25pt;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Mutual fund investments of deferred </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> compensation plans held in trust </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">56,596  </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">56,596  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Long-term debt </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">146,875  </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">146,875  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> </tr> </table></div> The following shows the carrying value, fair value and the hierarchy for our financial instruments as of            December 31, 2016 (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="7" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Fair Value Measure </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;"> Carrying Value </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;"> Quoted Prices in Active Markets for Identical Assets (Level 1) </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;"> Significant Other Observable Inputs (Level 2) </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:48.00pt;padding:0pt;"> Significant Unobservable Inputs (Level 3) </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Mutual fund investments of deferred </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> compensation plans held in trust </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">54,389  </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">54,389  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> </tr> <tr> <td valign="bottom" style="width:28.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Long-term debt </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">108,750  </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:9pt;text-align:right;" nowrap="nowrap">108,750  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> </tr> </table></div> For cash and cash equivalents, accounts receivable and accounts payable, the carrying amount is a reasonable estimate of fair value because of the liquidity and short-term nature of these instruments.  As further described in Footnote 5, our outstanding long-term debt and current portion of long-term debt have floating interest rates that are reset at short-term intervals, generally 30 or 60 days.  The interest rate we pay also includes an additional amount based on our current leverage ratio.  As such, we believe our borrowings reflect significant nonperformance risks, mainly credit risk.  Based on these factors, we believe the fair value of our long-term debt and current portion of long-term debt approximate the carrying value. </div> </div>

33225000

32794000

-33000

-236000

472366000

144065000

328301000

472391000

144090000

328301000

<div> <div style="margin-left:0pt;margin-right:0pt;"> 17.   Goodwill Shown below is movement in Goodwill (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:38.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:38.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Vitas </td> <td valign="bottom" style="width:03.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Roto-Rooter </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Total </td> </tr> <tr> <td valign="bottom" style="width:38.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Balance at December 31, 2016 </td> <td valign="bottom" style="width:02.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">328,301  </td> <td valign="bottom" style="width:03.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">144,065  </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">472,366  </td> </tr> <tr> <td valign="bottom" style="width:38.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Foreign currency adjustments </td> <td valign="bottom" style="width:02.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:03.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">25  </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">25  </td> </tr> <tr> <td valign="bottom" style="width:38.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Balance at March 31, 2017 </td> <td valign="bottom" style="width:02.92%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">328,301  </td> <td valign="bottom" style="width:03.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">144,090  </td> <td valign="bottom" style="width:03.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:04.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.38%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">472,391  </td> </tr> </table></div> </div> </div>

25000

40627000

42922000

15787000

13078000

3700000

-7567000

-10766000

41050000

-17972000

19448000

14655000

-212000

-322000

-410000

2140000

-140000

1992000

7061000

-8607000

-546000

-1003000

145000

92000

305000

490000

55065000

54976000

842000

995000

5755000

5433000

97000

85000

54389000

56596000

<div> <div style="margin-left:0pt;margin-right:0pt;"> 11.  Legal and Regulatory Matters The VITAS segment of the Company’s business operates in a heavily-regulated industry.  As a result, the Company is subjected to inquiries and investigations by various government agencies, as well as to lawsuits, including qui tam actions.  The following sections describe the various ongoing material lawsuits and investigations of which the Company is currently aware.  It is not possible at this time for us to estimate either the timing or outcome of any of those matters, or whether any potential loss, or range of potential losses, is probable or reasonably estimable. Regulatory Matters and Litigation On May 2, 2013, the government filed a False Claims Act complaint against the Company and certain of its hospice-related subsidiaries in the U.S. District Court for the Western District of Missouri, United States v. VITAS Hospice Services, LLC, et al., No. 4:13-cv-00449-BCW (the “2013 Action”).  Prior to that date, the Company received various qui tam lawsuits and subpoenas from the U.S. Department of Justice and OIG that have been previously disclosed.  The 2013 Action alleges that, since at least 2002, VITAS, and since 2004, the Company, submitted or caused the submission of false claims to the Medicare program by (a) billing Medicare for continuous home care services when the patients were not eligible, the services were not provided, or the medical care was inappropriate, and (b) billing Medicare for patients who were not eligible for the Medicare hospice benefit because they did not have a life expectancy of six months or less if their illnesses ran their normal course.  This complaint seeks treble damages, statutory penalties, and the costs of the action, plus interest.  The defendants filed a motion to dismiss on September 24, 2013.  On September 30, 2014, the Court denied the motion, except to the extent that claims were filed before July 24, 2002. On November 13, 2014, the government filed a Second Amended Complaint.  The Second Amended Complaint changed and supplemented some of the allegations, but did not otherwise expand the causes of action or the nature of the relief sought against VITAS.  VITAS filed its Answer to the Second Amended Complaint on August 11, 2015.  This case is in the discovery phase. The Company is not able to reasonably estimate the probability of loss or range of loss at this time.  For additional procedural history of this litigation, please refer to our prior quarterly and annual filings.  The net costs incurred related to U.S. v. Vitas and related regulatory matters were $2.2 million and $2.3 million for March 31, 2017 and 2016, respectively. The Company and certain current and former directors and officers are defendants in a case captioned In re Chemed Corp. Shareholder and Derivative Litigation, No. 13 Civ. 1854 (LPS) (CJB) (D. Del.), which was consolidated on February 2, 2015 and is covered by the Company’s commercial insurance. On February 2, 2015, the Court appointed KBC Asset Management NV the sole lead plaintiff and its counsel, the sole lead and liaison counsel. On March 3, 2015, Lead Plaintiff KBC designated its Complaint as the operative complaint in the consolidated proceedings and defendants renewed a previously filed motion to dismiss those claims and allegations.  The consolidated Complaint named fourteen individual defendants, together with the Company as nominal defendant.  The Complaint alleges a claim for breach of fiduciary duty against the individual defendants for allegedly permitting the Company to submit false claims to the U.S. government.  The Complaint seeks (a) a declaration that the individual defendants breached their fiduciary duties to the Company; (b) an order requiring those defendants to pay compensatory damages, restitution and exemplary damages, in unspecified amounts, to the Company; (c) an order directing the Company to implement new policies and procedures; and (d) costs and disbursements incurred in bringing the action, including attorneys’ fees.  On May 12, 2016, the court issued a Memorandum Order granting Chemed’s motion to dismiss, and  dismissing Lead Plaintiff KBC’s Complaint without prejudice to KBC’s opportunity to file within 30 days of the date of the court’s Order (June 13, 2016) an amended Complaint addressing the deficiencies in its duty of loyalty claim.  Lead Plaintiff KBC did not file an amended Complaint within the time specified by the court. However, on June 13, 2016, counsel for Chemed shareholder Michael Kvint filed a letter with the court requesting a two-week extension to file a motion to substitute Mr. Kvint as Lead Plaintiff, in place of Lead Plaintiff KBC and to file an amended Complaint.  Alternatively, counsel for Mr. Kvint requested that any dismissal of the action be with prejudice to KBC only.  On June 14, 2016, Chemed filed a reply letter with the court, reserving its rights to oppose any motion filed by Mr. Kvint and, if warranted, to oppose any other actions taken by Mr. Kvint to proceed with the action (including by filing an untimely amended Complaint).  On June 21, 2016, the court entered an Oral Order providing Mr. Kvint until June 30, 2016 to file a Motion to Substitute and Motion for Leave to File an Amended Complaint.  On that date, Mr. Kvint filed, under seal, a Motion to Substitute Plaintiff and File Amended Complaint, and attached a Proposed Amended Complaint.    Mr. Kvint’s motion was fully briefed by the parties.  The Court heard oral argument on Mr. Kvint’s motion on January 24, 2017.  On January 25, 2017, Magistrate Judge Burke entered an Order requesting additional letter briefing on issues arising from Mr. Kvint’s motion.  Pursuant to that Order, the parties have each submitted opening and reply letter briefing.  Magistrate Judge Burke has not yet issued a recommendation or report on Mr. Kvint’s motion.  For additional procedural history of this litigation, please refer to our prior quarterly and annual filings. Jordan Seper, (“Seper”) a Registered Nurse at VITAS' Inland Empire program from May 12, 2014 to March 21, 2015, filed a lawsuit in San Francisco Superior Court on September 26, 2016.  She alleged VITAS Healthcare Corp of CA (“VITAS CA”) (1) failed to provide minimum wage for all hours worked; (2) failed to provide overtime for all hours worked; (3) failed to provide a second meal period; (4) failed to provide rest breaks; (5) failed to indemnify for necessary expenditures; (6) failed to timely pay wages due at time of separation; and (7) engaged in unfair business practices.  Seper seeks a state-wide class action of current and former non-exempt employees employed with VITAS in California within the four years preceding the filing of the lawsuit.  She seeks court determination that this action may be maintained as a class action for the entire California class and subclasses, designation as class representative, declaratory relief, injunctive relief, damages (including wages for regular or overtime hours allegedly worked but not paid, premium payments for missed meal or rest periods, and unreimbursed expenses), all applicable penalties associated with each claim, pre and post-judgment interest, and attorneys' fees and costs.  Seper served VITAS CA with the lawsuit,  Jordan A. Seper on behalf of herself and others similarly situated v. VITAS Healthcare Corporation of California, a Delaware corporation; VITAS Healthcare Corp of CA, a business entity unknown; and DOES 1 to 100, inclusive; Los Angeles Superior Court Case Number BC 642857 on October 13, 2016. On November 14, 2016, the Parties filed a Stipulation to transfer the venue of the lawsuit from San Francisco to Los Angeles.  The Los Angeles Superior Court accepted transfer of the case on December 6, 2016.  On December 16, 2016, VITAS CA filed its Answer and served written discovery on Seper. Jiwan Chhina ("Chhina"), hired by VITAS as a Home Health Aide on February 5, 2002, is currently a Licensed Vocational Nurse for VITAS' San Diego program.  On September 27, 2016, Chhina filed a lawsuit in San Diego Superior Court, alleging (1) failure to pay minimum wage for all hours worked; (2) failure to provide overtime for all hours worked; (3) failure to pay wages for all hours at the regular rate; (4) failure to provide meal periods; (5) failure to provide rest breaks; (6) failure to provide complete and accurate wage statements; (7) failure to pay for all reimbursement expenses; (8) unfair business practices; and (9) violation of the California Private Attorneys General Act.  Chhina seeks to pursue these claims in the form of a state-wide class action of current and former non-exempt employees employed with VITAS in California within the four years preceding the filing of the lawsuit.  He seeks court determination that this action may be maintained as a class action for the entire California class and subclasses, designation as class representative, declaratory relief, injunctive relief, damages (including wages for regular or overtime hours allegedly worked but not paid, premium payments for missed meal or rest periods, and unreimbursed expenses), all applicable penalties associated with each claim, pre-judgment interest, and attorneys' fees and costs.  Chhina served VITAS CA with the lawsuit, Jiwann Chhina v. VITAS Health Services of California, Inc., a California corporation; VITAS Healthcare Corporation of California, a Delaware corporation; VITAS Healthcare Corporation of California, a Delaware corporation dba VITAS Healthcare, Inc.; and DOES 1 to 100, inclusive; San Diego Superior Court Case Number 37-2015-00033978-CU-OE-CTL on November 3, 2016.  On December 1, 2016, VITAS filed its Answer and served written discovery on Chhina.  The Company is not able to reasonably estimate the probability of loss or range of loss for either of these lawsuits at this time. The Company intends to defend vigorously against the allegations in each of the above lawsuits.  Regardless of the outcome of any of the preceding matters, responding to the subpoenas and dealing with the various regulatory agencies and opposing parties can adversely affect us through defense costs, potential payments, diversion of management time, and related publicity.  Although the Company intends to defend them vigorously, there can be no assurance that those suits will not have a material adverse effect on the Company. </div> </div>

38700000

355960000

385587000

880059000

886231000

171832000

164383000

P5Y

100000000

350000000

246300000

1805000

2471000

2300000

2200000

<div> <div style="margin-left:0pt;margin-right:0pt;"> 9.   Independent Contractor Operations The Roto-Rooter segment sublicenses with 69 independent contractors to operate certain plumbing repair, excavation, water restoration and drain cleaning businesses in lesser-populated areas of the United States and Canada.  We had notes receivable from our independent contractors as of March 31, 2017 totaling $1.5 million (December 31, 2016 - $1.7 million).  In most cases these loans are fully or partially secured by equipment owned by the contractor.  The interest rates on the loans range from 0% to 7% per annum and the remaining terms of the loans range from 2.5 months to 5.4 years at March 31, 2017.  We recorded the following from our independent contractors (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.25pt;padding:0pt;"> </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.25pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:14.25pt;padding:0pt;"> Three months ended March 31, </td> </tr> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:05.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> </tr> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Revenues </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.40%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:27.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">11,025  </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:27.30%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">9,858  </td> </tr> <tr> <td valign="bottom" style="width:24.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Pretax profits </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,689  </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:05.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:27.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,155  </td> </tr> </table></div> </div> </div>

146875000

81875000

65000000

8750000

9375000

65000000

10000000

6875000

100000000

137500000

<div> <div style="margin-left:0pt;margin-right:0pt;"> 5.   Long-Term Debt On June 30, 2014, we replaced our existing credit agreement with the Third Amended and Restated Credit Agreement (“2014 Credit Agreement”).  Terms of the 2014 Credit Agreement consist of a five-year, $350 million revolving credit facility and a $100 million term loan.  The 2014 Credit Agreement has a floating interest rate that is generally LIBOR plus a tiered additional rate which varies based on our current leverage ratio.  The interest rate is LIBOR plus 113 basis points as of March 31, 2017.  The debt outstanding as of March 31, 2017 consists of the following: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:53.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:38.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:53.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:38.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:53.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Revolver </td> <td valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:38.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">65,000  </td> </tr> <tr> <td valign="bottom" style="width:53.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Term loan </td> <td valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:38.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">81,875  </td> </tr> <tr> <td valign="bottom" style="width:53.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Total </td> <td valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:38.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">146,875  </td> </tr> <tr> <td valign="bottom" style="width:53.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Current portion of long-term debt </td> <td valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:38.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(9,375) </td> </tr> <tr> <td valign="bottom" style="width:53.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Long-term debt </td> <td valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:38.26%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">137,500  </td> </tr> </table></div> Scheduled principal payments of the term loan are as follows: <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:53.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:08.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:37.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:53.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:08.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:37.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">6,875  </td> </tr> <tr> <td valign="bottom" style="width:53.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:08.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:37.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">10,000  </td> </tr> <tr> <td valign="bottom" style="width:53.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:08.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:37.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">65,000  </td> </tr> <tr> <td valign="bottom" style="width:53.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:08.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:37.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">81,875  </td> </tr> </table></div> The 2014 Credit Agreement contains the following quarterly financial covenants:  <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Description </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Requirement </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Leverage Ratio (Consolidated Indebtedness/Consolidated  Adj. EBITDA) </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <  3.50 to 1.00 </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Fixed Charge Coverage Ratio (Consolidated Free Cash Flow/Consolidated Fixed Charges) </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> >  1.50 to 1.00 </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:82.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Annual Operating Lease Commitment </td> <td valign="bottom" style="width:02.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:15.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> <  $50.0 million </td> </tr> </table></div> We are in compliance with all debt covenants as of March 31, 2017. We have issued $38.7 million in standby letters of credit as of March 31, 2017 mainly for insurance purposes.  Issued letters of credit reduce our available credit under the 2014 Credit Agreement.  As of March 31, 2017, we have approximately $246.3 million of unused lines of credit available and eligible to be drawn down under our revolving credit facility. </div> </div>

4605000

-27957000

-11320000

-9090000

7223000

68786000

24840000

-7267000

32107000

13020000

19087000

29844000

-5377000

35221000

14624000

20597000

24840000

29844000

-2924000

2463000

44393000

41454000

7037000

6901000

873000

<div> <div style="margin-left:0pt;margin-right:0pt;"> 7.   Other Income/(Expense) – Net Other income/(expense) -- net comprises the following (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:54.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:18.75pt;padding:0pt;"> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:18.75pt;padding:0pt;"> Three months ended March 31, </td> </tr> <tr> <td valign="bottom" style="width:54.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:02.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> </tr> <tr> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Market value adjustment on assets held in </td> <td valign="bottom" style="width:18.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:54.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> deferred compensation trust </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,615  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,987) </td> </tr> <tr> <td valign="bottom" style="width:54.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Loss on disposal of property and equipment </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(236) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(33) </td> </tr> <tr> <td valign="bottom" style="width:54.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Interest income </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">85  </td> <td valign="top" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">97  </td> </tr> <tr> <td valign="bottom" style="width:54.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Other - net </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1) </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:18.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(1) </td> </tr> <tr> <td valign="bottom" style="width:54.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">     Total other income/(expense) - net </td> <td valign="bottom" style="width:02.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:18.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">2,463  </td> <td valign="bottom" style="width:02.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:18.62%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(2,924) </td> </tr> </table></div> </div> </div>

19752000

19050000

15549000

15805000

-1000

-59000

838000

-153000

70000

52460000

54262000

4020000

4744000

4081000

4251000

11473000

9020000

13105000

12102000

3709000

1663000

59000000

116000000

693000

147000

2887000

5635000

121302000

119394000

4242000

4249000

3500000

76000000

1875000

958149000

983742000

390389000

112861000

277528000

405864000

123548000

282316000

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="6" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Net Income </td> </tr> <tr> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> For the Three Months Ended March 31, </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> Income </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> Shares </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:27.00pt;padding:0pt;"> Earnings per Share </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:47.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Earnings </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">29,844  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,219  </td> <td valign="top" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.84  </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Dilutive stock options </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">490  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Nonvested stock awards </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">92  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> Diluted earnings </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">29,844  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,801  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:15.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.78  </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Earnings </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">24,840  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">16,720  </td> <td valign="top" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.49  </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Dilutive stock options </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">305  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Nonvested stock awards </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">  - </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">145  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:16.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:47.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Diluted earnings </td> <td valign="bottom" style="width:01.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">24,840  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:08.60%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">17,170  </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">1.45  </td> </tr> </table></div>   </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Three months ended March 31, </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Service Revenues and Sales     </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="top" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">      </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> VITAS </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">282,316  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">277,528  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Roto-Rooter </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">123,548  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">112,861  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Total </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">405,864  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">390,389  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="top" style="width:04.66%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> After-tax Earnings </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> VITAS </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,597  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">19,087  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Roto-Rooter </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">14,624  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">13,020  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Total </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">35,221  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">32,107  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Corporate  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,377) </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(7,267) </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Net income </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">29,844  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">24,840  </td> </tr> </table></div> </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;"> 3.   Segments Service revenues and sales and after-tax earnings by business segment are as follows (in thousands): <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Three months ended March 31, </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Service Revenues and Sales     </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="top" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">      </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> VITAS </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">282,316  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">277,528  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Roto-Rooter </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">123,548  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">112,861  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Total </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">405,864  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">390,389  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="top" style="width:04.66%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> After-tax Earnings </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> VITAS </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">20,597  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">19,087  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Roto-Rooter </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">14,624  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">13,020  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Total </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">35,221  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">32,107  </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Corporate  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.10%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(5,377) </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:21.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">(7,267) </td> </tr> <tr> <td valign="top" style="width:43.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Net income </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.10%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">29,844  </td> <td valign="top" style="width:04.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="top" style="width:04.66%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="top" style="width:21.08%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">24,840  </td> </tr> </table></div> We report corporate administrative expenses and unallocated investing and financing income and expense not directly related to either segment as “Corporate”.  </div> </div>

59045000

69458000

P3Y

7304

524099000

500644000

<div> <div style="margin-left:0pt;margin-right:0pt;"> 15.   Capital Stock Repurchase Plan Transactions We repurchased the following capital stock for the three months ended March 31, 2017 and 2016:   <div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;"> </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:26.25pt;padding:0pt;"> </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:26.25pt;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:00.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:26.25pt;padding:0pt;"> Three months ended March 31, </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:03.22%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:00.02%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> 2016 </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.20%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.44%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Total cost of repurchased shares (in thousands): </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">54,262  </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">52,460  </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Shares repurchased </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:14.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">300,000  </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">400,000  </td> </tr> <tr> <td valign="bottom" style="width:59.48%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> Weighted average price per share </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.20%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">180.87  </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.22%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;height:12.75pt;color:#000000;font-family:Times New Roman;font-size:10pt;text-align:right;" nowrap="nowrap">131.15  </td> </tr> </table></div> In March 2017, the Board of Directors authorized an additional $100.0 million for stock repurchase under Chemed’s existing share repurchase program. We currently have $95.9  million of authorization remaining under this share repurchase plan. </div> </div>

2563000

3001000

100000000

95900000

131.15

180.87

18083527

18407027

400000

300000

1110536000

1170933000

52460000

54262000

1900000

17170000

16801000

16720000

16219000

EX-101.SCH 9 che-20170331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - Consolidated Balance Sheet link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Consolidated Statement Of Income link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Consolidated Statement Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Earnings Per Share (Schedule Of Computation Of Earnings Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - Long-Term Debt (Debt Outstanding) (Details) link:presentationLink link:calculationLink link:definitionLink 40503 - Disclosure - Long-Term Debt (Schedule of Principal Payments of the Term Loan) (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Other Income/(Expense) - Net (Schedule Of Other Income/(Expense)- Net) (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Consolidated Balance Sheet (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Basis Of Presentation link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Segments link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Other Operating Expenses link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Other Income/(Expense) - Net link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Stock-Based Compensation Plans link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Independent Contractor Operations link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Retirement Plans link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Legal And Regulatory Matters link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - Concentration Of Risk link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - Cash Overdrafts And Cash Equivalents link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 11501 - Disclosure - Capital Stock Repurchase PlanTransactions link:presentationLink link:calculationLink link:definitionLink 11601 - Disclosure - Recent Accounting Statements link:presentationLink link:calculationLink link:definitionLink 11701 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - Other Income/(Expense) - Net (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Independent Contractor Operations (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - Retirement Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 31403 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 31503 - Disclosure - Capital Stock Repurchase PlanTransactions (Tables) link:presentationLink link:calculationLink link:definitionLink 31703 - Disclosure - Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Basis Of Presentation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Revenue Recognition (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Revenue Recognition (Schedule Of Medicare Cap Liability Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - Revenue Recognition (Schedule Of Cost Of Charity Care) (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Segments (Service Revenues And Sales And After-Tax Earnings By Business Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Earnings Per Share (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Long-Term Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40505 - Disclosure - Long-Term Debt (Financial Debt Covenants) (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Other Operating Expenses (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Stock-Based Compensation Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Independent Contractor Operations (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Independent Contractor Operations (Schedule Of Independent Contractors) (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Retirement Plans (Schedule Of Expenses For Retirement, Profit-Sharing Plans, Excess Benefit Plans And Other Similar Plans) (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Legal And Regulatory Matters (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - Concentration Of Risk (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - Cash Overdrafts And Cash Equivalents (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - Financial Instruments (Carrying Value, Fair Value And Hierarchy Of Financial Instruments) (Details) link:presentationLink link:calculationLink link:definitionLink 41501 - Disclosure - Capital Stock Repurchase PlanTransactions (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 41502 - Disclosure - Capital Stock Repurchase PlanTransactions (Schedule Of Capital Stock Repurchases) (Details) link:presentationLink link:calculationLink link:definitionLink 41701 - Disclosure - Goodwill (Schedule of movement in Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 che-20170331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 che-20170331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 che-20170331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information [Abstract] Document And Entity Information [Abstract] Statement [Table] Statement [Line Items] Document Type Amendment Flag Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Entity Registrant Name Trading Symbol Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Consolidated Balance Sheet [Abstract] ASSETS Assets Current assets Cash and cash equivalents Cash and cash equivalents at end of period Cash and cash equivalents at beginning of year Cash and cash equivalents Accounts receivable less allowances of $13,815 (2009 - $12,595) Accounts receivable less allowances of $15,908 (2016 - $14,236) Inventories Inventories Prepaid income taxes Prepaid expenses Total current assets Total current assets Investments of deferred compensation plans Investments of deferred compensation plans Properties and equipment, at cost, less accumulated depreciation of $127,848 (2009 - $115,181) Properties and equipment, at cost, less accumulated depreciation of $216,423 (2016 - $211,290) Identifiable intangible assets less accumulated amortization of $27,101 (2009 - $25,349) Identifiable intangible assets less accumulated amortization of $32,794 (2016 - $33,225) Goodwill Ending balance Beginning balance Goodwill Other assets Total assets Total Assets LIABILITIES Liabilities Current liabilities Accounts payable Long-term Debt, Current Maturities Current portion of long-term debt Current portion of long-term debt Accrued Income Taxes Current Income taxes Self Insurance Reserve Accrued insurance Accrued compensation Estimated Litigation Liability, Current Accrued legal Other current liabilities Total current liabilities Total current liabilities Deferred income taxes Deferred income taxes Long-term debt, Carrying Value Long-term debt Deferred compensation liabilities Deferred compensation liabilities Other liabilities Total Liabilities Total Liabilities Commitments and Contingencies Commitments and contingencies (Note 11) STOCKHOLDERS' EQUITY Stockholders' Equity Capital stock - authorized 80,000,000 shares $1 par; issued 30,207,002 shares (2009 - 29,890,628 shares) Capital stock - authorized 80,000,000 shares $1 par; issued 34,404,220 shares (2016 - 34,270,104 shares) Paid-in capital Retained earnings Treasury stock - 7,205,071 shares (2008 - 7,100,475 shares), at cost Treasury stock - 18,407,027 shares (2016 - 18,083,527) Value of stock payable under a deferred compensation plan. Deferred Compensation Payable In Company Stock Deferred compensation payable in Company stock Stockholders' Equity Attributable to Parent Total Stockholders' Equity Liabilities and Stockholders' Equity Total Liabilities and Stockholders' Equity Accounts receivable, allowances Properties and equipment, accumulated depreciation Identifiable intangible assets, accumulated amortization Capital stock - authorized Capital stock - par value Capital stock - issued Treasury stock Consolidated Statement Of Income [Abstract] Service revenues and sales Total service revenues and sales Cost of services provided and goods sold (excluding depreciation) Selling, general and administrative expenses Depreciation Amortization Other Cost And Expense Operating Other operating expenses Total costs and expenses Total costs and expenses Income from operations Income from operations Interest expense Interest expense Other income/(expense) - net Total other income/(expense) - net Other income/(expense) - net Income before income taxes Income before income taxes Income Tax Expense Benefit Income taxes Decrease income taxes Net income Net income Earnings, Net Income Earnings Per Share Basic [Abstract] Earnings Per Share Net income per share basic Increase to basic earnings per share Net income Earnings per Share Average number of shares outstanding Earnings, Shares Diluted Earnings Per Share Diluted Earnings Per Share Net income per diluted share Increase to diluted earnings per share Net income Earnings per Share, Diluted earnings Weighted Average Number Of Diluted Shares Outstanding Average number of shares outstanding Diluted Earnings, Shares Common Stock, Dividends, Per Share, Declared Cash Dividends Per Share Consolidated Statement Of Cash Flows [Abstract] Cash Flows from Operating Activities Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to reconcile net income to net cash provided by operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Provision for uncollectible accounts receivable Stock option expense Provision for deferred income taxes Benefit for deferred income taxes The expense amount associated with noncash long-term incentive compensation awards. Noncash Long Term Incentive Compensation Noncash long-term incentive compensation Amortization of restricted stock awards Amortization of restricted stock awards Amortization and write-off of debt costs Amortization of debt issuance costs Changes in operating assets and liabilities, excluding amounts acquired in business combinations: Changes in operating assets and liabilities: Decrease/(Increase) in accounts receivable Decrease/(increase) in accounts receivable Decrease/(Increase) in inventories Decrease in inventories Decrease in prepaid expenses Decrease in prepaid expenses Decrease in accounts payable and other current liabilities Decrease in accounts payable and other current liabilities Increase in income taxes Increase in income taxes Decrease/(increase) in other assets Increase/(decrease) in other assets Increase in other liabilities Increase/(decrease) in other liabilities Excess tax benefit on share-based compensation Excess tax benefit on share-based compensation Other sources Other sources/(uses) Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash provided by operating activities Cash Flows from Investing Activities Capital expenditures Capital expenditures Other uses Other sources/(uses) Net cash used by investing activities Net cash used by investing activities Cash Flows from Financing Activities Proceeds from Long-term Lines of Credit Proceeds from revolving line of credit Repayments of Long-term Lines of Credit Payments on revolving line of credit Payments for Repurchase of Common Stock Purchases of treasury stock Changes in cash overdrafts payable Change in cash overdrafts payable Proceeds from Stock Options Exercised Proceeds from exercise of stock options Payments for Repurchase of Equity Capital stock surrendered to pay taxes on stock-based compensation Dividends paid Dividends paid Repayments of Other Long-term Debt Payments on other long-term debt Excess Tax Benefit From Share Based Compensation Financing Activities Excess tax benefit on share-based compensation Proceeds From Payments For Other Financing Activities Other sources Net cash used by financing activities Net cash (used)/provided by financing activities Increase in Cash and Cash Equivalents Increase in Cash and Cash Equivalents Basis Of Presentation [Abstract] Basis of Accounting [Text Block] Basis Of Presentation Revenue Recognition [Abstract] Revenue Recognition [Text Block] Revenue Recognition [Text Block] Revenue Recognition Segments [Abstract] Segment Reporting Disclosure Text Block Segments Earnings Per Share [Abstract] Earnings Per Share Text Block Earnings Per Share Long-Term Debt [Abstract] Long-Term Debt Text Block Long-Term Debt Other Operating Expenses [Abstract] Other Operating Income and Expense [Text Block] Other Operating Expenses Other Income/(Expense) - Net [Abstract] Other Income-Net Other Income/(Expense) - Net Stock-Based Compensation Plans [Abstract] Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Stock-Based Compensation Plans Independent Contractor Operations [Abstract] Long-term Contracts or Programs Disclosure [Text Block] Independent Contractor Operations Retirement Plans [Abstract] Pension And Other Postretirement Benefits Disclosure [Text Block] Retirement Plans Legal And Regulatory Matters [Abstract] Legal Matters and Contingencies [Text Block] Legal And Regulatory Matters Concentration Of Risk [Abstract] Concentration Risk Disclosure [Text Block] Concentration Of Risk Cash Overdrafts And Cash Equivalents [Abstract] Cash and Cash Equivalents Disclosure [Text Block] Cash Overdrafts And Cash Equivalents Financial Instruments [Abstract] Fair Value Disclosures [Text Block] Financial Instruments Capital Stock Repurchase PlanTransactions [Abstract] Stockholders Equity Note Disclosure [Text Block] Capital Stock Repurchase Plan Transactions Recent Accounting Statements [Abstract] Description of New Accounting Pronouncements Not yet Adopted [Text Block] Recent Accounting Statements Goodwill[Abstract] Goodwill and Intangible Assets Disclosure [Text Block] Goodwill The amount by which revenues exceed the annual per-beneficiary Medicare cap at the end of the period. Medicare Cap Liability [Table Text Block] Schedule Of Medicare Cap Liability Activity Schedule of cost of charity care. Schedule Of Cost Of Charity Care Table Text Block Schedule Of Cost Of Charity Care Schedule of Segment Reporting Information, by Segment [Text Block] Service Revenues And Sales And After-Tax Earnings By Business Segment Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule Of Computation Of Earnings Per Share Schedule of Long-term Debt Instruments [Table Text Block] Debt Outstanding Schedule of Maturities of Long-term Debt [Table Text Block] Schedule of Principal Payments of the Term Loan Credit Agreement Covenants [Table Text Block] Credit Agreement Convenants Table Text Block Financial Debt Covenants Schedule of Other Nonoperating Income (Expense) [Table Text Block] Schedule Of Other Income/(Expense)- Net Schedule Of Independent Contractors [Table Text Block] Schedule Of Independent Contractors [Table Text Block] Schedule Of Independent Contractors Schedule of Net Benefit Costs [Table Text Block] Schedule Of Expenses For Retirement, Profit-Sharing Plans, Excess Benefit Plans And Other Similar Plans Fair Value, by Balance Sheet Grouping [Table Text Block] Carrying Value, Fair Value And Hierarchy Of Financial Instruments Class of Treasury Stock [Table Text Block] Schedule Of Capital Stock Repurchases Schedule of Goodwill [Table Text Block] Schedule of movement in Goodwill Effective Income Tax Rate, Continuing Operations Effective tax rate Revenue Recognition, Multiple-deliverable Arrangements [Table] Revenue Recognition, Multiple-deliverable Arrangements [Line Items] Revenue Recognition [line items] Increase (decrease) medicare cap liability. Increase Decrease Medicare Cap Liability Medicare cap Percentage of automatic budget reductions Percentage of automatic budget reductions Additional amount owed for Medicare cap Additional amount owed for Medicare cap Unbilled Revenue The amount by which revenues exceed the annual per-beneficiary Medicare cap. Medicare Cap Liability Ending Balance March 31, Beginning Balance January 1, Payments for medicare cap liability Payments for medicare cap liability Payments Charity Care, Direct and Indirect Cost Basis, Amount Charity care cost Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information, by Segment [Axis] Segment [Domain] Reporting Segment [Domain] Segment VITAS [Member] Segment Vitas [Member] Segment VITAS [Member] Segment Roto-Rooter [Member] Segment Roto Rooter [Member] Segment Roto-Rooter [Member] Segment Reporting Information [Line Items] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Excluded stock options Net Income (Loss) Available to Common Stockholders, Diluted Diluted earnings, Net Income Dilutive stock options, Shares Nonvested stock awards, Shares Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument Name [Domain] Debt Instrument, Name [Domain] Two Thousand Fourteen Credit Agreement [Member] Two Thousand Fourteen Credit Agreement [Member] 2014 Credit Agreement [Member] Debt Instrument [Line Items] EX-101.PRE 13 che-20170331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 14 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information	3 Months Ended
Document And Entity Information	Mar. 31, 2017 shares
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2017
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2017
Entity Registrant Name	CHEMED CORP
Trading Symbol	CHE
Entity Central Index Key	0000019584
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	16,082,181

XML 15 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheet - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents	$ 47,049	$ 15,310
Accounts receivable less allowances of $15,908 (2016 - $14,236)	109,726	132,021
Inventories	5,433	5,755
Prepaid income taxes	1,663	3,709
Prepaid expenses	12,102	13,105
Total current assets	175,973	169,900
Investments of deferred compensation plans	56,596	54,389
Properties and equipment, at cost, less accumulated depreciation of $216,423 (2016 - $211,290)	119,394	121,302
Identifiable intangible assets less accumulated amortization of $32,794 (2016 - $33,225)	54,976	55,065
Goodwill	472,391	472,366
Other assets	6,901	7,037
Total Assets	886,231	880,059
Current liabilities
Accounts payable	29,341	39,586
Current portion of long-term debt	9,375	8,750
Income taxes	12,614
Accrued insurance	54,150	47,960
Accrued compensation	37,382	53,979
Accrued legal	2,471	1,805
Other current liabilities	19,050	19,752
Total current liabilities	164,383	171,832
Deferred income taxes	11,875	14,291
Long-term debt	137,500	100,000
Deferred compensation liabilities	56,024	54,288
Other liabilities	15,805	15,549
Total Liabilities	385,587	355,960
Commitments and contingencies (Note 11)
Stockholders' Equity
Capital stock - authorized 80,000,000 shares $1 par; issued 34,404,220 shares (2016 - 34,270,104 shares)	34,404	34,270
Paid-in capital	651,269	639,703
Retained earnings	983,742	958,149
Treasury stock - 18,407,027 shares (2016 - 18,083,527)	(1,170,933)	(1,110,536)
Deferred compensation payable in Company stock	2,162	2,513
Total Stockholders' Equity	500,644	524,099
Total Liabilities and Stockholders' Equity	$ 886,231	$ 880,059

XML 16 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheet (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Consolidated Balance Sheet [Abstract]
Accounts receivable, allowances	$ 15,908	$ 14,236
Properties and equipment, accumulated depreciation	216,423	211,290
Identifiable intangible assets, accumulated amortization	$ 32,794	$ 33,225
Capital stock - authorized	80,000,000	80,000,000
Capital stock - par value	$ 1	$ 1
Capital stock - issued	34,404,220	34,270,104
Treasury stock	18,407,027	18,083,527

XML 17 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statement Of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Consolidated Statement Of Income [Abstract]
Service revenues and sales	$ 405,864	$ 390,389
Cost of services provided and goods sold (excluding depreciation)	285,140	278,435
Selling, general and administrative expenses	69,458	59,045
Depreciation	8,893	8,424
Amortization	46	92
Other operating expenses	873
Total costs and expenses	364,410	345,996
Income from operations	41,454	44,393
Interest expense	(995)	(842)
Other income/(expense) - net	2,463	(2,924)
Income before income taxes	42,922	40,627
Income taxes	(13,078)	(15,787)
Net income	$ 29,844	$ 24,840
Earnings Per Share
Net income	$ 1.84	$ 1.49
Average number of shares outstanding	16,219	16,720
Diluted Earnings Per Share
Net income	$ 1.78	$ 1.45
Average number of shares outstanding	16,801	17,170
Cash Dividends Per Share	$ 0.26	$ 0.24

XML 18 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statement Of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash Flows from Operating Activities
Net income	$ 29,844	$ 24,840
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	8,939	8,516
Provision for uncollectible accounts receivable	4,249	4,242
Stock option expense	3,001	2,563
Benefit for deferred income taxes	(2,415)	(4,202)
Noncash long-term incentive compensation	827	(305)
Amortization of restricted stock awards	336	539
Amortization of debt issuance costs	129	130
Changes in operating assets and liabilities:
Decrease/(increase) in accounts receivable	17,972	(41,050)
Decrease in inventories	322	212
Decrease in prepaid expenses	1,003	546
Decrease in accounts payable and other current liabilities	(10,766)	(7,567)
Increase in income taxes	14,655	19,448
Increase/(decrease) in other assets	(2,140)	410
Increase/(decrease) in other liabilities	1,992	(140)
Excess tax benefit on share-based compensation		(900)
Other sources/(uses)	838	(59)
Net cash provided by operating activities	68,786	7,223
Cash Flows from Investing Activities
Capital expenditures	(9,020)	(11,473)
Other sources/(uses)	(70)	153
Net cash used by investing activities	(9,090)	(11,320)
Cash Flows from Financing Activities
Proceeds from revolving line of credit	116,000	59,000
Payments on revolving line of credit	(76,000)	(3,500)
Purchases of treasury stock	(54,262)	(52,460)
Change in cash overdrafts payable	(8,607)	7,061
Proceeds from exercise of stock options	5,635	2,887
Capital stock surrendered to pay taxes on stock-based compensation	(4,744)	(4,020)
Dividends paid	(4,251)	(4,081)
Payments on other long-term debt	(1,875)	(1,875)
Excess tax benefit on share-based compensation		900
Other sources	147	693
Net cash (used)/provided by financing activities	(27,957)	4,605
Increase in Cash and Cash Equivalents	31,739	508
Cash and cash equivalents at beginning of year	15,310	14,727
Cash and cash equivalents at end of period	$ 47,049	$ 15,235

XML 19 R6.htm IDEA: XBRL DOCUMENT

Basis Of Presentation	3 Months Ended
Basis Of Presentation	Mar. 31, 2017
Basis Of Presentation [Abstract]
Basis Of Presentation	1. Basis of Presentation As used herein, the terms "We," "Company" and "Chemed" refer to Chemed Corporation or Chemed Corporation and its consolidated subsidiaries. We have prepared the accompanying unaudited consolidated financial statements of Chemed in accordance with Rule 10-01 of SEC Regulation S-X. Consequently, we have omitted certain disclosures required under generally accepted accounting principles in the United States (“GAAP”) for complete financial statements. The December 31, 2016 balance sheet data were derived from audited financial statements but do not include all disclosures required by GAAP. However, in our opinion, the financial statements presented herein contain all adjustments, consisting only of normal recurring adjustments, necessary to state fairly our financial position, results of operations and cash flows. These financial statements are prepared on the same basis as and should be read in conjunction with the audited Consolidated Financial Statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2016. EARNINGS PER SHARE In March 2016, the FASB issued Accounting Standards Update “ASU No. 2016-09 - Compensation – Stock Compensation” which is part of the FASB’s Simplification Initiative. The object of this initiative is to identify, evaluate, and improve areas of GAAP. The areas of simplification in this initiative involve several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The guidance was effective for fiscal years beginning after December 15, 2016. We adopted the applicable provisions of ASU 2016-09 on a prospective basis. The impact of this ASU on our financial statements for the quarter ended March 31, 2017 was to decrease our income tax expense by $3.7 million as the result of excess tax benefits on stock based compensation being recorded on the statements of income. The decrease in income tax expense reduced our effective tax rate to 30.5% in the first quarter of 2017 as compared to 38.9% in the first quarter of 2016. This, combined with the required change in diluted share count, resulted in an increase to basic earnings per share by $0.23 and an increase to diluted earnings per share by $0.22.

XML 20 R7.htm IDEA: XBRL DOCUMENT

Revenue Recognition

3 Months Ended

Mar. 31, 2017

Revenue Recognition [Abstract]

Revenue Recognition

2. Revenue Recognition

During the three months ended March 31, 2017 and 2016, respectively, no Medicare cap was recorded.

Shown below is the Medicare cap liability activity for the fiscal periods ended (in thousands):



	March 31,
	2017		2016
Beginning balance January 1,	$	235	$	1,165
Payments		-		(618)
Ending balance March 31,	$	235	$	547



Three months ended March 31,
2017			2016
$	1,937	$	1,806

XML 21 R8.htm IDEA: XBRL DOCUMENT

Segments

3 Months Ended

Mar. 31, 2017

Segments [Abstract]

Segments

3. Segments

Service revenues and sales and after-tax earnings by business segment are as follows (in thousands):



	Three months ended March 31,
	2017		2016
Service Revenues and Sales
VITAS	$	282,316	$	277,528
Roto-Rooter		123,548		112,861
Total	$	405,864	$	390,389

After-tax Earnings
VITAS	$	20,597	$	19,087
Roto-Rooter		14,624		13,020
Total		35,221		32,107
Corporate		(5,377)		(7,267)
Net income	$	29,844	$	24,840

We report corporate administrative expenses and unallocated investing and financing income and expense not directly related to either segment as “Corporate”.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

+ Details

XML 22 R9.htm IDEA: XBRL DOCUMENT

Earnings Per Share

3 Months Ended

Mar. 31, 2017

Earnings Per Share [Abstract]

Earnings Per Share

4. Earnings per Share


			Net Income
For the Three Months Ended March 31,		Income		Shares	Earnings per Share
2017
	Earnings	$	29,844	16,219	$	1.84
	Dilutive stock options		-	490
	Nonvested stock awards		-	92
	Diluted earnings	$	29,844	16,801	$	1.78

2016
	Earnings	$	24,840	16,720	$	1.49
	Dilutive stock options		-	305
	Nonvested stock awards		-	145
	Diluted earnings	$	24,840	17,170	$	1.45

XML 23 R10.htm IDEA: XBRL DOCUMENT

Long-Term Debt

3 Months Ended

Mar. 31, 2017

Long-Term Debt [Abstract]

Long-Term Debt

5. Long-Term Debt

The debt outstanding as of March 31, 2017 consists of the following:



Revolver	$	65,000
Term loan		81,875
Total		146,875
Current portion of long-term debt		(9,375)
Long-term debt	$	137,500

Scheduled principal payments of the term loan are as follows:


2017	$	6,875
2018		10,000
2019		65,000
	$	81,875

The 2014 Credit Agreement contains the following quarterly financial covenants:



Description		Requirement

Leverage Ratio (Consolidated Indebtedness/Consolidated Adj. EBITDA)		< 3.50 to 1.00

Fixed Charge Coverage Ratio (Consolidated Free Cash Flow/Consolidated Fixed Charges)		> 1.50 to 1.00

Annual Operating Lease Commitment		< $50.0 million

XML 24 R11.htm IDEA: XBRL DOCUMENT

Other Operating Expenses	3 Months Ended
Other Operating Expenses	Mar. 31, 2017
Other Operating Expenses [Abstract]
Other Operating Expenses	6. Other Operating Expenses During the three months ended March 31, 2017, the Company recorded $873,000 in expenses related to the closure of three Alabama programs at Vitas. The expenses mainly include employee severance and the write-off of leasehold improvements for one in-patient unit.

XML 25 R12.htm IDEA: XBRL DOCUMENT

Other Income/(Expense) - Net

3 Months Ended

Mar. 31, 2017

Other Income/(Expense) - Net [Abstract]

Other Income/(Expense) - Net

7. Other Income/(Expense) – Net

Other income/(expense) -- net comprises the following (in thousands):



	Three months ended March 31,
	2017		2016
Market value adjustment on assets held in
deferred compensation trust	$	2,615	$	(2,987)
Loss on disposal of property and equipment		(236)		(33)
Interest income		85		97
Other - net		(1)		(1)
Total other income/(expense) - net	$	2,463	$	(2,924)

XML 26 R13.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation Plans	3 Months Ended
Stock-Based Compensation Plans	Mar. 31, 2017
Stock-Based Compensation Plans [Abstract]
Stock-Based Compensation Plans	8. Stock-Based Compensation Plans On February 17, 2017, the Compensation/Incentive Committee of the Board of Directors (“CIC”) granted 7,304 Performance Stock Units (“PSUs”) contingent upon the achievement of certain total shareholders return (“TSR”) targets as compared to the TSR of a group of peer companies for the three-year period ending December 31, 2019, the date at which such awards vest. The cumulative compensation cost of the TSR-based PSU award to be recorded over the three year service period is $1.7 million. On February 17, 2017, the CIC also granted 7,304 PSUs contingent upon the achievement of certain earnings per share (“EPS”) targets for the three-year period ending December 31, 2019. At the end of each reporting period, the Company estimates the number of shares that it believes will ultimately be earned and records that expense over the service period of the award. We currently estimate the cumulative compensation cost of the EPS-based PSUs to be recorded over the three year service period is $1.3 million.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

XML 27 R14.htm IDEA: XBRL DOCUMENT

Independent Contractor Operations

3 Months Ended

Mar. 31, 2017

Independent Contractor Operations [Abstract]

Independent Contractor Operations

9. Independent Contractor Operations

XML 28 R15.htm IDEA: XBRL DOCUMENT

Retirement Plans

3 Months Ended

Mar. 31, 2017

Retirement Plans [Abstract]

Retirement Plans

10. Retirement Plans



Three months ended March 31,
2017		2016
$	6,157	$	526

XML 29 R16.htm IDEA: XBRL DOCUMENT

Legal And Regulatory Matters	3 Months Ended
Legal And Regulatory Matters	Mar. 31, 2017
Legal And Regulatory Matters [Abstract]
Legal And Regulatory Matters	11. Legal and Regulatory Matters The VITAS segment of the Company’s business operates in a heavily-regulated industry. As a result, the Company is subjected to inquiries and investigations by various government agencies, as well as to lawsuits, including qui tam actions. The following sections describe the various ongoing material lawsuits and investigations of which the Company is currently aware. It is not possible at this time for us to estimate either the timing or outcome of any of those matters, or whether any potential loss, or range of potential losses, is probable or reasonably estimable. Regulatory Matters and Litigation On May 2, 2013, the government filed a False Claims Act complaint against the Company and certain of its hospice-related subsidiaries in the U.S. District Court for the Western District of Missouri, United States v. VITAS Hospice Services, LLC, et al., No. 4:13-cv-00449-BCW (the “2013 Action”). Prior to that date, the Company received various qui tam lawsuits and subpoenas from the U.S. Department of Justice and OIG that have been previously disclosed. The 2013 Action alleges that, since at least 2002, VITAS, and since 2004, the Company, submitted or caused the submission of false claims to the Medicare program by (a) billing Medicare for continuous home care services when the patients were not eligible, the services were not provided, or the medical care was inappropriate, and (b) billing Medicare for patients who were not eligible for the Medicare hospice benefit because they did not have a life expectancy of six months or less if their illnesses ran their normal course. This complaint seeks treble damages, statutory penalties, and the costs of the action, plus interest. The defendants filed a motion to dismiss on September 24, 2013. On September 30, 2014, the Court denied the motion, except to the extent that claims were filed before July 24, 2002. On November 13, 2014, the government filed a Second Amended Complaint. The Second Amended Complaint changed and supplemented some of the allegations, but did not otherwise expand the causes of action or the nature of the relief sought against VITAS. VITAS filed its Answer to the Second Amended Complaint on August 11, 2015. This case is in the discovery phase. The Company is not able to reasonably estimate the probability of loss or range of loss at this time. For additional procedural history of this litigation, please refer to our prior quarterly and annual filings. The net costs incurred related to U.S. v. Vitas and related regulatory matters were $2.2 million and $2.3 million for March 31, 2017 and 2016, respectively. The Company and certain current and former directors and officers are defendants in a case captioned In re Chemed Corp. Shareholder and Derivative Litigation, No. 13 Civ. 1854 (LPS) (CJB) (D. Del.), which was consolidated on February 2, 2015 and is covered by the Company’s commercial insurance. On February 2, 2015, the Court appointed KBC Asset Management NV the sole lead plaintiff and its counsel, the sole lead and liaison counsel. On March 3, 2015, Lead Plaintiff KBC designated its Complaint as the operative complaint in the consolidated proceedings and defendants renewed a previously filed motion to dismiss those claims and allegations. The consolidated Complaint named fourteen individual defendants, together with the Company as nominal defendant. The Complaint alleges a claim for breach of fiduciary duty against the individual defendants for allegedly permitting the Company to submit false claims to the U.S. government. The Complaint seeks (a) a declaration that the individual defendants breached their fiduciary duties to the Company; (b) an order requiring those defendants to pay compensatory damages, restitution and exemplary damages, in unspecified amounts, to the Company; (c) an order directing the Company to implement new policies and procedures; and (d) costs and disbursements incurred in bringing the action, including attorneys’ fees. On May 12, 2016, the court issued a Memorandum Order granting Chemed’s motion to dismiss, and dismissing Lead Plaintiff KBC’s Complaint without prejudice to KBC’s opportunity to file within 30 days of the date of the court’s Order (June 13, 2016) an amended Complaint addressing the deficiencies in its duty of loyalty claim. Lead Plaintiff KBC did not file an amended Complaint within the time specified by the court. However, on June 13, 2016, counsel for Chemed shareholder Michael Kvint filed a letter with the court requesting a two-week extension to file a motion to substitute Mr. Kvint as Lead Plaintiff, in place of Lead Plaintiff KBC and to file an amended Complaint. Alternatively, counsel for Mr. Kvint requested that any dismissal of the action be with prejudice to KBC only. On June 14, 2016, Chemed filed a reply letter with the court, reserving its rights to oppose any motion filed by Mr. Kvint and, if warranted, to oppose any other actions taken by Mr. Kvint to proceed with the action (including by filing an untimely amended Complaint). On June 21, 2016, the court entered an Oral Order providing Mr. Kvint until June 30, 2016 to file a Motion to Substitute and Motion for Leave to File an Amended Complaint. On that date, Mr. Kvint filed, under seal, a Motion to Substitute Plaintiff and File Amended Complaint, and attached a Proposed Amended Complaint. Mr. Kvint’s motion was fully briefed by the parties. The Court heard oral argument on Mr. Kvint’s motion on January 24, 2017. On January 25, 2017, Magistrate Judge Burke entered an Order requesting additional letter briefing on issues arising from Mr. Kvint’s motion. Pursuant to that Order, the parties have each submitted opening and reply letter briefing. Magistrate Judge Burke has not yet issued a recommendation or report on Mr. Kvint’s motion. For additional procedural history of this litigation, please refer to our prior quarterly and annual filings. Jordan Seper, (“Seper”) a Registered Nurse at VITAS' Inland Empire program from May 12, 2014 to March 21, 2015, filed a lawsuit in San Francisco Superior Court on September 26, 2016. She alleged VITAS Healthcare Corp of CA (“VITAS CA”) (1) failed to provide minimum wage for all hours worked; (2) failed to provide overtime for all hours worked; (3) failed to provide a second meal period; (4) failed to provide rest breaks; (5) failed to indemnify for necessary expenditures; (6) failed to timely pay wages due at time of separation; and (7) engaged in unfair business practices. Seper seeks a state-wide class action of current and former non-exempt employees employed with VITAS in California within the four years preceding the filing of the lawsuit. She seeks court determination that this action may be maintained as a class action for the entire California class and subclasses, designation as class representative, declaratory relief, injunctive relief, damages (including wages for regular or overtime hours allegedly worked but not paid, premium payments for missed meal or rest periods, and unreimbursed expenses), all applicable penalties associated with each claim, pre and post-judgment interest, and attorneys' fees and costs. Seper served VITAS CA with the lawsuit, Jordan A. Seper on behalf of herself and others similarly situated v. VITAS Healthcare Corporation of California, a Delaware corporation; VITAS Healthcare Corp of CA, a business entity unknown; and DOES 1 to 100, inclusive; Los Angeles Superior Court Case Number BC 642857 on October 13, 2016. On November 14, 2016, the Parties filed a Stipulation to transfer the venue of the lawsuit from San Francisco to Los Angeles. The Los Angeles Superior Court accepted transfer of the case on December 6, 2016. On December 16, 2016, VITAS CA filed its Answer and served written discovery on Seper. Jiwan Chhina ("Chhina"), hired by VITAS as a Home Health Aide on February 5, 2002, is currently a Licensed Vocational Nurse for VITAS' San Diego program. On September 27, 2016, Chhina filed a lawsuit in San Diego Superior Court, alleging (1) failure to pay minimum wage for all hours worked; (2) failure to provide overtime for all hours worked; (3) failure to pay wages for all hours at the regular rate; (4) failure to provide meal periods; (5) failure to provide rest breaks; (6) failure to provide complete and accurate wage statements; (7) failure to pay for all reimbursement expenses; (8) unfair business practices; and (9) violation of the California Private Attorneys General Act. Chhina seeks to pursue these claims in the form of a state-wide class action of current and former non-exempt employees employed with VITAS in California within the four years preceding the filing of the lawsuit. He seeks court determination that this action may be maintained as a class action for the entire California class and subclasses, designation as class representative, declaratory relief, injunctive relief, damages (including wages for regular or overtime hours allegedly worked but not paid, premium payments for missed meal or rest periods, and unreimbursed expenses), all applicable penalties associated with each claim, pre-judgment interest, and attorneys' fees and costs. Chhina served VITAS CA with the lawsuit, Jiwann Chhina v. VITAS Health Services of California, Inc., a California corporation; VITAS Healthcare Corporation of California, a Delaware corporation; VITAS Healthcare Corporation of California, a Delaware corporation dba VITAS Healthcare, Inc.; and DOES 1 to 100, inclusive; San Diego Superior Court Case Number 37-2015-00033978-CU-OE-CTL on November 3, 2016. On December 1, 2016, VITAS filed its Answer and served written discovery on Chhina. The Company is not able to reasonably estimate the probability of loss or range of loss for either of these lawsuits at this time. The Company intends to defend vigorously against the allegations in each of the above lawsuits. Regardless of the outcome of any of the preceding matters, responding to the subpoenas and dealing with the various regulatory agencies and opposing parties can adversely affect us through defense costs, potential payments, diversion of management time, and related publicity. Although the Company intends to defend them vigorously, there can be no assurance that those suits will not have a material adverse effect on the Company.

XML 30 R17.htm IDEA: XBRL DOCUMENT

Concentration Of Risk	3 Months Ended
Concentration Of Risk	Mar. 31, 2017
Concentration Of Risk [Abstract]
Concentration Of Risk	12. Concentration of Risk During the quarter VITAS had pharmacy services agreements with one service provider to provide specified pharmacy services for VITAS and its hospice patients. VITAS made purchases from this provider of $8.9 million for the first quarter of 2017. Vitas made purchases from two providers of $8.9 million for the first quarter of 2016. Purchases from these providers were approximately 90% of all pharmacy services used by VITAS during each quarter presented.

XML 31 R18.htm IDEA: XBRL DOCUMENT

Cash Overdrafts And Cash Equivalents	3 Months Ended
Cash Overdrafts And Cash Equivalents	Mar. 31, 2017
Cash Overdrafts And Cash Equivalents [Abstract]
Cash Overdrafts And Cash Equivalents	13. Cash Overdrafts and Cash Equivalents There are no cash overdrafts payable included in accounts payable at March 31, 2017 (December 31, 2016 - $8.6 million). From time to time throughout the year, we invest excess cash in money market funds with major commercial banks. We closely monitor the creditworthiness of the institutions with which we invest our overnight funds. We had $30,000 in cash equivalents as of March 31, 2017. There was $72,000 in cash equivalents as of December 31, 2016.

- Definition

The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.

+ References + Details

XML 32 R19.htm IDEA: XBRL DOCUMENT

Financial Instruments

3 Months Ended

Mar. 31, 2017

Financial Instruments [Abstract]

Financial Instruments

14. Financial Instruments

The following shows the carrying value, fair value and the hierarchy for our financial instruments as of

March 31, 2017 (in thousands):


				Fair Value Measure
		Carrying Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Mutual fund investments of deferred
compensation plans held in trust	$	56,596	$	56,596	$	-	$	-
Long-term debt		146,875		-		146,875		-

The following shows the carrying value, fair value and the hierarchy for our financial instruments as of December 31, 2016 (in thousands):


				Fair Value Measure
		Carrying Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Mutual fund investments of deferred
compensation plans held in trust	$	54,389	$	54,389	$	-	$	-
Long-term debt		108,750		-		108,750		-

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 33 R20.htm IDEA: XBRL DOCUMENT

Capital Stock Repurchase PlanTransactions

3 Months Ended

Mar. 31, 2017

Capital Stock Repurchase PlanTransactions [Abstract]

Capital Stock Repurchase Plan Transactions

15. Capital Stock Repurchase Plan Transactions

We repurchased the following capital stock for the three months ended March 31, 2017 and 2016:



	Three months ended March 31,
	2017		2016

Total cost of repurchased shares (in thousands):	$	54,262	$	52,460
Shares repurchased		300,000		400,000
Weighted average price per share	$	180.87	$	131.15

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 34 R21.htm IDEA: XBRL DOCUMENT

Recent Accounting Statements	3 Months Ended
Recent Accounting Statements	Mar. 31, 2017
Recent Accounting Statements [Abstract]
Recent Accounting Statements	16. Recent Accounting Statements In May 2014, the FASB issued Accounting Standards Update “ASU No. 2014-09 – Revenue from Contracts with Customers” which provides additional guidance to clarify the principles for recognizing revenue. The standard and subsequent amendments are intended to develop a common revenue standard for removing inconsistencies and weaknesses, improve comparability, provide more useful information to users through improved disclosure requirements, and simplify the preparation of financial statements. This guidance and subsequent amendments are effective for fiscal years beginning after December 15, 2017. We are in the process of analyzing various contractual arrangements with customers at each subsidiary. We believe that it is likely, as a result of adopting the ASU that certain expenses currently included in bad debt expense will be shown as contractual allowances (i.e. net revenue). We currently do not have an estimate of the magnitude of this potential impact. We anticipate a modified retrospective adoption of the ASU. In February 2016, the FASB issued Accounting Standards Update “ASU No. 2016-02 – Leases” which introduces a lessee model that brings most leases on to the balance sheets and updates lessor accounting to align with changes in the lessee model and the revenue recognition standard. The guidance is effective for fiscal years beginning after December 15, 2018. We are currently evaluating the impact of this ASU on our financial statements, existing lease recognition policies and disclosures. In August 2016, the FASB issued Accounting Standards Update “ASU No. 2016-15 – Cash Flow Classification” which amends guidance on the classification of certain cash receipts and payments in the statement of cash flows. The primary purpose of ASU 2016-15 is to reduce diversity in practice related to eight specific cash flow issues. The guidance in this ASU is effective for fiscal years beginning after December 15, 2017. We have analyzed the impact of ASU 2016-15 on our statement of cash flows and do not expect it to have a material effect. In January 2017, the FASB issued Accounting Standards Update “ASU No. 2017-4 – Intangibles – Goodwill and Other”. To simplify the subsequent measurement of goodwill, the FASB eliminated Step 2 from the goodwill impairment test. The guidance in the ASU is effective for the Company in fiscal years beginning after December 15, 2019. Early adoption is permitted. We anticipate adoption of this standard will have no impact on our consolidated financial statements.

XML 35 R22.htm IDEA: XBRL DOCUMENT

Goodwill

3 Months Ended

Mar. 31, 2017

Goodwill[Abstract]

Goodwill

17. Goodwill

Shown below is movement in Goodwill (in thousands):


	Vitas		Roto-Rooter		Total
Balance at December 31, 2016	$	328,301	$	144,065	$	472,366
Foreign currency adjustments		-		25		25
Balance at March 31, 2017	$	328,301	$	144,090	$	472,391

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

XML 36 R23.htm IDEA: XBRL DOCUMENT

Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2017

Revenue Recognition [Abstract]

Schedule Of Medicare Cap Liability Activity



	March 31,
	2017		2016
Beginning balance January 1,	$	235	$	1,165
Payments		-		(618)
Ending balance March 31,	$	235	$	547

Schedule Of Cost Of Charity Care



Three months ended March 31,
2017			2016
$	1,937	$	1,806

XML 37 R24.htm IDEA: XBRL DOCUMENT

Segments (Tables)

3 Months Ended

Mar. 31, 2017

Segments [Abstract]

Service Revenues And Sales And After-Tax Earnings By Business Segment



	Three months ended March 31,
	2017		2016
Service Revenues and Sales
VITAS	$	282,316	$	277,528
Roto-Rooter		123,548		112,861
Total	$	405,864	$	390,389

After-tax Earnings
VITAS	$	20,597	$	19,087
Roto-Rooter		14,624		13,020
Total		35,221		32,107
Corporate		(5,377)		(7,267)
Net income	$	29,844	$	24,840

XML 38 R25.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2017

Earnings Per Share [Abstract]

Schedule Of Computation Of Earnings Per Share


			Net Income
For the Three Months Ended March 31,		Income		Shares	Earnings per Share
2017
	Earnings	$	29,844	16,219	$	1.84
	Dilutive stock options		-	490
	Nonvested stock awards		-	92
	Diluted earnings	$	29,844	16,801	$	1.78

2016
	Earnings	$	24,840	16,720	$	1.49
	Dilutive stock options		-	305
	Nonvested stock awards		-	145
	Diluted earnings	$	24,840	17,170	$	1.45

XML 39 R26.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Tables)

3 Months Ended

Mar. 31, 2017

Long-Term Debt [Abstract]

Debt Outstanding



Revolver	$	65,000
Term loan		81,875
Total		146,875
Current portion of long-term debt		(9,375)
Long-term debt	$	137,500

Schedule of Principal Payments of the Term Loan


2017	$	6,875
2018		10,000
2019		65,000
	$	81,875

Financial Debt Covenants



Description		Requirement

Leverage Ratio (Consolidated Indebtedness/Consolidated Adj. EBITDA)		< 3.50 to 1.00

Fixed Charge Coverage Ratio (Consolidated Free Cash Flow/Consolidated Fixed Charges)		> 1.50 to 1.00

Annual Operating Lease Commitment		< $50.0 million

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

+ Details

XML 40 R27.htm IDEA: XBRL DOCUMENT

Other Income/(Expense) - Net (Tables)

3 Months Ended

Mar. 31, 2017

Other Income/(Expense) - Net [Abstract]

Schedule Of Other Income/(Expense)- Net



	Three months ended March 31,
	2017		2016
Market value adjustment on assets held in
deferred compensation trust	$	2,615	$	(2,987)
Loss on disposal of property and equipment		(236)		(33)
Interest income		85		97
Other - net		(1)		(1)
Total other income/(expense) - net	$	2,463	$	(2,924)

XML 41 R28.htm IDEA: XBRL DOCUMENT

Independent Contractor Operations (Tables)

3 Months Ended

Mar. 31, 2017

Independent Contractor Operations [Abstract]

Schedule Of Independent Contractors

XML 42 R29.htm IDEA: XBRL DOCUMENT

Retirement Plans (Tables)

3 Months Ended

Mar. 31, 2017

Retirement Plans [Abstract]

Schedule Of Expenses For Retirement, Profit-Sharing Plans, Excess Benefit Plans And Other Similar Plans



Three months ended March 31,
2017		2016
$	6,157	$	526

XML 43 R30.htm IDEA: XBRL DOCUMENT

Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2017

Financial Instruments [Abstract]

Carrying Value, Fair Value And Hierarchy Of Financial Instruments

The following shows the carrying value, fair value and the hierarchy for our financial instruments as of

March 31, 2017 (in thousands):


				Fair Value Measure
		Carrying Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Mutual fund investments of deferred
compensation plans held in trust	$	56,596	$	56,596	$	-	$	-
Long-term debt		146,875		-		146,875		-

The following shows the carrying value, fair value and the hierarchy for our financial instruments as of December 31, 2016 (in thousands):


				Fair Value Measure
		Carrying Value		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Mutual fund investments of deferred
compensation plans held in trust	$	54,389	$	54,389	$	-	$	-
Long-term debt		108,750		-		108,750		-

XML 44 R31.htm IDEA: XBRL DOCUMENT

Capital Stock Repurchase PlanTransactions (Tables)

3 Months Ended

Mar. 31, 2017

Capital Stock Repurchase PlanTransactions [Abstract]

Schedule Of Capital Stock Repurchases



	Three months ended March 31,
	2017		2016

Total cost of repurchased shares (in thousands):	$	54,262	$	52,460
Shares repurchased		300,000		400,000
Weighted average price per share	$	180.87	$	131.15

XML 45 R32.htm IDEA: XBRL DOCUMENT

Goodwill (Tables)

3 Months Ended

Mar. 31, 2017

Goodwill[Abstract]

Schedule of movement in Goodwill


	Vitas		Roto-Rooter		Total
Balance at December 31, 2016	$	328,301	$	144,065	$	472,366
Foreign currency adjustments		-		25		25
Balance at March 31, 2017	$	328,301	$	144,090	$	472,391

XML 46 R33.htm IDEA: XBRL DOCUMENT

Basis Of Presentation (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Decrease income taxes	$ 13,078	$ 15,787
Increase to basic earnings per share	$ 1.84	$ 1.49
Increase to diluted earnings per share	$ 1.78	$ 1.45
ASU No. 2016-09 [Member]
Decrease income taxes	$ 3,700
Effective tax rate	30.50%	38.90%
Increase to basic earnings per share	$ 0.23
Increase to diluted earnings per share	$ 0.22

XML 47 R34.htm IDEA: XBRL DOCUMENT

Revenue Recognition (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenue Recognition [line items]
Medicare cap	$ 0.0	$ 0.0
Percentage of automatic budget reductions					2.00%
Unbilled Revenue	$ 1.9
Two Program Projected Measurement Period Liability [Member]
Revenue Recognition [line items]
Additional amount owed for Medicare cap			$ 2.1	$ 2.1	$ 2.1

XML 48 R35.htm IDEA: XBRL DOCUMENT

Revenue Recognition (Schedule Of Medicare Cap Liability Activity) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenue Recognition [Abstract]
Beginning Balance January 1,	$ 235	$ 1,165
Payments		(618)
Ending Balance March 31,	$ 235	$ 547

XML 49 R36.htm IDEA: XBRL DOCUMENT

Revenue Recognition (Schedule Of Cost Of Charity Care) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenue Recognition [Abstract]
Charity care cost	$ 1,937	$ 1,806

XML 50 R37.htm IDEA: XBRL DOCUMENT

Segments (Service Revenues And Sales And After-Tax Earnings By Business Segment) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Segment Reporting Information [Line Items]
Total service revenues and sales	$ 405,864	$ 390,389
Net income	29,844	24,840
Operating Segments [Member]
Segment Reporting Information [Line Items]
Total service revenues and sales	405,864	390,389
Net income	35,221	32,107
Segment VITAS [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
Total service revenues and sales	282,316	277,528
Net income	20,597	19,087
Segment Roto-Rooter [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
Total service revenues and sales	123,548	112,861
Net income	14,624	13,020
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Net income	$ (5,377)	$ (7,267)

XML 51 R38.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Narrative) (Details) - shares	3 Months Ended
Earnings Per Share (Narrative) (Details) - shares	Mar. 31, 2017	Mar. 31, 2016
Earnings Per Share [Abstract]
Excluded stock options	402,000	421,000

XML 52 R39.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Schedule Of Computation Of Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Earnings Per Share [Abstract]
Earnings, Net Income	$ 29,844	$ 24,840
Diluted earnings, Net Income	$ 29,844	$ 24,840
Earnings, Shares	16,219	16,720
Dilutive stock options, Shares	490	305
Nonvested stock awards, Shares	92	145
Diluted Earnings, Shares	16,801	17,170
Earnings per Share	$ 1.84	$ 1.49
Earnings per Share, Diluted earnings	$ 1.78	$ 1.45

XML 53 R40.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Narrative) (Details)	3 Months Ended
Long-Term Debt (Narrative) (Details)	Mar. 31, 2017 USD ($)
Debt Instrument [Line Items]
Standby letters of credit issued	$ 38,700,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Unused lines of credit	$ 246,300,000
2014 Credit Agreement [Member]
Debt Instrument [Line Items]
Revolving credit facility period, years	5 years
2014 Credit Agreement [Member] \| LIBOR [Member]
Debt Instrument [Line Items]
Basis spread on variable interest rate	1.13%
2014 Credit Agreement [Member] \| Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Face amount of debt	$ 350,000,000
2014 Credit Agreement [Member] \| Term Notes [Member]
Debt Instrument [Line Items]
Face amount of debt	$ 100,000,000

XML 54 R41.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Debt Outstanding) (Details) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Total	$ 146,875
Current portion of long-term debt	(9,375)	$ (8,750)
Long-term debt	137,500	$ 100,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Total	65,000
Term Notes [Member]
Debt Instrument [Line Items]
Total	$ 81,875

XML 55 R42.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Schedule of Principal Payments of the Term Loan) (Details) $ in Thousands	Mar. 31, 2017 USD ($)
Debt Instrument [Line Items]
Total	$ 146,875
Term Notes [Member]
Debt Instrument [Line Items]
2017	6,875
2018	10,000
2019	65,000
Total	$ 81,875

XML 56 R43.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Financial Debt Covenants) (Details) $ in Millions	3 Months Ended
	Mar. 31, 2017 USD ($)
Debt Instrument [Line Items]
Annual Operating Lease Commitment, Requirement	$ 50.0
Minimum [Member]
Debt Instrument [Line Items]
Leverage Ratio (Consolidated Indebtedness/Consolidated Adj. EBITDA), Requirement	1.00
Fixed Charge Coverage Ratio (Consolidated Free Cash Flow/Consolidated Fixed Charges), Requirement	1.00
Maximum [Member]
Debt Instrument [Line Items]
Leverage Ratio (Consolidated Indebtedness/Consolidated Adj. EBITDA), Requirement	3.50
Fixed Charge Coverage Ratio (Consolidated Free Cash Flow/Consolidated Fixed Charges), Requirement	1.50

XML 57 R44.htm IDEA: XBRL DOCUMENT

Other Operating Expenses (Narrative) (Details)	3 Months Ended
Other Operating Expenses (Narrative) (Details)	Mar. 31, 2017 USD ($) item
Other Operating Expenses [Line Items]
Other operating expenses	$ 873,000
Segment VITAS [Member]
Other Operating Expenses [Line Items]
Other operating expenses	$ 873,000
Number of programs closed \| item	3

XML 58 R45.htm IDEA: XBRL DOCUMENT

Other Income/(Expense) - Net (Schedule Of Other Income/(Expense)- Net) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Other Income/(Expense) - Net [Abstract]
Market value adjustment on assets held in deferred compensation trust	$ 2,615	$ (2,987)
Loss on disposal of property and equipment	(236)	(33)
Interest income - net	85	97
Other - net	(1)	(1)
Total other income/(expense) - net	$ 2,463	$ (2,924)

XML 59 R46.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation Plans (Narrative) (Details) - USD ($) $ in Millions		3 Months Ended
	Feb. 17, 2017	Mar. 31, 2017
Performance Based TSR [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted	7,304
Shares vesting period, years		3 years
Cumulative compensation expense	$ 1.7
Performance Based EPS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted	7,304
Shares vesting period, years		3 years
Cumulative compensation expense	$ 1.3

XML 60 R47.htm IDEA: XBRL DOCUMENT

Independent Contractor Operations (Narrative) (Details) $ in Millions	3 Months Ended
	Mar. 31, 2017 USD ($) item	Dec. 31, 2016 USD ($)
Independent Contractor Operations [Line Items]
Notes receivable from independent contractors \| $	$ 1.5	$ 1.7
Roto-Rooter segment [Member]
Independent Contractor Operations [Line Items]
Independent contractors with sublicenses \| item	69
Maximum [Member]
Independent Contractor Operations [Line Items]
Interest rates on loans	7.00%
Terms of the loans to independent contractors, years	5 years 4 months 24 days
Minimum [Member]
Independent Contractor Operations [Line Items]
Interest rates on loans	0.00%
Terms of the loans to independent contractors, years	2 months 15 days

XML 61 R48.htm IDEA: XBRL DOCUMENT

Independent Contractor Operations (Schedule Of Independent Contractors) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Independent Contractor Operations [Abstract]
Revenues	$ 11,025	$ 9,858
Pretax profits	$ 6,689	$ 6,155

XML 62 R49.htm IDEA: XBRL DOCUMENT

Retirement Plans (Schedule Of Expenses For Retirement, Profit-Sharing Plans, Excess Benefit Plans And Other Similar Plans) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Retirement Plans [Abstract]
Defined contribution plans expense	$ 6,157	$ 526

XML 63 R50.htm IDEA: XBRL DOCUMENT

Legal And Regulatory Matters (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Loss Contingencies [Line Items]
Life expectancy period	6 months
Period in which the opportunity to file amended compliant addressing the deficiencies in the claim	30 days
Extension period	14 days
Proceeding time period for law suite	4 years
U.S. v. VITAS [Member]
Loss Contingencies [Line Items]
Net costs incurred	$ 2.2	$ 2.3

XML 64 R51.htm IDEA: XBRL DOCUMENT

Concentration Of Risk (Narrative) (Details) $ in Thousands	3 Months Ended
Concentration Of Risk (Narrative) (Details) $ in Thousands	Mar. 31, 2017 USD ($) item	Mar. 31, 2016 USD ($) item	Dec. 31, 2016 USD ($)
Concentration Risk [Line Items]
Accounts payable	$ 29,341		$ 39,586
Segment VITAS [Member]
Concentration Risk [Line Items]
Number of service providers \| item	1	2
VITAS made purchases from Enclara	$ 8,900	$ 8,900
Sales Revenue [Member] \| Segment VITAS [Member]
Concentration Risk [Line Items]
Percentage of concentration risk services represent from vendor	90.00%	90.00%

XML 65 R52.htm IDEA: XBRL DOCUMENT

Cash Overdrafts And Cash Equivalents (Narrative) (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Cash Overdrafts And Cash Equivalents [Abstract]
Cash overdrafts included in accounts payable		$ 8,600,000
Cash equivalents	$ 30,000	$ 72,000

XML 66 R53.htm IDEA: XBRL DOCUMENT

Financial Instruments (Carrying Value, Fair Value And Hierarchy Of Financial Instruments) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Minimum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Period in which the interest rate will reset	30 days
Maximum [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Period in which the interest rate will reset	60 days
Carrying Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Compensation plans held in trust	$ 56,596	$ 54,389
Long-term debt	146,875	108,750
Quoted Prices In Active Markets For Identical Assets (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Compensation plans held in trust	56,596	54,389
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term debt	146,875	108,750
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Compensation plans held in trust
Long-term debt

XML 67 R54.htm IDEA: XBRL DOCUMENT

Capital Stock Repurchase PlanTransactions (Narrative) (Details) $ in Millions	Mar. 31, 2017 USD ($)
Capital Stock Repurchase PlanTransactions [Abstract]
Stock repurchase program, amount authorized	$ 100.0
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 95.9

XML 68 R55.htm IDEA: XBRL DOCUMENT

Capital Stock Repurchase PlanTransactions (Schedule Of Capital Stock Repurchases) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Capital Stock Repurchase PlanTransactions [Abstract]
Total cost of repurchased shares	$ 54,262	$ 52,460
Shares repurchased	300,000	400,000
Weighted average price per share	$ 180.87	$ 131.15

XML 69 R56.htm IDEA: XBRL DOCUMENT

Goodwill (Schedule of movement in Goodwill) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2017 USD ($)
Goodwill [Line Items]
Beginning balance	$ 472,366
Foreign currency adjustments	25
Ending balance	472,391
Segment VITAS [Member]
Goodwill [Line Items]
Beginning balance	328,301
Foreign currency adjustments
Ending balance	328,301
Roto-Rooter segment [Member]
Goodwill [Line Items]
Beginning balance	144,065
Foreign currency adjustments	25
Ending balance	$ 144,090

EXCEL 70 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ȴ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end XML 71 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 72 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 74 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 53 189 1 false 21 0 false 5 false false R1.htm 00090 - Document - Document And Entity Information Sheet http://www.dvk.com/2010-09-30/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 00100 - Statement - Consolidated Balance Sheet Sheet http://www.dvk.com/2010-09-30/role/StatementConsolidatedBalanceSheet Consolidated Balance Sheet Statements 2 false false R3.htm 00105 - Statement - Consolidated Balance Sheet (Parenthetical) Sheet http://www.dvk.com/2010-09-30/role/StatementConsolidatedBalanceSheetParenthetical Consolidated Balance Sheet (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Consolidated Statement Of Income Sheet http://www.dvk.com/2010-09-30/role/StatementConsolidatedStatementOfIncome Consolidated Statement Of Income Statements 4 false false R5.htm 00300 - Statement - Consolidated Statement Of Cash Flows Sheet http://www.dvk.com/2010-09-30/role/StatementConsolidatedStatementOfCashFlows Consolidated Statement Of Cash Flows Statements 5 false false R6.htm 10101 - Disclosure - Basis Of Presentation Sheet http://www.dvk.com/2010-09-30/role/DisclosureBasisOfPresentation Basis Of Presentation Notes 6 false false R7.htm 10201 - Disclosure - Revenue Recognition Sheet http://www.dvk.com/2010-09-30/role/DisclosureRevenueRecognition Revenue Recognition Notes 7 false false R8.htm 10301 - Disclosure - Segments Sheet http://www.dvk.com/2010-09-30/role/DisclosureSegments Segments Notes 8 false false R9.htm 10401 - Disclosure - Earnings Per Share Sheet http://www.dvk.com/2010-09-30/role/DisclosureEarningsPerShare Earnings Per Share Notes 9 false false R10.htm 10501 - Disclosure - Long-Term Debt Sheet http://www.dvk.com/2010-09-30/role/DisclosureLongTermDebt Long-Term Debt Notes 10 false false R11.htm 10601 - Disclosure - Other Operating Expenses Sheet http://www.dvk.com/2010-09-30/role/DisclosureOtherOperatingExpenses Other Operating Expenses Notes 11 false false R12.htm 10701 - Disclosure - Other Income/(Expense) - Net Sheet http://www.dvk.com/2010-09-30/role/DisclosureOtherIncomeExpenseNet Other Income/(Expense) - Net Notes 12 false false R13.htm 10801 - Disclosure - Stock-Based Compensation Plans Sheet http://www.dvk.com/2010-09-30/role/DisclosureStockBasedCompensationPlans Stock-Based Compensation Plans Notes 13 false false R14.htm 10901 - Disclosure - Independent Contractor Operations Sheet http://www.dvk.com/2010-09-30/role/DisclosureIndependentContractorOperations Independent Contractor Operations Notes 14 false false R15.htm 11001 - Disclosure - Retirement Plans Sheet http://www.dvk.com/2010-09-30/role/DisclosureRetirementPlans Retirement Plans Notes 15 false false R16.htm 11101 - Disclosure - Legal And Regulatory Matters Sheet http://www.dvk.com/2010-09-30/role/DisclosureLegalAndRegulatoryMatters Legal And Regulatory Matters Notes 16 false false R17.htm 11201 - Disclosure - Concentration Of Risk Sheet http://www.dvk.com/2010-09-30/role/DisclosureConcentrationOfRisk Concentration Of Risk Notes 17 false false R18.htm 11301 - Disclosure - Cash Overdrafts And Cash Equivalents Sheet http://www.dvk.com/2010-09-30/role/DisclosureCashOverdraftsAndCashEquivalents Cash Overdrafts And Cash Equivalents Notes 18 false false R19.htm 11401 - Disclosure - Financial Instruments Sheet http://www.dvk.com/2010-09-30/role/DisclosureFinancialInstruments Financial Instruments Notes 19 false false R20.htm 11501 - Disclosure - Capital Stock Repurchase PlanTransactions Sheet http://www.dvk.com/2010-09-30/role/DisclosureCapitalStockRepurchasePlantransactions Capital Stock Repurchase PlanTransactions Notes 20 false false R21.htm 11601 - Disclosure - Recent Accounting Statements Sheet http://www.dvk.com/2010-09-30/role/DisclosureRecentAccountingStatements Recent Accounting Statements Notes 21 false false R22.htm 11701 - Disclosure - Goodwill Sheet http://www.dvk.com/2010-09-30/role/DisclosureGoodwill Goodwill Notes 22 false false R23.htm 30203 - Disclosure - Revenue Recognition (Tables) Sheet http://www.dvk.com/2010-09-30/role/DisclosureRevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.dvk.com/2010-09-30/role/DisclosureRevenueRecognition 23 false false R24.htm 30303 - Disclosure - Segments (Tables) Sheet http://www.dvk.com/2010-09-30/role/DisclosureSegmentsTables Segments (Tables) Tables http://www.dvk.com/2010-09-30/role/DisclosureSegments 24 false false R25.htm 30403 - Disclosure - Earnings Per Share (Tables) Sheet http://www.dvk.com/2010-09-30/role/DisclosureEarningsPerShareTables Earnings Per Share (Tables) Tables http://www.dvk.com/2010-09-30/role/DisclosureEarningsPerShare 25 false false R26.htm 30503 - Disclosure - Long-Term Debt (Tables) Sheet http://www.dvk.com/2010-09-30/role/DisclosureLongTermDebtTables Long-Term Debt (Tables) Tables http://www.dvk.com/2010-09-30/role/DisclosureLongTermDebt 26 false false R27.htm 30703 - Disclosure - Other Income/(Expense) - Net (Tables) Sheet http://www.dvk.com/2010-09-30/role/DisclosureOtherIncomeExpenseNetTables Other Income/(Expense) - Net (Tables) Tables http://www.dvk.com/2010-09-30/role/DisclosureOtherIncomeExpenseNet 27 false false R28.htm 30903 - Disclosure - Independent Contractor Operations (Tables) Sheet http://www.dvk.com/2010-09-30/role/DisclosureIndependentContractorOperationsTables Independent Contractor Operations (Tables) Tables http://www.dvk.com/2010-09-30/role/DisclosureIndependentContractorOperations 28 false false R29.htm 31003 - Disclosure - Retirement Plans (Tables) Sheet http://www.dvk.com/2010-09-30/role/DisclosureRetirementPlansTables Retirement Plans (Tables) Tables http://www.dvk.com/2010-09-30/role/DisclosureRetirementPlans 29 false false R30.htm 31403 - Disclosure - Financial Instruments (Tables) Sheet http://www.dvk.com/2010-09-30/role/DisclosureFinancialInstrumentsTables Financial Instruments (Tables) Tables http://www.dvk.com/2010-09-30/role/DisclosureFinancialInstruments 30 false false R31.htm 31503 - Disclosure - Capital Stock Repurchase PlanTransactions (Tables) Sheet http://www.dvk.com/2010-09-30/role/DisclosureCapitalStockRepurchasePlantransactionsTables Capital Stock Repurchase PlanTransactions (Tables) Tables http://www.dvk.com/2010-09-30/role/DisclosureCapitalStockRepurchasePlantransactions 31 false false R32.htm 31703 - Disclosure - Goodwill (Tables) Sheet http://www.dvk.com/2010-09-30/role/DisclosureGoodwillTables Goodwill (Tables) Tables http://www.dvk.com/2010-09-30/role/DisclosureGoodwill 32 false false R33.htm 40101 - Disclosure - Basis Of Presentation (Narrative) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureBasisOfPresentationNarrativeDetails Basis Of Presentation (Narrative) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureBasisOfPresentation 33 false false R34.htm 40201 - Disclosure - Revenue Recognition (Narrative) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureRevenueRecognitionNarrativeDetails Revenue Recognition (Narrative) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureRevenueRecognitionTables 34 false false R35.htm 40202 - Disclosure - Revenue Recognition (Schedule Of Medicare Cap Liability Activity) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureRevenueRecognitionScheduleOfMedicareCapLiabilityActivityDetails Revenue Recognition (Schedule Of Medicare Cap Liability Activity) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureRevenueRecognitionTables 35 false false R36.htm 40203 - Disclosure - Revenue Recognition (Schedule Of Cost Of Charity Care) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureRevenueRecognitionScheduleOfCostOfCharityCareDetails Revenue Recognition (Schedule Of Cost Of Charity Care) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureRevenueRecognitionTables 36 false false R37.htm 40301 - Disclosure - Segments (Service Revenues And Sales And After-Tax Earnings By Business Segment) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureSegmentsServiceRevenuesAndSalesAndAfterTaxEarningsByBusinessSegmentDetails Segments (Service Revenues And Sales And After-Tax Earnings By Business Segment) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureSegmentsTables 37 false false R38.htm 40401 - Disclosure - Earnings Per Share (Narrative) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureEarningsPerShareNarrativeDetails Earnings Per Share (Narrative) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureEarningsPerShareTables 38 false false R39.htm 40402 - Disclosure - Earnings Per Share (Schedule Of Computation Of Earnings Per Share) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureEarningsPerShareScheduleOfComputationOfEarningsPerShareDetails Earnings Per Share (Schedule Of Computation Of Earnings Per Share) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureEarningsPerShareTables 39 false false R40.htm 40501 - Disclosure - Long-Term Debt (Narrative) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureLongTermDebtNarrativeDetails Long-Term Debt (Narrative) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureLongTermDebtTables 40 false false R41.htm 40502 - Disclosure - Long-Term Debt (Debt Outstanding) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureLongTermDebtDebtOutstandingDetails Long-Term Debt (Debt Outstanding) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureLongTermDebtTables 41 false false R42.htm 40503 - Disclosure - Long-Term Debt (Schedule of Principal Payments of the Term Loan) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureLongTermDebtScheduleOfPrincipalPaymentsOfTermLoanDetails Long-Term Debt (Schedule of Principal Payments of the Term Loan) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureLongTermDebtTables 42 false false R43.htm 40505 - Disclosure - Long-Term Debt (Financial Debt Covenants) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureLongTermDebtFinancialDebtCovenantsDetails Long-Term Debt (Financial Debt Covenants) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureLongTermDebtTables 43 false false R44.htm 40601 - Disclosure - Other Operating Expenses (Narrative) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureOtherOperatingExpensesNarrativeDetails Other Operating Expenses (Narrative) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureOtherOperatingExpenses 44 false false R45.htm 40701 - Disclosure - Other Income/(Expense) - Net (Schedule Of Other Income/(Expense)- Net) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureOtherIncomeExpenseNetScheduleOfOtherIncomeExpenseNetDetails Other Income/(Expense) - Net (Schedule Of Other Income/(Expense)- Net) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureOtherIncomeExpenseNetTables 45 false false R46.htm 40801 - Disclosure - Stock-Based Compensation Plans (Narrative) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureStockBasedCompensationPlansNarrativeDetails Stock-Based Compensation Plans (Narrative) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureStockBasedCompensationPlans 46 false false R47.htm 40901 - Disclosure - Independent Contractor Operations (Narrative) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureIndependentContractorOperationsNarrativeDetails Independent Contractor Operations (Narrative) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureIndependentContractorOperationsTables 47 false false R48.htm 40902 - Disclosure - Independent Contractor Operations (Schedule Of Independent Contractors) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureIndependentContractorOperationsScheduleOfIndependentContractorsDetails Independent Contractor Operations (Schedule Of Independent Contractors) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureIndependentContractorOperationsTables 48 false false R49.htm 41001 - Disclosure - Retirement Plans (Schedule Of Expenses For Retirement, Profit-Sharing Plans, Excess Benefit Plans And Other Similar Plans) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureRetirementPlansScheduleOfExpensesForRetirementProfitSharingPlansExcessBenefitPlansAndOtherSimilarPlansDetails Retirement Plans (Schedule Of Expenses For Retirement, Profit-Sharing Plans, Excess Benefit Plans And Other Similar Plans) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureRetirementPlansTables 49 false false R50.htm 41101 - Disclosure - Legal And Regulatory Matters (Narrative) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureLegalAndRegulatoryMattersNarrativeDetails Legal And Regulatory Matters (Narrative) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureLegalAndRegulatoryMatters 50 false false R51.htm 41201 - Disclosure - Concentration Of Risk (Narrative) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureConcentrationOfRiskNarrativeDetails Concentration Of Risk (Narrative) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureConcentrationOfRisk 51 false false R52.htm 41301 - Disclosure - Cash Overdrafts And Cash Equivalents (Narrative) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureCashOverdraftsAndCashEquivalentsNarrativeDetails Cash Overdrafts And Cash Equivalents (Narrative) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureCashOverdraftsAndCashEquivalents 52 false false R53.htm 41401 - Disclosure - Financial Instruments (Carrying Value, Fair Value And Hierarchy Of Financial Instruments) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureFinancialInstrumentsCarryingValueFairValueAndHierarchyOfFinancialInstrumentsDetails Financial Instruments (Carrying Value, Fair Value And Hierarchy Of Financial Instruments) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureFinancialInstrumentsTables 53 false false R54.htm 41501 - Disclosure - Capital Stock Repurchase PlanTransactions (Narrative) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureCapitalStockRepurchasePlantransactionsNarrativeDetails Capital Stock Repurchase PlanTransactions (Narrative) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureCapitalStockRepurchasePlantransactionsTables 54 false false R55.htm 41502 - Disclosure - Capital Stock Repurchase PlanTransactions (Schedule Of Capital Stock Repurchases) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureCapitalStockRepurchasePlantransactionsScheduleOfCapitalStockRepurchasesDetails Capital Stock Repurchase PlanTransactions (Schedule Of Capital Stock Repurchases) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureCapitalStockRepurchasePlantransactionsTables 55 false false R56.htm 41701 - Disclosure - Goodwill (Schedule of movement in Goodwill) (Details) Sheet http://www.dvk.com/2010-09-30/role/DisclosureGoodwillScheduleOfMovementInGoodwillDetails Goodwill (Schedule of movement in Goodwill) (Details) Details http://www.dvk.com/2010-09-30/role/DisclosureGoodwillTables 56 false false All Reports Book All Reports che-20170331.xml che-20170331.xsd che-20170331_cal.xml che-20170331_def.xml che-20170331_lab.xml che-20170331_pre.xml true true ZIP 76 0001157523-17-001278-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001157523-17-001278-xbrl.zip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
EJ3/,RY!*OMW-+Q/YC O8N:H9S[Y(Z#D8Q?P<#F+UUIM5> MG1_0;7039TMKS9D/F.N?K;<;S?:AH,QP0-CFYY&'1>;JE)5NK=7?#91740CU MP"VY5ES./USX:^&X,N7:<3V;#EQGR!7'H4A&<@L>K^Z JR;BJ?R[&&TW/!V5 M NM9[HF7*MJ:6A 43TO0Y+!L$1:P9X2?B*3N1/@\B'G,?J3>G*N:B5V7T2*[ M+Y8RTKOMXO I(Y+3;'996F6.7G5[, )'^GVUQ&<#:IO.%H[I6\0SQMR5$_\= M.;;_-+)]CX2'3_SHV+">&7B;07B$[VC8M6,PI*<$T/"3>63H6[HKG,LQ_9E!M3ZZ5;)/\"F -7-S"F^:GA!A K$]WP7FS'&P&@;A0(-2Q C^>+ M,T,^L @(S^#A)Z+/V_(] T<)%)M80:H6XT?]^O:;=-L!FK4*_+WU/C>R^;%I M0W 68#/-343P.U^9O2Q^[XBP\-;H[#9R0F>$CFW'FD-G[IKF.,Y_DMD[87PB,]&K) M2R@9P-@-_!FO3O2;W9S@!\/+$#E;R.HV#_HQ2S- NKZZQIEEF)]./,=G)QFY M]D..\[R!EY1I@EMA5\8S'LWKT?T"V*HF/X'9G(_:"W<@:M5&*T:&-:;/&>"W M&2<5X$Y. -]1Y];A66\ZW]GABYDX91'">BIXRR;+ [H,Z,L).%$$X=SW1K8# M!H.>"66+-W%ZPGRII0(W/]3K6PRX_DQS6QJO9X*B[]YP?ZK( M_DZ.%=5BU&+48LJQF(5S.'&8U]CN,&^MX[NXM,;8%$KL\J'R.,X"Q$4IWPES MAL,LLM]O'L\?>*A[ O;*F&I3XC+GV=!@6OKDL"!K$&/QN28$K7S7SOZ*M4%. M8[A:D=VKBVN?P=\$\WF-H<'2D(/)M@)YX=W/D>U.^$BP8?AUMK1-)5X94QA] MXCO:B+HP5G:P^74TGA0]F 22*$N=)AK+-)@FT\O+_%=B-W26IX_#;>#%?91^37)^D$AG@%E\%C MYG2_ J2?[9B'O_,+OR-AFALL=U%"$OG@VD@)70A>QG51A'9HXN;2<*73_'( MQ?2"6=H(3]03)7$?J,GZWY=-:E\^8"7[;3CD:O MS:M';@@?/O%%W!C)L[Y6L]7N]SL+4,5GVP*6C&>7G59K/M/W35BNV,"[L5S/ MX06)^>G0PP0OO]]:OU/'P+2Z>]@%&VW#Y-C1IGE\L1]'MN^"T7MM^Z#%F'7) MDWG.0V=A;A_& 4ELWZ^VI=O6#>H@3!:Z'0[!8-#QL:\W%[?W:^S(%N[(6KW> MG.%K78R\A<=K:CBKX[+1.J+'+Z;?&$5=$DV=6&]X?"J*!3!=G.-%;\]44?K* M%\O#]KIS94>7+&,W:XW^_)O!',P!FGX%46PFEAP]Z:_[+>77KGXX?AOU ^(+TC=_+_QK< M!Y]>!O? F?X=+)X<*MZU6XU>;PZU&>?/'_SURSUW:HW6KJ'' L,Y5$ULMYJ] M_DI89Y-M"5@&'+;GC*Y-X(K*C@?6T86XOYVC=7C::LQ5QUPQ=WZ 9C,=3QNB M"/F6@,)C7V=E('+:[O56HU]/A6W9=%L#MWX*5GU1RF>$#6]8\V8TQL /N1;- M]GNFV4_60@;&EOF9C85MLWK^O$'.QIJ=>KN[/:I8VSIG*+Q8VQ3/"5NYE&IK8>6J1&VV()8N#@## M_GK!/;Q+H!W8D8Z;4JXM."5T"8V:?,RJ>7DV%A)S@.XF7EG!S@X6)8I_^("AU2VC8KT\4"D7NXH6O8&8=G6![0BB_F@C:)IAC-I8 M8@P+ BP.!$OD!JDM.-$+XS^Q.,#K(H6%H,358 "!Z\2I0N 6F%XZC?T31AJ MB(55N8H#0.!;QPWO6H;CZ+'BL&%IGJ#N*E^B*"L7X@W+GT:I.,O*YQKN#/-O MHVF+"FOI)_M+;E$*D@1KL+7@LB<%'IERJC\#;]A!AT'D-ZRG2AT'RQ/-4D^( M%K(?7A/G9ZA1<>WILON; V8:#"M)C> =\+8 -Z;QDV%I9*P8&ZL!Q@N^A9DQ MN$7X*V&]9!9%^H4'8$X3%]D'%.C(!EY4S^K%,$VL0NN.[!=+%(V*+2WL..*2 M=T:558G%O) KWR];R6SBH, PK^M, 300J'BV'MZ?'5/83!Z6'@YKQDUL#PL; MPLRBF-RR*2@\!/L2QZ+ R+I(>W&8%ZMJ)] D&## U&+&@E25?O:B6:2L17MX MM)1!X5ZS@>-C]>L\"Z0VDEKW*UX\3%.K0%+'QM)X**Q,5$&H8G1F"O$T<'BM MKS&XS? KS]P1N@:A3)0S%XK,YW"Y?"20^+.:HVD2 8;A* ND+Z\6%U5]3\"" M0XO2C08W7J(!JICJ;%9#T01%U MCO?$DB>V:42V0ZSV^YO%0(]/."B965J9>>X_ 7[SE)CU=E)B\AI2UV!'D(4&,*F3B M.Q/;98G:P; R47Y:U$ %@?$,-BX69(;))F@S8D)QV(, GN.N>YB7K,VF%_A= M#L1,O%HS&;>=J,WD!00&*QK]06'EFW9SD:3=TU92D-Y8\.:3,E2QDX&+&*1A_$L*P7W\U,P>&Q-X*F/P=(2O838A#2B)/3H M:2XP#$<4PP>_=TU1Q](E'?X0]/["YS()OG[JU%\H=L6)7&2#5^$5G9?6\;D3 MKC6\' 6H^-JY?+/L2&@**;FRQ50> G /APH#JOU\KX M1B=#FFQD16,#>T -,86N+[2+>ST-X&5^4RECGD+U4VF"=S044Q M$S=NLK\7%VX?;OC5%K261,DGCT5G#!7,9-R_? M$R _;V>8?=QNI5EK;8#J.^;P\SJT&T6+*DPQF6MI>??PFYL$%%4RKX#E$7\2 MQ!:H-L)CI\A[#0(+GNVA;8;Z?03[$(^R'.;YCI68C M.!,\RT^O"!I/$_QSPICHL4DM@\T: F5'B#=RV :WJ4_1@MX _1->C0\;%J'9 M/5\#(>D$LR/4Q("0:8#V_Y4%H_IAW6@U.>B.-KV&H/=@%@/N@ M0Q=PA1@5R3)@4;<>7@![O^@7K2.C&^T"J<8F^_,O]0WN(F_1R2F7"[ %4T)Y M1V$*MOR8#B88X-A&VX$&(=1T[4-H#E *6?1 2I.>A +X0K@ .(\R%%,G^ M1X1$D= MWIJZ"%AFIHO<4JFA[*_4JYOT^@K4T :\N:SJQI[#4]O%EI*!JB^!B KK7U[P M!FXYU5MMG'RN5UO]&>BILVT+4(9ZJAR@7FNO $67]LYGS=:O;>>-N&)T 7OV M0!3V%U%_Q'RMGW[A;W[!V!%OJP5?!2WGP=* N9H M;+EH"8/64AB^2Z)QI2Y5J%:G5J=6IU:G5J=6IU:G5J=6IU:G5J=6IU:G5B?_ MZEK+DCUGAS@\XE'DE:O32"])T76.Y40/JO&$!_>PQ*RX2B88" ^)GIE#GU(. MFOB-AHG!LT%XIHGM>SS;%X9XF]G$E3(13DPY1DQ 1/' T.27)M[Q1&A1LY-? M7M,8$&GVGDX]^O[L"&E>*I;?;TV76&CVQ="]$:RW]DN46NCQANX:,\T@B1&; M7O+/[H1JX>?@_> RB ;<2B$WT4GW7RS+&, M$^ %FY,Y>#O5>N>7M2[H\!FS7]\)?@\231=_GD]Z)W^FOF=_#/D'U@R+#/ W MM^#-DO63(^.Q,%ZJ.AL9.G#G4E[*F9V2K!2PEJ=G(UZK6ZWU%/'2B#<_UW_, M'4]OB_I:O=JO*=0?!/6-:DMQ_6%0WZMV%-3<4B[8/47YQR=&] M R7-:VF08(L>'[YA%>Z$ L([)RMP7ZO6\M;24N ^%IK'V\_,.:AZ^,X\(IIW M9%(.:VK[B-J-HE.[T=W,*I.+VF\: ]L.?AU<'7S$^USD&[PQ*'RK M?)OBY-L$XYYC"R"5<",[R=X(5AW?661QI-M1&TO[#?&MDF>+U5'+G_(?$"Z) MC?6H4$^EX D \.+0R:<3\5\1X.Q7>JW6;%.HK;#3R@72N='RD6?'#%_O5!KU M?E:&!W0=";?+RKTYH[L!O^NVC[?WY-W2."6D.\@Z5RL)7BEQ/=F=2^^ZA!205, K9UTYZXIDFYB\ MWVT+&Q,S/?#61;-BY:R7SAS8'MVR%4R0VQK8@3 N#;9C M?[W?4.ZZTL^RH+LPZEGVLH^E%>Y'X:JWY?+[E*N^*Y+-NK$T#G#('FO* M^ZXI)IUYL,75J!VD:FTHX\J?99?W+=G=T4ZEM!]:X\MOKRF>SYK5WJO5%<\K MEURI7)78OG?I4^WV5&*[? >OR@$_N@"O[-YSR="MTM\.38$%%Z"$%"BTCR:[ M.W'DY"GM_I$5X27=#X5!=UGXNS :6B6HJU-O^:@G4T;AQB7,TRN6=Y0;7W2M MI=QX99,=D8E0D#NPY3,0U/8H 7E*NGMD17=)=X-"M]+-*F5=(N&OG'=U8JY( MMDD\15575\I?:G27/S6N(#[)KE/16Y5>2Q6V*K8=IA@^4QYZMY&9X55U]4-S MK_Q)Z$K3%C8)?5_5U5LKVSHHEUJYU(IDF[C4JKJZ4OP%0G=AHNL%<1L*G%RE MRK4IMUQZ\NS8-F[6VBH(50;M7,+4:;GULTI>5^??$E)/.>N*9*JZ^M&; ]NC M6X;BWL6Q!HI2_%FYZT?FP,AOS95K@^WZ+*NE_'6EH*5!=V'TL\I55[ZZ=-13 MOGK12*;*JY>78M*9!W*5*U9I=L4M-:URVN401@6PUQ3/9_/'NY5Z5_&\J03R)0)RM F]GW M/8 3QST-:5!K5WO-7P0J#0ND"WS7RUD)Y[#X-!_\.)9_;3O$&S'XG\,8& -1&??^@\E2*#=@ON"I! M7IC#"'O53!^9:^C88[XK-'L\\3V*SQ![2/2Y"!#N%.*.*+P[8!KU7=Q';$I> M;-_4R8@^X_?, L[QC%,]N*11G:V3K"-PDHN!??[II!XR1OMY3CUW" MI(;EP_NW@ (J<*C!ES#(/1M^.KGRQ;<_ZO /;IH?C_:/YH]F\"$8_<>YCA)O M#'+1!4$$,NUOQKN#VW$?LP>>/" /S%UYK>)#B#A MN+7^-S8>,.>$^)8A /D-_J@W3HC.-&-,3??32>ODF^V3 MS_4FM]47D;=W;)2+*!P6/M?(-L&SNF>>[UC92-.5E#2O&G-=D$T7S&)#P[L& M#9X.R[5A 4* -\]1J/$=F$%SK=KX_7GT; /7IDL,)+)T2TR!*[G$:VHXOU/3 M9Q?3"VHBWSZ,&//^"D[^!%Z+3)0,VO3D,YH_<5,(_D[Z<") @2YV\%D$'!*A MGK5V:=HO@$T75QBXU'&F^-4SHKU"AD !\3=W=_"1D0%4 M V=K"@,XQ/8=,A2L2DV8PO4M2WUT0"L M.>>3@>3(T3G!PC$!J6\2M!:!UA#,W:;"2'^NJ5F%>J/#/4@U*?1>GD*B?2](J9Y!(@ISI6-RHO]6EG-E ?15%DH6Z!\PFEC[2=-SDD=Y@ M.'KRR!VQ*CUY8-7NA )]NBBSR]UW&28F<2&\D_TGM34J M WV5-:K(D^6,=8O+YS+*QP.;H/_CVWC7Z,XQ-)C3L C/FF5X\^TG\UR>C7F# MN::&1DUR[KKXY;NO[)F9I/Y^7Q;+EC27;$^N07+IKLN7BP(%EXHI!\%**N8I M%1\ !F,((@_&X%="R.W 9^L2;^3 @VE! LIQ!,,=S+18%""\'4PVDE M!'.[,LH/2XD6YQ[%)8?%^&NU2ZXJW.Y5VOY-75P-E*ZBPD9(Y M!2X:4D"94TK%*Z_,*26Z2RYSY*X;4G2:J6[EY9)PI31BI=DMNY!PLAZE1ZW96]_93Q4GR& M/X*(79')4Y3@W/&9D4K;%W]W*?)(39ZB1 D+98PIAI>7X96M+#5Y5$Q/5F-L M+J8G/F;L,E^8AG9+@U_1TC?H!R?G4O?6NR]+#'&>57?WUP8MR,D5TQ9KAJU\ M#1N@DF:]LF&7]PV:Y,G#EEFX?64L.GW=>30'#-X/M(7J!BA+"7[5#;# MQ#OZHX7RHEYZOZK4J)?[?*&\J)?^[*"\J%=J5J'^^% O?;R^O*A77*^,R^-# MO?0!^4*B?BZ87LX@D00G60=+D"V_MI& NBJ)59&GH ;#T9-'[HA5Z16;S,S7]F21; E9:!NR6S)7$6L#/39Y>X[]FZ ,M!76:.*/$7M M!I@#@50WP#4L%HD*HNZ'Y-+=VRH7!0HN%27O!EA\J:BZ G"R.6B0*&% MH/3= ,LE!%4WP**=(APL:+G5R*H;H*3L)%V45")=K"IB*G27-PA9,G2K;H R MA),4>RMTEP'=JAN@8N]RHUN9@@6/:ATGOE68:2DU5#= %4 J6.TRU0UP1_4O MVZU*L]=7MH;H#%HYGJ!BAYZM"[YR+/C!C2U7J7;KJD( M7/D9_@@B=D4F3U&"<\=G1BIM7_S=I<@C-7F*$B4LE#&F&%Y>AE>VLM3D43$] M68VQN9B>^)BQ&^"ZJ]Y#_[YD) MF_712#Q"T%"OQ59+XAU\_^.[I$Z63,ZSL MQVM*74POJ$DMC3V,&//^"APU 7YY!#:X,&WMY^?__!,AORZ\=66XFFEC04 W M>I1H M\N&?#3R=7OL/SVW[4X9]&K=[]\6C_:/YHB@\GGQ&J.(2QQFCS#]E6@J>2?,Z_.'BTQ\$T<0;+A^ML@X?]LEH$]&MF-XE!=<>O(-'>4$ ML:UXQ\VQJ LJ;D'K; COPYNQ!IPO(T,;D8ECX%" -'#TQ!7](VE8Z7R>%#6 M*3DI=>:@\%VLF/>'*!PUB0I'45$X:APK'&5$A:.H*!P%WYD&'1@F@,K>@J$Q M/R4#X3PK1V#SFBRQD@1BO6\,V%QK4?$Y?&MA_ #9#OO#-V 2C#5F%I3XME M&YC&GA #E_EBX8K]\01E=#I8-Q:,HX$1@O,BR6*$LH7U]LM0.F45P' M?(NCF 9 H!O>E,_DPA;QQ"F113U85/"8R^*-9F-K(R6754^AATJ5$O=RY&>5$O?9Y%>5&OU*Q"_?&A7OKZ^8^^<+ -]E36JR%/4 MSLDY$$AU3E[#8I&H>/Q^2"[='?=R4:#@4E'RSLG%EXJJ<[(,%)8NC%PN"A1: M"$K?.;E<0E!U3B[:*<+!@I9;C:PZ)TO*3M)%2272Q:IZN$)W>8.0)4.WZIPL M0SA)L;="=QG0K3HG*_8N-[J5*5CPJ-9QXEN%F9920W5.5@&D@M5Y59V3=U0K MO-VIM/N=O$J%*UM!A8V4S"EPT9 "RIQ2*EYY94XIT5URF2-WW9"BTTPUA"J7 MA"NE$2O-;E&=DXM',]4Y6?+DG&+&Z53GY,-SCG1I7?*19\?-^EJ=2J_;5A&X M\C/\$43LBDR>H@3GCL^,5-J^^+M+D4=J\A0E2E@H8TPQO+P,KVQEJW=ER6&.,^JN_MKL5'V:KBNF+98,VSE M:^,!5&O5RGR^4%_72GQV4%_5*S2K4'Q_JI8_7EQ?UBNN5<7E\ MJ)<^(%](U,\%T\L9))+@).M@";+EUS824%>IMJVZ *XGH MW0!S()#J!KB&Q2)10=3]D%RZ>UOEHD#!I:+DW0"++Q55-T 9*"Q=&+E<%"BT M$)2^&V"YA*#J!EBT4X2#!2VW&EEU Y24G:2+DDJDBU5%3(7N\@8A2X9NU0U0 MAG"28F^%[C*@6W4#5.Q=;G0K4[#@4:WCQ+<*,RVEANH&J )(!:M=IKH![JC^ M9;M5:?;ZJA:Y5+KKJ,-&I98YLA<-*:#,*:7BE5?FE!+=)9#13W0 E3\XI9IQ.=0,\/.=(E]8E'WEVW("FUJMTVS45 M@2L_PQ]!Q*[(Y"E*<.[XS$BE[8N_NQ1YI"9/4:*$A3+&%,/+R_#*5I::/"JF M)ZLQ-A?3$Q]5-\#"+_7:=HA&W1'O\KY3O@8/!]K.5B-":+HKW.7#'V'UW'0F:LYQH#Q M=,!KV_8L&\!H5W@30]OW7 _F0LC-1'128,5W')B#3 0S"V$^>>>&M%G1D!D M4@^'X,2#I1('EHJ]%2F, W##=PS^\N)+XL\"%@#53\QB#C7-Z08="INU[.\0 MH'SVMSJ;S*33:3J%L!=E EWDA2%+$<"(#;]HI@^4 RH0%+B(?6J&S#6@+I 3 MZ0$D#&ED,E!>](GA8(:]C"M<7QM5<*H!,PUX@P\!FL'A/3&1V8EDXMBO8JE>%JIHVU3]U'D'P7IJW]_/R??R+DU^A1PS(\]M5X9OJ-!=OS MR0 1(BI1G6N:/_9-6)]^/D8T_%MD_6H %0QVSX:?3L[='[?#'_7&CV;]!S;@ M/"$^C,=_^@W^J)\ KC3 D>E^.CEMGGQN-AN--FC-&*R9 =C! IH!_-V5\#>Z M_5:N\/\5>/NK[;JWU@.H@]OAG6/##O"F=R;LAR\@HRA,P7_E\WUD_ZC\$ MUG\\VM$25I+@M-E,+& ] '('NAL'>B7>3QO-SO90V[;^8ICF5AS!/7&=>_YJN#^T$?MQ;WOV/>A4YGQCV/1V M%:#U5JO6:1\ T."+WPV/NNN!VFSTFK7Z=J"NS4I(P'Y>D^V8?OW:_N'< _G. MK059.=-4D:+*(CX^HR*,*\58L^+Y)L+!9^&<)GS+3?*IXH[!?OLQ*T@5I)M! MFLF!Y2^^B,C,P#9U 6V]F\E#21\DU8J?_16*"_FQ41C:S0_UYK3Q@$I,<$:" M-!:?(\W.+!P3X&1[_LCN!#^,[!<+O3W[!>,B8_N9*SN,1T1J\AW>51S9O@M^ MGOO^3"9ZE5MDQ71R$(BNU7Z)",WCG$1CIAGPU:>3V@G_[$ZH%GX.W@\"S)IM MFG3BLK/PCX]B8$![K0J#+[!L0 J>NU.RA!([<65'E13T( MG*9"O8S]O*7WV79PQW=I_"%S;8^:F3:.L@#EMP S MCG5!39[;23URQ32>8$*:]0K!+*-]1?U+4/5WT\L.>;##;BIII43L)*33)I?D MZJD$2[TEUVST*LU:/9];/WR\7T(65J)&B1I,X6JU*K5..R]1HWR70T?Z M)61A)6I2C@4DI-..14VKVZ@T.YU5HD9Y>TMWQD9])61S_:YM!Y!@!9?KM"FA M.M[%Y?2%OM-Z2JGM%!N6YD/Z;Y11QN%)W2+MS[E.Z$# M!YGHMH^WR>0Y?2])-"O?P/GN**5.Z:26?-(Y75(RL1(W2MS,3NKZ.97.55[; MX;TV*9E8B9M\S^H**V[X:5U_I74SY_:)CQF+U4I:J6)7A1FS%?X[&0W M6%BGLMN'Y IN+,T>,X3PVK''EP"58?F@)&XG3 #E7K AK$X\]TA?F?OEU7,H MB#G#HL[T!D!RO]L6KL>Q3=B>3S=A)=K\2EJV:IU&-T&Q'<(M!X*R;>-6H]]H M'!)!,,"7UPFS7';!+#8T\J1^O=WMI5%_8<[M V,%P+AWHOQYGD5PN^W. L^\/7N>P&8L?ENO=>=*SN8&[?VL MXGR.\KA>:R\PP$H <@8Y*XZ[_>Z"B,P#9M#G>DR*YL_+]7ZKM2!FUH5C-PO( M*"=;G79[5PNXL9Y!P-F.P=ZV+3/*CT9]%;/$)LX+QHPLW5S4^9O#>(L='@+K MP'H2/DN>"&W55TF,- ARASJC>U1O[1[JKP8=&*;AY2VL07FN><9SWJ3HUCKU54M9 Z*=KRJC^.EU:JM, MK#R6=>>P"37TP++,T6ZN,KN3<.4*:V4"L-;<%%?T :E[:X[%M/8PH>'+G MGN<8 Y_']!YMP;MCNOCQ'X8W I]BR S^^Q502V>6OLV^:"T:!BEF04YP M'@@#;Q-V 0-I,NYP".#?\2X[8'SAP^>.0ZTGX4+F2?AF;0/"OPG=7E>;D<6F3R!G<^F) M9[9YY@JZ?,!_.B_,-8.01 MKOQU3:\UO]$3,VT.1C9%TN\OD/$M,(3S, 7$;<<^W07W;S9RICDS<$-S7F&^ M-:6(H0GG1%B;;#IIL].\MTF%-:-R4GF/K-12*7KR8?@-3Q1>B M#R2;(:*2X7.707^U>X8]V7A++=_R4J9=[X@'.*#77[+:M,7L=.'1GW\SP%MQ MM-'T*WMF9F+]T3,WU@3,9OY 78*UOG%RM-8/N/Y M W%%[D+8O1C\H@FUI@$J@._['UTR"!(?B,UC?@"'81%*1HP^ VBGCJ U[TZL MPU*S,SW\[ M S??-#2!/P"0>'2<:2B1YD0UOHZE_82'MFGR/KY &?%HU/V9(RU[4$S7G-*Z MXO:E W?!&V):-+7M=U^ MM#T8 M"+[T@"40%+L MVF.66 MK7[(I%W4.WPM?C7 CK-4ZNMPX.@Z.X4_>6L &4]+@]^N:0N7$5,;0 M,$'=4'(-QC((19,:8Y><:^CUCV$P@VL5^(_K):0F[V'.' ]^04F$ A?$V,30 M&.A!H05!F;F&;E"NPGA//$9^JSY4"=C.GF/ %)>V[WA<[UG?.JLW3[7GTUJMU>J?7ES^@[S#US-V==7']^G*J([ M4'P.ZAEO! H(4Z>29H3#DT>8'JG(0$DG-2,09V(S"\R#H6./8[1A$^IXH2GT M=^16O*8);]S>_%5,.:+/V/">6:!JV#-. >I%%_X0TY=J]-@B :\F>P(2X'@5 M E:5N IJ@KKRX,$:,"LG347 RG^'KUN)E59P$6/#0Y("1C3JNV@XP0/\>U#2 M-N?-(>=L37 VQQLCWYAN:*#J45O"!ARC/?6.OB<#@Z<:SGY'YM1$]B+B8' ]+=*[5\9$QG]84 M,[Q0W#9T D]-P+1!.B,VW@V6@#F;?V0OPA!ML^B=8+\"*47^WX!Q%.)#2$^= MO\Z)38EI#,&>>9V +4:QL!*@-?O&<(W7#2S%,3PQ!C?0#8< "M 8 M!WR"/11\9]G.&-$'(L---^,>T6";B3:7L9_ % Y##.ET# 8T;'\7!(3/%>@$ MMHCI"8O:$LREV:[GAGZ",&,K9&+Z2"P1S5ZZ!70V9)9.D4:AV!W;?$, 6\+J MD6G!H@5!-/%$X>)&2XCMU"%OXT\V:_S):(N@9 5U9 1;0LP#0NU5@U?";0 : M"7HEX>&.PBG9S# ME\#P? MS"BS%U;(7B#9"\UJ;P*SF=$$!(ZS^"OAM7L3/-AK6 M+X;+N3DB*?(]IZF@9[@=+6 #)QH3])K!AC"-#]9%I!2YG$I=A5 N @$H=L\M M]X4Y(>J7K@^F/_>?0/"2NK@3WWZ#D2DLQ(BT*PIA1#WP[0A^J9+'I)^#"."N M <"PX!IXPK$2[@,FLO!=CHY%PN?@7\0]GU3HKN$5O.Z%V(0-"8-J3/<=^!-> MXSN+(Q6&,".S%'<1YA( :$.!)V!B>!75W1\^:"7FF,+PH);EPU" 6A""RWU( MBY]=X&X%!8(NGDY"VP0&Y^H.;0"\KL"'#7]T9@9TX)6)79%=>/VE46UL(O)0 MO*.:!* VFK2YQ:2H)Y(U&3@<&%^O8-P"=0#8%^9T0T>R,(;S$?D("4$1-^V# MR C_#AAC#/M2-\#"A,TA]HP]'((-X2R65\Q:> XMDIA^Y)$U+MXT.D'IP#)N MA447(&76&PLXFER.0(6@"'8F5<+S'D;@.O+XBPX&L6,\4^3XF >][6JYBP!* MDUP:(('JO7:+O/MZ]_">O+O\^P7\^PH-<;/ZOA+$J] 4!'7!+XMR$07[])H- M')"*H6?7%@$O? XT &KOZ?)()AA 0$H-(T>@Q$ N@X%=+7%8($LUF[(O_':1 M=>(V(_@;ML'MJ?^^N"0\,=U.T \>& M%7]A8V#3FO $0&<>E@IR"WA7]\%"C8>F4C'! M7Q=#ZB;Z=X!9[(Y>+08/,).2,&T M,0Y\-C#07\@$6%P+#[E"/X&Y'T6L0W\?6/!\FQKN !U[D2 9V?0 W0#7'4X5 M^N2SHRXPXFW'8E,WK@7)D+$M=ZD(KX(9)YAIP"F(\I"_:5@;8*U9R_Y.;)5T&D5?4#2&?W-L)Z'F:";O M_NY;+ Q0=#B#T@6G&WQ58#HW9"'8.\B4_"P5^0NU#94A/^Y#)BR?'_ MHN8*P@\<[&S MOW3Z BI/Q!/=0%X)7H\),#P0XJJ&D6].-5@*F"/)_<+5#4R@\:V=LI=XU,Y> MOI72LRY,/%NB(G*1Q/8,E@!Q7 %3CQ^_!T(5]'0BXDL&0@ NR$V@K)F>]W$K M2![3%JV0]@&]0ZHZ; *F2BIMN;K&>/0GF)KI0Z%Q(>SI&:P!DM[-5/!@ M&H3KD&18 &#,,)@W3[OT(Z\%U#7JBXJ6MY_D<6$0_$ O(?W%$0L_*XG(C-.; M8O\%4?-.C%^_1?SZ,.-7Y+G@!V09X,IG3O'K@ G7BVO?6O%#NQ1<7J/)TY-2) 0Q=;8E M2!A1<6(P93$K%FQZC!V!8Q$>E#@\&WDEG20X)BBW;7$<9E1*P.'OX&]2?A2* M6^1=/+&"?Y=(J0 6OF?([GQ_?T=W$D^S^%G=_R4WEHF,\V4\,6*Y 6(3@P,= M^' LRJ9!UR6/>CE!#J9OD M(3S/A/&#A!70#-Z('^)CT!HWR>5Y60"K6-Z0=D;%C& M&-S2%_#VPW@)&>$9.GFQ01+HX-DWTE[$D$B4_)CR4C/M)8H9G7CT.6:XY1$G M^&PK[5E>I@JC(C]=>*0=?P0Y-XF%\<>LSG2GHO "@RLZ6"W+.5[@3XMR&;P M,'IG)4)I1H3),5!U@'FT((?@?[@9@R#B#-MA#@QFS>+FF:$N>$QD1O$/&/@* M \X\-N8&#X'"0R,<9D%OHA(%^%!=B1P!=&'^Y5O\G#3Z*HBFQ8UBP81#KD3Q MR-GA"<+AIA*;:1:[%-N*9S/PY"%J@*D(H(P-V+L3<4E7C(8>"PLV&!\<=I'8 M:$$>BV\YS!CS8)HN=@PL]WV%[V$ZF9B&QM,$HNP76+QK:P:/1'/NXW8'CX!P M$$3PSG91&>@BD3Y,AHF,4!&!^[\\[";.&#&P]^;6<9XCD0?R+?(N J:II+T: M*(/SJM 'A+MJ(VH.D>/ I0&G3YC,W,%QB6N ?J)H,;@@,_@"9WF!23%K!T%< ME+81XZ"!?L5,GC<.*XJ>^OB6J,:7(BF"O.A-@20_+?LE$#Q7MU\>2!U%5KU6 M"R*9+C#31_+5QD22)V8"$NVT&KUV%Q%PJWEV+$FG4V)+ M2!WT)0[Z9OE9K;C#?!>X$%%REF=,?).&;J:']4.'PS'>7.KHO<&_5,/4--34X?QA:!<9&T"[ CW"5_.6M70;>Z[>"5<="9&%="PN M\H6D>7'0B[)B:51V8%9N=6.8Y-(JR2OQLOP+F7(S"5*'EW(OXX M >TW,H*\"<$MW'SX&R85"B%.SKG-&SL^;U>"9.7D'2+R%8Q""U7K[[9& ]]6 MN!JHG0-? [?/E<&>[-#/6)WCV>C.(H8<^B5.AQ@VN;TJPI) LR/T C"W,3@: MS. "A&]E\P%B<\VLGMGCP;%H: 9A+&+F$\S-&/,;8E[!W$-)SZ&3^@Q/$F!! M= ^DC\]#(!P%;ECL&-_N+BPA!#ZRHKC)$QI2\$KO_7)O(? M^N_)LV&;D4W! M3TEG!ND=3SMBY#RTG,A?F<4P-'*NI=O+ 4\$*%+G[$0[\ [0S>#I MKGOW2]"OV-(O^)MR"PKB%N3C#41\O<(=$((]DNQS9GQTNV?>?K^QM"H:Y'&J MK[3C\_ %,HU!] %=&$8 O\IE6*81$@Y#LWN*<:Q3L B:S7ZW=WKYV^GME]/+ MQZ^H\2([LKFNY94TO#);78*&2[,SRF>5')$!MJM+"2CB@BO70HNX+';G+7%C MH=P(/E9>@EFQ/"*F2O'<-["OGFQ'I'#&$P5C69IHJ(2IA?RG 8B@B&M2Q=P] MO.OH_"Y:\%+:E7X6,V^BJ_UX>\*VA,ECAS<5@VN8(@^56Q*(<8-+;)58 8'04 "# MQ,#7 \4TGF7^XLZI).[)3/P!YNYY2^IK'JO*'6U<44^[!G1FV\:L6JV.=B65)G.6HRPV1:EJ.* +*L< M_?:<:U?=:_;:[;D.)NM,"41[$!&(@/-_?*'C^IWF[7W>K5:N[\,D-3YMH9N M_=J$O4ZC6<\'N,O ==X&6?5NO==L+(,GF&$#"-:O@-YI-7O-C !8+-Q/UU3C M!MN7UXDA?)@[[FMNTF?FB@V\&U#?#L$BIK)/+[8CZ!C7-BUU\%]"#'W^9/# MN-8*BJ1]OFO_,[Z*U5"N7M/PIK\_?H2?OX.>7]J2:T;UF^_70/9:\']O(VS9\LN N'OV;)N8 M8SD'^'H(;+9WC,![AM$L>&4S%.YFZ:AC&ZU.P8,15FA3[Z.VZP3-NB$;#<%"TH7Y[^/W- M/GYSA%\D^S(8.SFX+/;Z^]DOQ:\8<44J^ WXO)AAA[(OY'3;(;.^ MCL=(A;PC;DN1(5W$8RHZXD:E55T>+N)G2B+"M6U^86?; ;)MGK0, M1R.V&[1H-P07!\4B'UP Q&>6W"L*C;'$G$B.@P%\3>Q)4O:48O0^CG\E2>SC8);6H3E.E MRS_PL@&_((G5O&;M%WF:$1X8+T.SF&_;M?)4[FT'B:UKRY'"LCM;D]"S/1%/ M7NQFGW&H>K8RB"DCM+=>35"?:.MQWD6'E &BMQ8CY%0&#&_-+S,.#E"=?AGO MQB)C&[M'4Y=7<.3';#:U7%["1]S^XM4('3Q8P,1:IOE!8A66*)B(:UTO5OQJ M<[BEE^8-A@D$1!3>#B+Z8EYQ#,B%Q;8XR'8U/66 7U#T'YR4OV!>![__-([J M%CJAUTW0^8\$=>XH;%1SV.LVK_F8 RK;U59.UQAHQF(FRQ0-B)WM=3^(K8,S MV3)5CE<$'3VH.SFKX[Y2F;_C*6(BB.>^/UO#CHZYP2^&[HW 5J[]^TX:SIX3?12?L2BOF&]@>YX]/DF"WVA56ZU?/@:3>_;DK#[! MK"Z+D3]?]?$?$O[(9USZJQA]^>\B.I#R,]5^/CFV;^FG@N#DS]3W[(^A*P)K MAD4&Z)Q;\&:]*Y(C8_[/$/CE;&3HP!\)MR3NE:SKMO%7XJ/"O5*X.P"]>*S M4VY;ME'MMG,FS=(H>LZ7\H[#3-H!@:+=0I156FYT2Z\8#HWN%>)HU9E&^8VF M0Q/HR&S41:1(4[0E_/73AD\QU3S:Z0!?A8C]U1C.574HOV82ET+8JE=CJ M]+IS9<5B0V\VZ8Z*_/%:E_5#@;MY?3D NQ-4ULL*=AYUXP3"EDR=7J=M+0C6 MYK%^\PV2K03@&_5\AQ?NO&=AK>?;X9UC6)HQH>:-]4]&'9&D[ ,A(*R[N0T"7NR-ER^*,H)BOAU>@]BD)@YX*%YX2SIMLH[E6/EN6UH> M525K;U)O-LN&D*ROB824V 80"4L4;A2XRGRR'A0,>;O^'6+J%%%%$%?KV#V' M7<\NFT&04WD*T2VL?GZH-Z>-KRK&HIQEQ2)C[AU'1(B5CU&]D;5#G-G?R&TM MM4.OA+]Q:Y&_^^#S-6NBGW:%O##>KYYJV,3>=P@#'8+M HC&S41"PS+.L]X8 MCR/#T\:[F>E$V)8DJOV<;(W-.WC//S)[X.IC>MVKQWC5I-0Q M4%ZZ +?HK)8=+4/CF65_ZQ3+$U4VF.XOS7:V).FQ K\"2#VDT#&QYT>)K M$X! BVX!$-H@O)S5TB)BZ50;\89P0WB3V*$ MZ^'U"J4!Y!L@- 9O]K>SU:42KS0W !)P!&29V+#>3=8H*D=&*?C9"R[.E\#* MO4&93,IUYY:$9$O%C:1CO,.>-8798"_DPV2A6HF43U13;9T::?*08?/@XR;L MET=MN(,6@VLWJ[6.S('XPA:#V\<%GEZU(_6A52'KTJR%^F:OVE#[1L:20-)+ MM(*G595?:I7KJ%UZ2548="OI)+]TRCB6."AFBWTRE)1;0NB29;T713KN.A&I M78%Q]Y'UK@2@5 +P,0QG*PDHK^%Q,$FVDUOP.Q9EO7JEU\V:5*E$60E$&3:B M4F*LE&+L^*XAUEL=)<>.4HZ%6;P3V\&S>SR/,S$=C&<>Z//I8$K&E47&'9^I M]JY?:7;;[Y5D.Q+)]E6),15SVX&)UX#?==O'9(MB"93B;A;0L2WL (#9:Z0;*26ZQ4I4,DQQUF,:N2Q4D@ M$@+5V ]7A>:+,+)&6["4;@V2"L;P) MCFVIJRRI!,0KVD"8YR2[3-O%S2Y!TXHGN"AW1Z M\PQZ[*@$O>R2484Z"B%%]U7G:']'64HV%DHV]I1L+/IIEI)Q/)9;VV,*I1)R MA1)R?27DE) KQ9']7A/%RRCEI)%B2@(=LPMZC*?M&V6&E_NP_9BJK62RX_@K M;Y7@\JAAN0/GSJP''-*AH9%+'\KR3<;J+^6];;5R%?,U1QC@E?LE%B4=Y\> M3"RJC9C8+O?L#]]P1!7S+-ME=W)6PCOA.S(H]RM5E? K@_ K^>XX+J-0=FH4 MTP+\&O8ZN,=>!^3=I6WQ7<.[>]Q8>$>9Z19SW0_Q7]):(ISK_ZJ2+Q5S:P4T<$5D1+S2LP?)[J5J"J8J-IJY'/+\JE) M;B?,$>U_OS+JHO4\'AM>YB-5)1F59)0!W84.&O^E7:OF;0$'/<*WL5G%QWRO M&VV4MKH*&_S)?S!>@-.PB&:/)Z9!+8V1%\,;D91.#"M',T4WY.C&3%[MLPF M.:+/V*?<]9F^41/[7G63GLIATWA $&_P/)@2(&SF<3R/.1P5FKB(E ]>-MQ9 M_-TQA4_3#3 YM!WX[/H.9Y6)[TQLE[FI?>9O!+5,-K]\^+OI,#5-< M\1&_@?QC#K^6%=S^6$2WX5\"\4@3A_?4 M0RLG&&)(-<,TO&DU 6 D[9*WV)*P@V#Z=%(7L"X7JW$Q2>(??OW@NZ=/E$[. ML/0X]KJZ @GS" +RPK2UGY__\T^$_!H^\IUY&*R\<^QG0V?ZQ?0WP,>-=2VN M\EE/YYIG/!N>P=Q+ ,*P?/@NL.ALR^5W F'@>S;\='+EBV]_U.$?8([.CT?[ M1_-'4WPX 609XL'?X(_Z"<@]#8AONI].3ILGGUN=6AM4S SX[2#;VRJ[\55V M5ZWRM-'MM[O[7N>-]R-G MM]%HKK/*-2';VRJS$;/3Z_8ZNUSFC046(_MJNWG2IM'JM198<#93/D#\" ;X M\>"!ND83X<)W46FZ#^R)5ZD_?S7ZW6KH'8L4AH-[L[Q^.N14*[ 4)![C7L M022T.HW],:.$(J%1:_UZYY8><-/L #$_(O6ZS47(EDR[$P!W MIG%J6R].<"D\RS\%+UP9KF;:KN^P*)"8A1R?,4 9#U;&"EC-%Y8*/HLSO\21 MW;+S.@S?GH9G?K5VM=?\93?G/_S%%S'1 '1%6N&1;#'Q=49,C<;/_N)D(H)J MN<_]_]N[TM^VD63_?8']'_@,[$,&D#4\)2H78,?)(L#D@.V=P?MDT%3+XAN* MU)!4)O[OMYND9!W4P:.IZF;M8 /)DLAB';^NJJZN^O55K@"[Y:IU+ZWDI0=4 M08PW5#K)*9GR:D\G?W,8L>I9VMC8+'BY3+*^\8A7J$:FB1T5J0']2[B(G6 <_W+*<,0FFNGE91)9OX)S3_\R^P,5'.HKR+)WV[/X 67\6UJ/6(^N[QWH$'*BM/<$[5(*W]I0?M22K M^X:.5'*Q&[4;V2TONQ%,T-4I(0U;?E>'7C.>.U1"UL41I%+[:M.FTVP'V(K2 MJMP!MK3\3MFHN)^RGAXS^LUIK)!@3,8OIR!*";@3!MJ!6&1EH'HE ZW9I53L M'LU<+)33N/E"1U""'K/EA,?7-T1;@F=+ QZK6DU!XPK7U I7\EK4U?F3)$QD M"Z(X8S8G+QT'& :*DY9R*5/BC^D%F@?@XM!0 @ &&HICY@, NU&]V\TT(;\Q MU=2D-%X*^G1Q%_TQF9 H2@]DS%C97EK;JR017?QQ]ZZ"7R_#3'51$O6Z/(O*[L19F2$F5=Z;V0/?T'WJR-IEO04(O6QV%?#V/%9-ZIY MQ,Y7)L]9%ZJ_%MZ<6]M,1$9P@2D\_G.'/&.P!_ ZK<9 M596=B-JB(4:AH%> M4E>\I,]L>Y3$R;Y3J0AJXH :92XB6A&BV:732[NLE%6/SZ^V"!L(&R!A8S0\ M!AOH$$GG$&4].M*.&&(X0] J[J# 6FLA'ADK1<_7-F8H%/2/J)>ARK?O)-LM0JT,%3:.!!>LE&_X;=/.DKW,PE!+ E_MJZRT[L>I/G[$_Y MF]<>*Z2X],8D?**+\+2:)W728KA^W#S]Z>[I\O+7*&R)7VZ&;/&%L_V4EXD. MN83C4Y9JL<10OW7]1F=Z8P#E<=-O4N-CXF.MX9.T?4\IW4@OL=[PYT7)TLX_ M+V^7@Y![Z:T^A+.Y$SPK$7&9VUUIZK8]-'H4LLK_D@W MX/J+,?W[;.Z'SU3N,:&A>#IWFQ71,U[\'7D)N0PG$\8-GS@Q86.?%&]&[_HC MQ?Y881.[69Q$07=.@8"M26R=Z2L5+074A!)((H#G0>Y'_]:>,ESDR/4MF>V'KQQ4S26G*HVW)KF M5X'&;Y,;C\UQ#L8Q'PTU55LK)++XSHU169*5NE6?ROOPRJ6LCLCW_(S:=]\) MT@%CRV-J#?)5T\QA,?8>)X,+^>48/MIG7Z6IIPLCI6*9L/L>QDE$$OK[='X< M"KM!=84M#U2P46*X# MF*BHZWT#2N:J@!U7?MH)8"VY]+^KJ9FC-[$R9VI!/W82UBV >6_*BTN0ICQB MCQ+I1,IC[A\H3D2H@S*A-\SF;4?>XR)M[Y1>:U^F)5[+M2R3+(PJCQ+E)HS& M6=8H\LGQ*$7LSM0+8=_>:12I%'>7VG_[CS_KEH?EA+.TSEY6OO"M=C$:>WHJ M#LKNRWCJI)G(].EZE(.E,'+QL:]G%6E+8>5_IY)RXGRV95QALF5UZ^!@ M"N?<1I=MQ*IHC1&_>$ 17F688=H1 0?JG$GP1B'X MF1+Y34>R4O8.V@.RNROL1C!I>>V5:*Z>%).&*I__/.7B;0_MPSE67=(N3@/G M"A=@"0:4X, Y--36!\YUWM1:/R/;9$.'>N=M=YO$%7O; 7.^:CMH*=91QO% M'6>GK+&B*#U^$+_ G?%'S-F'.98^*-F:,GM;\I!_-TL;>!W/J5ILO%6R')&Y MXRT/]332*L#0MHZ@%]ZC&AFG'X37-56O2,6]\W/K1$]9'AA#=51T\_3*I>YY M^@,/!L;)MWPY1_1;&#S=DVCV&U7]^-OD0T3&7I-' ]*3Z5MT';E[D\26.PB@ M:8,&J5T[ 9-:Z")*TEC[X-C&V$+DMK\7&8KZ3FVJ%KQ@YL[[]7+:I* MH,+(&)G5B?KAL76:*NU-N'A,)@O_RG6IQY]]&Z*P[*DV1)X9W5J@:Q69^@_#7Z'YTHH,M13-5X,5ND#1YNJ!ON>O50<639VI;Q'+]C M Q2>?H#2-H9;^%.6P#O')_$M^4&"!=G&ZYH6/5(->Y-[6S=KBI*'_!(/'^C2 MR9((Z7<_)V067_WTXM7'JYX*=^0I5; O9/;(2M8E>9#5YZMF3=>+F*%0O/Q> M>A5W2A[R/]R&27@;AC2X/XT5FJ;; TU*5J3M5$[C@CX<6KK-APLE%W?5L@=F M&Y1PMC%A'J0%&],-RVQ%NT#;F*T;:5;@5"[0VXP7/ODV86["YR!.HD762^"\ MA_V;.&!UUA-5EM%705?C"7NBJH6Z;-7N#VP4WEE.D]A]'>T&XFD2\(C6]=,D MX%%+F )P.9!*&'8C.L%'IY+7HO%&Z%-E0923OU!):'3D71YIIO;00BCK'I2Q$9<(8U+"6/>*QS5S@#C6 M21Q;EFG/PRAM$,G&=83!TV7"7+4Q>>0QJ1UMV%' EG3FF,)!.[AVO$=I74[2LIOU. MHKNI$Y%K)_;H9$VZ&N@EV(L--HO/'/85T$OK$)6 MNYSFTVC]D8JL/POK];Z)6G\>UE-/'K4>M;YCK$>M1ZU'UB/K6V/]L#\$W=60>8%]^" V9 MV>GJSX$;SDBIQ>'$U;YF_VU TM:'U;PR6-+FVB?_4SYP-9O&\"5,IS%\K#&- M08HEL1W%P3;ZH,3!VXXK('8-AP=0':H,UE0A&XH6U+0%I24/,5J0D!:$ZQ$P M:UK6$BES$BFI:?&()BKD#@$97L5X43'Z&OW9LM]]>V619X\G^,S=*LY8BJ\G M8!T:X/&9;.R&[G_(QF\>_CKR6]Q]<\G8C>J-ZMTU=J-ZMUMZ@_S&>AMQZFWR MZUY%GN-CP0UTD1U(5G5O+U(<=.NTL]1NBN\8GG$X"PV^Y+^=@]#ZJ&>;9MGY MS%TUA=I#7,&%T?#$P_OD_Z"G:Z,&!I)+JNU0M;=A=O/K7($K+>>S+N(V'>G; M1U=:#*DQI$:150FITYXQW@]"?\*:Q839Q%\,L''A!\GN4LL^A@T<2IKTLY0T M%2"7\B*RR[:J0847((;E4H7EYNAH,[Y.:SM4[=UA]X'H3"B&"[,^[T37$DH M*,!CL([!.HJLBLO[-0Q^D#@AXSQ:=_YVHC$&Z_*Y _79#:UA FQO@$,T 4$ M&*Z+CECPO3FY#(QSO#[2,5S']1D*NX59GJ&W?906W#L1JENPXCX,U7F);.D' M*YI^ADUV&K63[M:O\Y88./< UGRHBA@G?Y5=TZ=D^+#]]=0Y\M6 MM=NJACJ/(3DNN5C8WCKZ](\*0'J:*P<@OSXH[E PSC M15^U,(Q'GZQ#+H(@9V#E[:)C:W$]L-0X4O5H0_UT@J/W=7/K;WP MB]!QI16V"+VM[NKFT;$.&%)C2(TBJQ)28W=U7/@%8K#%P]DW-E0+DU RK,X2ED[#7I^Q>!WWOP%*#X-U%!EV5^^\.U"?W1":>XOC M#8C2_!G#]8X%,/"].;D,C/=>EHGQ.B[08-@MS/J,M>H8JX.3'L;JHHD,VZO+ M*S%P[@&L=L589B=NJVFL:8+Q84\;HLYC2(Y++E:VGZ.R_6@Z M<"L S]XZ]%E7XAA[/]8_;2Q2/:8^+V'HBU4O]61%ZGR#M"7-V67I/=]=:/GF MP%XM6W]&9?W-VU\7\>63X\Q?W[E3,E[XY-MD>4#X.XGNIDY$KIW8C.S-Q7M&XCJY]/6F1#*E9F+)WV=*N@$/6S_,\RBJ^J^+ M)7]2'5!"F,I3-^Q@V\*P=?>:&%\3-*Z^6QYW54=&J8'6&+TLR^6: Z/HZ0N$5"H^W M:Z.9?1-T*D=>UJM&WT+6GX?U)O"4L[RL1\ Y)^!HN,R>"W!@)VSD93T%' -9 MWS3KF]BK!Q^S =NKY[$S3Z])8W@J(?WB"(+1J+UI84$H6UU/G[F$[:GPS8'^ MG5'[&/KC(H'^[B4.CQU[Z+&&,YH/FD\M M\[D/$\Z]KQG< EBI,H-\0ELT<2*8;64_B, RK.^M>H#($B M_7.>?.*PA5ZL\8#-IH>BMIM'>V@UY-AGZ?PH@R(5#< M1121P'U6G#$[:# C0<(C'9-NB].Y$Z7.W1# 7;H.GCP5=#$ MN;#G7'&73MAEO?%=.H0;A)LV=NIMUP*CM_%$;2"5&N&EVKTY8N$EWZT9' MO9NML"]["ZR11U$XM"*VY58>.UTX]K7K^.(DB\A+/!)_F_P6!D_W))K=D,=D ML]D']O"HE&BPJ+MM0E[_L(?'P3YO%AZS/,L)5V/8MY'U$$^X@D@7=SGLK4*82AN,Z\ Z8.^C;H"A#< 3N WJ/^$/3H22&W8=!ND/7( M>@0#*%Y<.4MN%,N M?C^-"%%F])O36"'!F(Q?SKV6<@S**E>USM0U.XBA=K6K79Q*_@H78(#-Y?AJ M!N@6\FBH31MJZ3;A_$)MN4Q-Z)J:>OND5* G>=L !SAF7/'>^R4]98 ML93Y@(O5 :JS2/B%F,,'A>IZ40QXU!)F'UL.I)*+W:C=R&YYV8U@@JY."6G8 M\KLZ$A6)5906K.J MNNXQ#;0#L0B6+\#S$*Y#1$I< 0![IUB+1S:4I.VQ*46 MKJ:@<84[4Q4<=77^) D3V8*LS=95PD!QXI@DL3(E_IA>H'D +@X-)0!@H*$X M9CX L!O5N]U,$_(;4TV-=IA<_E_3Q5WTQV1"HH@PKVW&*O/2TCLEB>CBC[MW M\M<1"YVHYSVZMC?0&IIU+:G> UW^964WPHR,,/-*[XWLX2_H?G4DS?);&,^; P#(G6=POD"J,8(-@LRIVTLW3O+7L+?9EW=N7M4R+ MU7UM6N_($RLUNB7S,,HN,0FC65H%?OV\ N[*"]YF 96#7KWL5 M>8XO7_,R".*#T%RGI'D)&(] M*TZTR#!FQ:T'5@ G9+.U1<0S16; J)YGJLI M8&$<)D$3&0A^"]H27%OB.B"W.TO:476#LN:5O-8=B7YX+E%NR0\2+"C5[,SZ MG>.3N,'2'F4+2GBG\26 ]?-7*9R:NY> V9#64(%3R1)PO\B#*9 $#_<%@B@: M8WRMY>+PJP/U%NC0B!>CE[S6[Y_OK^[*J0 BJWB%=P(6#K14WVOK/4,[.A0= M=1[0:1]DOJ" [N"H"7 &0Y[EFXW?$8=_2S@?M9MF(27MV%(PS$!G"UHJ5^X M*P\/-TK$0Z::;O0L\RBLX5(.6IL12\Z,)8U[2$)BB:;W[(&&+E+-R1NZ*:Z_ ME)U/A[Z[A6="VTM-@1039R0T58LBH8E>E=#K.L*.*+!3X'Z!%!-GV#%&:L^P M1^B "9ZC:AJV#BBT4/(18M78]8*0_6=?M,7')D&9C[I_UD04LA\/)6))>+54 MUM4D87)R?BH?G2B@'-DM!<>E"JBQRE-')27S4?.1^=UDOBC55 (R'QTTX&DM M+'$'8G_P$_I"N&:\*T[5GG5\*!*J/.CU'IDO!-X(X9/Q+M\:]52[Z2%LZ&4! M][*PP%W.A0<+W'-4,WL#'2NQQ%9FA!+9Q:-63]>/'MY!1PFT,B.4P'.4 '*?-Y3H/4W%3%+',DD?PF@>1DY" MJO8HPS@0/+QA2HFRZY75,X;#/>,>T4$"K<.((/ <)(#5VZMM BDFWN5-HYYMXL:PK<>0SX)>?-I;&.:8LAQV2%;'S#>(V?15ZUW<76GJA _F9]:=4 MUM^\_7417SXYSOSUG3LEXX5/ODWNR-.,!,DMF8=10HWL&%P_9Q_ M>$_E<^V'[I_O__D/17F[>Y'[B#CQ(GJ^2^B7KI\_^$XW/QGI&[3CI]O2F?EZ'W^?M,:3>@8>N'F2%I MJOJOBR6O4HU07.+[.;:\NU OTO?QW'&7[_/?Y]9!U=MWYC%YO7SQ)KLP50.U M3R_^9IO 3=4H.V36&O5-T*6-YQO_JVA5!DUE>+,DL[$N'L73P8R^#CJ.$W)V M,[(>-NLULZ^#/OTA+^M1ZY'UW6.]9O1-$UG?,.M+9K'%]%Z[M<&_)?QN^;KG MGB37L>5&+G:#]VGE8C=J-[);7G:#]U>%87<7?%1]T-=%]E&E1R<> FII.+1U M<83UA?.A 95[5>5]N5'==W?&;6/H3\N/)0VC0A19O2;TU@AP9B,E2]. MY$X50^N5LJ"B.^["#AWHE/*QY/@A:]3$ 0&15 &T9#L#377R% MA[8$2APMV-( G0AT(M") )=ADV#I D?(A*YB.<*>QL^4669/'^AE3[)VRC00B>1$HI: 1Y"*%]XX MH_?,0=/]9]%#AN\AWV5^\)IKC#XPKCS(;G1=:W?J5-4>O3#ZKN*I-+(;0 X7 M'KLY X9Y&F"@$RJ=$_I'^M1DK#C4")TGHLPCSZ7_DBC+TZ)+*CC"R#!;H!;+02WN@_> M>+'KA_3'Y,SM ^N(4"\CPO6+?@@7D4>=UXDJ CH-.+-="Q+]8!%B M1'Z08$&_[@1C)7;\_)4S2=BJX?Q4B!,%U&QCY?%9>5S$]%YQK,298!4:62I. MK$Q"G_HB.[5 2A.L/;B G<)&#EQD9&VO;L^$\:"2>C71R#1W!;(S*>WU-15P MO@$V-16U5[N0K=:.\YW'Y";D.^H[\AWYOH4SC<]W0KXWL9D&WF<"MIFV?MVK MR'-\+F=LS]I)!X+X(+0>*&E> L8C$&WKR#Z9V*:%?23 -*E"#P?%UB#X+6A+<&V):\ND[BQI1]4-RII7]D!/OC5VN[XU=L>VQNI> M67G!#V4+2GBG\26 ]?/70[4P,1@*LR&MH0*GDB7@?I$'4R )'NX+!%$TQOA: MR\7A5P?*NM"A$2]&+WFMWS_?7]V54P%$5O&J? 4L'&AI:KBM]PP:U)4\2X Z MCZX<-.;#!QS8%00M S;L,DO+P-0QJ.">!L04O]PEUY M>+A17+C/^ZB4;O0L\RBLX5(.6IL12\Z,)8U[2$)BB:;W[(&&+E(U95\=@=)- MX72#'Q[ATY4GN&/4('3/ <5=.P=4"AA9*/$*O&KA>$[#_[HBT^-@G*?-3] MLR:BD/UX*!%+PJNELJY6[9 ^YNV0!-@!A* 0 (Q5GCHJ*9F/FH_,[R;S1:FF M$I#YZ* !3VMAB3L0^X.?T!?"->-=<:KVK%'I;OFH\J#6>V2^$'@CA$_&NWQK MU%./3^= +TLN+PL+W.5<>+# /4MGJX?/;R#CA)H948H@>0^;RC1>YJ*F:2. M99(^A-$\C)R$5.U1AG$@>'C#E!)EURNK9PR'OT!28@BP)80.(X+ _LF\@((.%2*L1_V#*!&9AU&BN,OYP>A] 9/Z2<3+W "E[W+G+?T MC_EOJ9I18_ BXB;^,[VAG_X^"17B)5,2*3%YFE'F*$ZLY+S75>W#5KHL_>/- MF_Z^W-D>X6QZH91/[RZT]-$/9-[6]5=9?_/VUT5\^>0X\]=W&N'\2(B]U22UY1'?[[_YS\4Y>W+#WS*]J=_DX!$CG\5C*\VV/PQYY1+Z:$7 MN"63=Q.A&Y=F(R_A#.V.3W?T@O<_\\)U<_ MO?C!G9('>K%)&%&+=;.;+D_,TK^GE-Q3\"!)_(7,'DET\?Z[\7]K'&CP:43C M4UI/D-(P#7VZ>MZ29!$%@G'KXU\++WG^'%"=7; _QM\8[MU/G>#;G%TB_C>] M1!)_#K+;%G-2?Z",6[+RY4U3*K=EE^:Z87[^^NGB_=!0S0:X7)(74DG@%&46 M0PX)7>"R9XBS"VUP["I^^#9YT/23URK=5$>C3=3?N4,%"DY>=>A".3#-F@1\ M#1-2X >461S?,V]CW?.@KS?=RRSZ8.Y\_CZ+)C9BMA,"MI/\SBJ11DDO-/UA MU;G:)_OC,#QN?-;-9]6L4KGB4RZY%AT4O?K@S#U6GIC:KD*=]T7D3BDP*M]] M)U#N*>#%CIN"G\B\YZ)6#8>T+4!+ 1NR<#<7.HU IT29A#2@_9O%K6ZN''&J M''3=3C]/V SXNGL:>V;(*PSSTT"YA7J3OX[GC+M_GO\_S6I0FWYG'Y/7RQ9OLPE1N:I]>_,WV M"K8IRP,[>(6CH:U1WP1]*)$^<\.U39M77J6T=S+:BE9E1'26*=S),#;;C;-X MRK?1UT'OQYY/E UN3B#K8;%>,_LZZ"X.\K(>M1Y9WSW6:T;?-)'U#;.^9#6: MF+YLMPKU]P12W<"_[P?NT MO6>;<7LVTTK94Q?P4/2877H\%,=]V,%#O1(>UNSS >T4,0! 9 4$;1D.P"XM M?(6'M@1*'"W8TFX-#CH1Z$2@$W'N#)L$2P]0?A?GZY'?F$&6F-VHWNUF[)'? MF+*7TKLL>:VL-[8;QHD23C9.(L3LB%ZLO/(")9F&B]@)QO$OK]&;A6N>G69W M:YU?3HG;Z[6"$;J*Y0A[3I-*B=XPEMG3!WK9CE2=,@U$(CF1J"7@$:3BA3?. MZ#UST/0<&?20X7O(=YD?O.8:HP^,*P^R&UW7VA,W5+5'+XR^JW@JC>P&D,.% MQV[.@&&>!ACHA$KGA/Z1/C49*PXU0N>)*//(<^F_K%,I\T_1)14?0[R UV%!QM*7JR7-G"\#IUHS.HM;M(!!&$4*]1TIF%$*:8N?J P:&,] M/QU?V86.DK=,.QW6O8A"V>Q3@M(>E%DWRI>$N$(Q@ 8B'Z9D1L8O@Q%&;V*% M_/2R>0QIE++^FWG$1#[K*W\0Q5U$$549_UF9TOAF=PI";;0M>8&1U1_5YM@+ M)LWJ7BOG/5489U'W6IF:I0V?J3AFCL?ZK^<23*9>7" IWPGZIZ##)D7-S;4X MM:MU03/LK&\X:Z7;_#0+W1H8ZDY[[IT[UJ:JW+ *2I)6C:J7WL/?,]N\6F'2 MU8RN\XE6N9VY=?%>4_/_;5%V_*ZGD'J[U.277[]\IP'J1];H).)/H6/S>>XC MXE M?DZO=^52_8[HDV=9G@]AG"PG(]107&O]:70JBM1G>GF44TG@0/AAW=XA M/ TJ&R4\W]TM,RE@=_P!I!)GV1@;SEK/)YDYU?73NRYC4ID,-1/DD@Q*;R> MHK0T=&U4]RG^Y_+R4Q@F 8U0E#N2#NZXO*0?O?WUYV/DO_\O4$L#!!0 ( M &4_G$JCQ5BD. X )F9 0 8VAE+3(P,3Q=)ZZR%Y?M;/*6$C,"E!TDHM'8YO[Z:VD^880T M@R%0=?.P:YCI;G7KUY):+0E=_/PV#= +$2'E[++5.^RV$&$>]RD;7[:BL(U# MC]+6SS_]^U\7_VFW_[AZO$,^]Z(I81)Y@F!)?#2P,-($'2/ M&1X33?CQ\.-A][!W>HS:[432%0Z!DS.D11X=]K(WUXE4SL[12>?H4^>HV_N$ M>MWSD]/STQ]1_SZCO R\TWE]?3U\/3[D8@Q< MW5[GC_N[)TW7B@G/WX8BH ODZDG*<-RA+)28>22E#RC[;B%7KX=@=":^1)]H MTSL[.^OHMRTDL1@3^15/23C#'ED@]U^^'WI\JFWN'A_W +A 5_<-%]//9(2C M0%ZV_HYPH"NIA;"4@@XC218((E8@R2WW9598T8[33OPR)671U&RS+T5'SF>D M Q1$4"]CX*P"#V?M)3[*7DBXI%-(O,,Q?^G$[U1%'+>[O;:JBI@)\'1464P' M?J[*S9UCA,.A5BE]HU@^)L+!I1"ZP(QQB24T&_U=/9G-*!OQY"L\4!B>"QZ0 M9Q"!U(??'F]7*=1M=\_:Q]V.(NL\@62-Y35G(0^HKUK$%0Z4OSU-"('ZI_YE MRTV6*9.JXY,1952K#5[?[:(VRJ3 YZ(@E$A"6M1%9YE_670$+7K ?M*?9X*$ M(%'7SQT\2+@3$ANGAP,O"M9@S#5;S9<\33'9&E39P\'H%GK3*;'@5::U@W9D M!RU_,1BA6& #W7K07>-PCFY'<#C&@ JF4@+;4 T@YA''%^P8!"V MA ]$/$VP(&HX]Z. #)\.HOBRAB,ELD^$XEID&"\,6DV%SCIGG2/ /9"L-1& MJ2 $DI 6A0[2,K4GY*6JKV7R']!!4O@/C:^X?.6.L_$S46'04*I_@TBJ:$Z% MO2O\H0*''?/3,N9*9EL)14JBP@_^+PAN(%T3TKRQ/@C*/#K#P0.>JTXU'(P4 MT1W'K +0M>2XX#]VP9\U=SY"67DH+5 ]E1."-(,JM_&.&MXQ@*H3<3CTY6U& M6$B^D@*\QM5)]#H8$%RTQ*=??85#FFHAM[<].6^V$1B@ZP' MA97Z6"U$=:%%,0T\+G@>R0MA$?SQ^#A69!D= X4=G*,R.(D,5!#20.."YHF, M=8>Y0# 0FI'[4=#3*"$)2OY17%(RVMP<^%VRWP" ME>;'DU$IL"=YVN?Q,G8N^QN;V_)K*T2] MKFGVDPIH&E7%0(^,<=!G_B,9*P.XF-]C*8DHY_E7$MI1,B00M"B=N\N%H41: M@Y@+,>AZ/*)ZGWA%]9&&WY>Q,I'843)D$A:$J'2/$M/ XX0'AY/!"Q&^P",9 M@I.K!U_^CN@+#DPY!B>]'3A#[D%O@LA%ZH:FGQ6D-CBZ<+RA##./XN"6A5)$ MQOR0D<:.ER$_D4E!!3$-0.Z&-J,2!SJJ?B2S2'@3"*W5L ]]%H36GC$JK,AE M!]&0UDCDQD$^RB7K..2Y(+H!UATDJG&G[WD\8BH)D:T7&>+%E91V V9CU@6 MRH7EZU0-9D[,?N'D9#X-RCG EG0V;X^Y1 M>2>.89$)'<3"FG7:RJM-9I26WMJQ.2YCD_(W@*R]!&4&9@65':"3,D"FG:L- M5&NL2YEA,E#8(:JPT["!YSV+(&:<;*1VP#Z5 ;-O^VO@VTR&W0QD-28[I&=E M2)W9]@;7==/NJ\)#$Y$5MU[7%!LNIN ;F-Z5>A MS#C6XK4C:PAC*N>D&K1K)SK,>"Z]M2-FB&-2_@:0]^QZ_HJ%BA%>5IU5K,)B M@^ZD\JYH=) );@Z5O"NEY<*T H<=TFI[J1M -P5H?@+LGOC4PWHPO*-X2 ,J MYWT8F%[@;V6TZXESN4+IZ*G1%8K'R=)2U:"+LG)16G#C+!MREFL>JM\.F& ! MM7J]^CSZ6C)<;E$M$;YX##V,?Y@@+@Q=-R?/UTN6/Q'Q0KT45K5/X@D'^F]_ M)(EXQF]I7O5J?A6%E)$P3'A7>,@&)=O]QG(\!)PE+CWUI'BWAE9 ?](JM$&' M/&U\-4>I&JFD>UW119.>COZE0ZD-&'%^Y<#7#A::>T8.H^Q-/B]'[\L M#Z6^7'/H#C'TD!7 M#.ZD#UU(9OGQ_3WK( &Z'>?8G(UV8I<=HAKG')JFO'& M3]2X(*[#:L>Y]HF;!NVMK!*Z$*_+;D=]G7,Z#?!; 3Z?8!L)5PWE&Y+J"FQ1G\F;R)@IXQSIT#FTZ -]P4: 1?$2EFA_!&*T9OKQY,.N](@P,B47 M'%D/YD]T2@,L]+.5&:%_LG"K.U8YNK;H?5F$ DH62#^@6,]VHFC,^@'%NJ)$ MV42@RB?$D4^B!-')=SSCXK,]H]I^9QNF:HV]@A.Q?"55CLV%8]A-> MNIVC>4Z$Z_+;X5[SZ%Z#_N9V5UU#3B!=_@>D5(D_:R_+M%&=C%%$XVP;WQ3F[G#6DF)W MF?<<7FSZGFVZ0V&%VDB_JMO9L'27^Y1FTC7<9V%M? 5;T].LLR&QL &&O^C) MX2U+WZWPFSJL=J>PG-]<_)WN:5( HBRC^/^"6_VG+C9Z)".DKRTZ5S?F7+9" M.IT%ZKHC_6PBR.BR!1773B_?^1.*/GR;!BF%$F^Y/TE[R:*V2:FI !CM2S)* M=RIU9H+/B)"4A)U4\U2 I%*Q?\X*0:J4\ /"ZAQP9U-V!WA8UVY@(<$63;Y3 M\K=C+?AT76N7F\&6C%[8U[H5VZ%5UK5]J2%OR?3KO!2CY1>=XF56\&WQLJL+ M,)P+B9CQ8K)5UZ3%U[#=<4\+LK"H;^V4KZT>M7M'[>/>X5OHISK642&OA'HJ MI'SO5N$LQI:1L?I9\&IJ!$(L<"DESI02O8_5E#!?VU:Q!E(&5>IIC?+2*]E\ M0M40?Y+>Q[:B6"./^M#.F=>H\O+E,5+K.KIP=G7S>A2M$#*[I MP?MD[<*+M^>-,9X5+\^S>H*1L4,"&:9/VKFH!5V2JP]U/ @%_&F[G*$_#/5B M5TNKGE_HX*"%P$X=8;EL21%!5Q(/ ?J2R'.@H6Q\*\E4Q4=@8P1L5$9*PB^" M1[.4D ))"^%$:"HJ?@==-N7^LQ;K1W&"=+5]9$2$6-IC@.=*P5NF'F(VU].0 MS,@:#!9+IQP< HMY95O+ML4=NTQ?#>,[$L LT([*E18_RR^$ZD34;] 4>& ]<.0R/!7$OBWS(3#LXC" MS!O79]\N;+G=]7!;R#%G'N<%D4_ GN37B<+D15H)=9GVTF._G.OEN] M\$%?2!&[U."*M#N"V"=#BYVF\RGZM-\S>9-70:$3JD1I:[TRI=MF [:@O5;[G1%Z7(C>!3B^JIG;6YWA_= M^/)\ N^%%PW)[:;B'+/2OU,Y>8J& ?62NP-BHZL26VRE3)(Q$9MPYY6C@B25 MD,F'ANH,NVFI]N'A%JI4D% ^PBP6HAGMF3EBQG?F1@0*/ MR:,B*]XXIQ0>PE]UEJ[XO.__!7,$)>,+-%4?9\/$!@19ZF*F=L-NL1YNZ!M, MA2#:&A-UBL5HR8T@)+V9>^%YSINAOT%Y.ZR5/@0G.,@.@]P1'*IYQ)1JW%); MG53[V9@=FZOO*--U:X\)S/1[E>"YUM70'X.W)9=5)J>TS'%M=?*=![0/Z:JX M&DJ>H%H#\@T XEE&QT:PEQ-@\ZFNA7C<3K*GP;=9Z5(3[C;L)+OO*HC0F7BP5I]Y>^9JEX\Z7S[A@4_4Z89( ML&"H2ZFW9J8_+[#-RKQDAW&-WNA[*J5A]6O M=ZOV;T_?#/5;>KIC7\=SO0GWA@M;!^PFV\^^]_F5/T]X%&+FW_!(2$+84HBV MB$X-^MWBUI]R(>E_TS,A1(W?'DQ_]-IA_Q4+/XL+JI'N943W$.>98/XW&/4C MR=5BL'<5^="3/A(_2F]BR7K@2L2[S&KU?5\/[S@ 5"(F!Z\P8\W:%#2I#+0* MA'O;Y!X$'PL\A3]_$>5I]Q"S14*??M0%9/U&J?'5Y]QM,_P:*34&H^37ED#O M%^J30M)X]?NM9K_=J2LZTC^/[JG-7?.XAJW92[ MMD9PCT!/Q<;/=$IBC:$'O<.O3Q$(S9/J+K(=V[%P"Q7SU7#]VTRE.M46K.[9 M8A=:E7@_>LVDMP^O QX2?[G/++W]!WO,BTZ\/^ZG_P%02P,$% @ 93^< M2EY#1>75#0 5\< !0 !C:&4M,C Q-S S,S%?8V%L+GAM;.U=6U/C.!9^ MWZK]#][,R\Q#2$(@$*I[IL*E9ZFB"07,99^FA*T0;3M61K*![*_?(\5.[,07 MR0[M2WAH&I*C8WWG.Y*.I2/ITR]O,]MXP8P3ZGQN]0ZZ+0,[)K6(\_RYY?$V MXB8AK5]^_N<_/OVKW?[S_/[&L*CIS;#C&B;#R,66\;0P+C!SQ4>7A)LVY1[# MQE?DH&^X;[3;OJ9SQ*$D=0RI\O"@M_KFPM=*G3/CJ'-XTCGL M]DZ,7O?LZ/CL^-08?5U)?H5J3DBVJ$V<;T_P/ .P.OQS:^JZ\[-.Y_7U]>#M MB=D'E#U#R6Z_$PBVEI)G;YQ$I%_[@6RO\^?7FP=SBF>H31SN(L=1*"'^:@=B;?%1NW?8[O<.WKC5 AL8QB=& M;7R/)X:LP)F[F.//+4YF"DVZ[.VSWNQTAUE%0UWF/&J\^ M'$^NP<-G> ?5CM'YWG6_0'SZQ::O?+?5#ZDMBF#=!UPAYD!'PN\P>Y@BAD6# ML3P;P^/H;.ZYTN_'DTVQ2^PB8FL"W-U3=X?_ACK/CYC-+O&3*_Z-/5=T%:)S M+8A11?/[X%A;\XX1QR1S9-^AA7 B/IX(H1N*G!VBTWO>[C"/W2EFRT9]]3;' M#L>W.%29V*\+PB[T2!^YB6S3LZ6+WP!.'ZUXT*XZY[!-\1N,^A:V5I\25SP( MQL=NUV@;*VWP>UBAX6LTEBIES:'N-C4CVFTQ,E(6I_">)/<@R$0.49 MH;F ,^A@V^7!)X+=0;O;\X?"'_R/_[HAZ(G8Q"68CQSH!ZGY;4IM"^*@J[\] MXBZ"9]KH"=LR$%(J]M>@?S3H#8:]0;]W.#P=GAP>!\R4AB\;"M1Z<'AZ>CHX M.3[IG1P?]0>#4*U#'C5B40"(F8%V^'7+R:(ABB_1X=YL)K6U"3A'4'["Z*R@ MG?V:476,E(%*B'I;AL>AZG0NJH7LEO&*R?/4E=^4S-Z%QQ@TH&P2?<%*N-(MI==PF4P.@"J%S1BB#'N!SZ["D MMAF*33(:Y[9D@WA51>>3>EAI4L%)F8>M97#UB-ZR^MU$^081K(?1I[FO1G-Y M/?,2$D3;(OY4)#DJW42*%1#Z!!]5FN K>,6C"PSO?K9XSU".HS++-8CT?%A] M^H\K3;]\0U8F/4&Z053K(/0)'E0MFKZ!FC]+"]UCCME+1J>=)-X@5K4@^K2> M5#K\NL03#! LB#)"5KFECIG*=5:QJ$$&U>)Q<&&L13F!W4ZQZW"J2 MLLVF$K3*KE-8%EE6Y0X1Z]JY0'/B(CN$*6EB++-@@RC.";86#?A>) \XV I2 M84:FZ&%W6XB3GV$U*XUE^69F\ MHV5U,M;5PC)16H85<,,4B\9$!YE8JAK]B81?>)$1_XG&]H)LD5(YI6R564VC:R8"#\W5+ULEI)SE>ZQB0$<])JW.".M):U(,SC71EB+8/_: M>8'Z4[:XQ4G4AD6:064F(I4HO0RV[AB>P_NFS+M)8"LLT@RV,A'58F;;1^'G MZ*=WIK&RC2)3 9I*%%Z5I:P[&SFI 7EZH:I2JQCNY@!7B[7H.T;GF+D+@<6% M<$^$>G.Q<25YK$PK$C'$:;=N+&M#J\54U[7C(N>90#2W- : N7HS;4_LF?N5 M4NN5V'9B7)1=M.:$K+L%3H7]J[>7(8 '7$06UR#?677 R7! M]%"_9X@,,,,\W4'>Y8E-B)DJF4:/V0LQ,7^@MI7":WR!ZC&LQ%,\O1H0:]%J M'[ <@GZ%-VJ&;( ULF;$(=P53> E([13*]P8_@O U8O42FKSEWC.L$FD]1)7 M3=%5#V$M%LCD MPH,PQ]H:JW E;?TEH4ACJ-8&F3.CO)QUF="AOTI+,WV-I1FAVU@JKTQV\QT& MRXL3K<1^#WR)E_]K)3G'JP!7.#[J'I\.AH->_[0G?I0TB89=4>$[1E\(,'B^ M^(V+\YU6/CLR(:)8GCD2,\.0O(Y50&D%^X*BS,;,K^W>1+4(\_,L@U;,&]Z! MNEC_R+"!'MU'.]EH)J8+ 7IP! G4$!H"O'&$T_LV2%4MMF<\%S)++:;;I=W$ M+2$0\UY2[\F=>':P42(Y13*QR)[Y1VZ3U.(546ZP',^#;.",R9U8X3WU!PUC MZ+U':GM"[ 1?KD=3^XQ=QDQY3L$5'OTBIBUV?852^T9W46L4HO$S?!4%_QN M8\F=8RG,%ZD4W3-W*6P:O>S0DD^*TTM(S"BUMYZB;Q6]HT&UWSAVEM 8>1^_ M=K9WYR9G)F86W5-WR6T:WV=.%1>9*^,TP3[@Y/MP4LM\N(FB37S_&-;-/Z*; M595=)%KLPTO4S1),=W7KYBD;]]EHCSU^N0]?T;!+X"R*DZ/E[;W8QK9QA4H. MKXG7\.$_N2P4>%*U$V:V4MGT.S29RC$R,(1+\JI#./?6UW=LL\+_D.>9*["J, MKKI\(0YR3 GTP&3$EA3BNRI^VB;)/".:M\[E6 [,@[V_;+E MBIA()8>FE+09M!!#.'^D(Q.LQW#BX5I)233*"JKG.N_ ;,\"5%+7ON4$6LI+D9LR2O2C#G:GS?Y?BGJ+1Z/O?] MQK\B)JKL.<;KQG2/YQXSIV"F\23[DJ'L@M5SE7?@-;5[TC%,/0Z! 40^O/$D M2*2^(0Z&/R\8ME(N),HHMZ?.DL\NFJ-761GI*V271)C0L;AZMQ)?:$^])(=1 M,L>;2IPV$7;_Y0V;H=MV%;J2K3)[ZB#Z-E&Z*ZOT+B1F(<=SN8L<<>SQQ12; MWWB,(=77S124[:E'[=!8>@GR)1UXJ#X!K^YPA71&3=G?%[_;O"I]:9E\=1MLFFAGY%>AT=.9],LOMJY_DLDMV4O[W/+WH MDG#3IMQC.+AY^PXS&:L]F%-L>?9RUG/NN7Y>PJ;8I;BXVU8[W.BH>]0]--K& M^J'P1Z#0 (V&5&G\&#Q;GG&T?KKX@%ZB$2HQ]I:'+' MOV_YDMB>FQ@%YM!3P\-H*M(YY&-,\;"9ON)B0!7&A#]D7; U>H'.[QG?>K,G MS,04I00NVQB>SU.+4)R7L MMU1FQ03F_(.X4W@_F6 BOU\M*17Q.L5'[*__%3%0S@L=WCOJ#Z\QB7\A,^E% M]L?;D;W0W1;*#:%91.GP,_2 D@-WA67*J$@9?4.X!IFW-<8+1]WQJ +M-<[R MX<:H@:,6P4083_I5Y3&2]:8O#43.P?E[=HGK29 [1AR3S)&]SN.0\ST4.;H= M93^KHUQ-?]")L7JN$3Q8?.I.L2$+B.=_]*-ZE?R*7(_)R;]PRL7*T-?.?S!B MC_#TI",$\BFK=T,NB+-V_;0:WE>Z,Q=YI5'#G3;201)0UN(]30/M/9XA MT_ M$QOY.% GP!=WE5BUC78;=<05?<'R=[2$;H.\Q:&P(O9KO8#BI-O;#"BD5O_B M[LZ/ON*?X M0'EU=B9>4@F6OJ^SJJM*='-+[%;%OV/T=V1[^%1R2CYWE*2;_ MQK9U[00G0X93FQZ9MW6?PE433CI21;2#GUQ])B1T;2[*=V'BER M'1)=UK<^7=9:7I:^_.-YZCN/F >$T:][O?V#/0=3EWF$CK_N14$'!2XA>__X M^U__\N5_.IU_G0W[CL?<:(IIZ+@ MP>?WQY^//SJGUTG):R'FB!07]0G]^2#ZBYL%1-RZXMRCY^3D@F=)/1W'97O=?U_T[=X*GJ$-H$"+JKFK)9G3U>I\^ M?>JJ7Y.BHGLO3,JFI3GN+GX410/R.5!=]9F+0D54(03'6$+^U8F+=>17G=YA MYZBW_QQX>T)=CO.%,Q\/\R\D8W&'^2-RX M\^"4>G?(5_^>CD+,[]'S!>)4S/_@;'X6!83B(%C6W1!OG1+4IY<^H^-[S*?? M\$-8%[/V-IN17?XWB$*Y%LG5NT8$II:;P2%752_RL9SAA+IDAOQ;-%<#9S"2 MA?H,T1K15>NO&L =CXC>I5^ZYRP[2J-*6B$T[(JBW669KK:!!@5.>NEX M;(I(16GSM5]'5#Q"D1^N+6M]7$T]5:%)[BJ#.%$\?,*^HN6S5I9!" MBV3A]_6%.$NA9/DF'.*T&O!S*'=D+_F6A++3]Z*'GM-)!W$ZCFK<&8R<=//. MNZ2#WYQWRSY^6T0/!#"?N9G^?!FW8%RK=Z6S$0H>E.*BH#-&:";!GG2Q'P;Q M-W)E/.D<]):!BK\MO_[S3@BD5JE[]+!BUDDS"0PX*K:1P%P-M%.>!2P&:-S70W2XJVU!=:T MB#=2H>;$&>$ &WZ7(Q&V)6&K\147H T#GY1OPH7'F\!:PDI5^5E^,Z M>4D@%#/SI9N-1-0;G2CSE+M4<.(P'YQ8MNVD&H<3FL@#OQ:&/9GY KQ 3YJY/)"@AG4(9D@Q0_F5B,EZ]N]AQ3(V)TL+K_[ Q?T3N^5L MS-%4_/,?8:]B[QHCL1=)X<7&2YC7)^B!^&*[-48QUFD$0DBC<"S&<8UU *8 M:Y47^J+XQR8-MAL'?)^'+XB-&C>Q!07 ="0*4^JDH MAA: ^4[%G/>Q)]!C\BB1!N<1YXOE6K==VBI ",/4NS':T+8=L:DS3[]49.+:6(8SV!(_IWE"#JDQ*E(V1Q8F&, MRT=_5W3$^%1%ML_FRQ^MJ2SKM-1J$.C%R+#EMQ34@1,4VH!/;41(CQ? *AY/ M9VO0(5L&6@3(-OXR9&1A;*/RLV&08Z!1GK4(T4*KWQI=]OF#A"@P1G!TA4!$ M:'3C)38A=4(W;-K':R,+V9 QL4T7:31?$H*/7$:M>/GC(LM2DQ!:QY< MKA0$E]=(@%%J$/JF ?.)ITP!Y098#!]3X18L'M,DJ,?B,0$%29AUXS47!V( MV0>@G11 1E!-M( VC3:GJG[SJ![VDG=U8V//NOL82T.PKHH&8IHF(Q E%C6 M[Z(G6N6JMICC6P%:]KGR&IO;MJ8&J]#9,IAV@TW1V%PI0)9X=7Y?@H%FG NA M%GFO?1:8)M^+,H ,\\I\O(#2=KS;?EI+J0CV<3Z"+5OMR&8=V2ZIM M=5NL65NRC>F1%<3B1^D*PHD:6S2?GATZ$ #6J*Q8-VB*K8:XN3@0_\@\J,QD MI&'\.I1DG8<36+[19C1IH362&'@_85& J'?)(AYB3,\Y]DAX.N9868*V=,"2 M52$X044C+I4#6!(5-%-,;MOATAB0;W%:=AM]43@QNY+[C1X&0"JLBYNI,)#= MQC:L;&0 VFUJH".[''^ M=-L1I$6&@#6A-O+_$?AG"W6WTODFM/32]:!L!'9 M!^.+%&0;& 4R32^:"I=Q1L68GN(U% 60G2F/"4&$ "H^($XD?ND?/G8LO/G MB[6PZQN",B5W_3P$8.JW;B^Z@D!V>M,0,BD?T Z_@?I![^SK40)U1Q?KK,?H M%15K[0.B/P>C$18[FY2[?W4V&%JWCY)U(>SPYL'XPA@K P@ ;=EUN>A1F[%T M>T_7"@"8PS%;_L!,(AV,LM;CQ?.,+,XC6;S0:)INI:I",-XJD%L.%+BXCD;J M:_1,IM'TC''.GJ2'@&;BE]PK?>LU >$!W8:LFL%!8S<+5)U9>C?C&'D#FMY' M>J566UMU".^5K;T0VX!!8[2/U4GJ\9!,W3^Q> 7.-$<+JT%XEZS*O"P$!(XY MS4HRQ%([0NA-UEI;(Z_*ZDDCJZT-'J04"=-U,&E=6Q(E#HL2)=3_4QWL\B7> MPC.LS7(F=L^P=L^P=D]#=D]#=D]#=B&K7' . M4$HZ^YDGVI+;%CC288!,R0VC;FE6TH6W+/9C@@')EZQV^69)#_.HR,.,>W68 MO-9HV:\3=RR_#2?8415D_SL'=.> [AS0G0/Z%KV;C1W.G7>S\VX:-.:N41@) M8X;(]SMGB>60;.J+F+I0HKRJ-7"1_V^,++DQ&S:[Q5[4>H AF_D%B*ZHA'#_ MQ#8?#:FFMMAW*P]R^UD7O9MLZ'4;VV+GL I,R-S#BW35\/B_8J3K]5SWY.IS M%?AACUC\F;K\O*2O?ESDJR?=+/Y..MHYY96??>.KWK7._4[(#6)24 M-/9GBND20+SKW/C(*1B0\U9)Q=E,_D^P7DXHJW8M" !,7 OE3:.I/9*1+0,A M@J$90)FP159B"'I>)./:]9PM \$?+=)S5F( >MZ%A6#( MC[$T[+7"7@J_\QP%DTN?/66^7]757>E37]-;$M.I%W33M_Y0&B$_.2:S+V^, M.F?3*0FG^>?R92IL2?BE#)2VG?Q!.,$\$6]YGWJPYL%X)_F#\53[3M*!$_=0 MQQ%YVL&F!Z3SV0M+[VY2JF5(W7=VDJ M (FU:UU4MO6)MP)USH+PE'I+2 E$PSICK]*F%U.1U'* &K97;R*)2#X44Q<; M!^=J2&@FD:E@FT[$&K/(!*-MV_0N9.[/,V$P>\)BEA@69P[XB*YKH'[4W#TH M.^FH7IQT-X[J!\Y)SJECZX7;AG-J25]&>39?E5DFNIX^(>Z5O&MPT_;;6#07 M_=NS3U^4:=\N;HS;]%+Z C4$RWEMD"LLU)/SL_ 4Y&:Z F+':\=\QFYO!/UN M!&W:5>;I7J\'ZQ%E*Z-*JY%&KHQ7EU90=R'Z?B^:/&]$J8JQP7U(3PH:H/= K5LPU9A4HHI M>E)GPRW>GE6;6@QW:VUJR&YK]&9MQ5[\-Q*^]NJ14J"\^/L)H@.EA>!W+E,A MK^R'$+Y>]UNQY*TWBE]-A] 2K-=&KO[W P6LNJ&+&1# MQD+,C6'N?!$(2[LUHRXO?9K, MX!%FQ2H^U=18'(B?:!Y79C* G6M:$R79I+\C6&F0F]&DA5:_@?#][H?]G;F7 M!2!X]T6C)][H7\H.[1EV;F4U10+*5&@O$ZP81O:(.OUV L3#[Y,1EN\[N2&B M[ER;*64N!B':7HX-,P9PDR29['%D)Q2?DJ8<32LZPOIMDGKPJCB7 D(1Y.6UVQ._(85>LN9 MB[&\$/)>&&Z+3B\9[Z.GNXB$NFR2PAJOJG##I:'E%5X(I^T AX#A8AEPD4T- M1D,2_%PSM'&8#VUD&G<&(TFD1%/BF:+:9@*M[$;YV0YFY^)@3B9(O[3 M$N$HK@8GWF'G)KTW%Z,"8#_EA8Q%M+KUO;47!7YM%=H+_!;#L.[3L *_\1E6RW>-A/O\2 1X;;*0L2B$ M ' Y5NPXF@[.1-R=H ',@GICM"QCW\(UY[IUAU+60C1W/+:M@"!%G//@;H5 MIH;X HVQZ:U<>Q4(4> -5ZL,'FB$G;JN?"00W**Y7%3MUXB;"D,(*%9"5Y.YO"PQ7Z]:*/1]/A2Z MNA(KU:KS+I;'47+\KR-%6GQ6&6&)5#)XJFVBY1#J2H5!@(7Q3+T^00_$5S?3 M76,DT7L#.L3R)G.!4Q2X893'?YZA@%@SR6ILOXT5(1'_;)Y\3#B55SWX%H^V M;&4X0=O:1T-ZF2FK#@ ;02+?$K.:J7FAK6YSQ3: N-75!KR6WG)XWR++V1CJ M,:R@\2LQK]4!I,%P16=1&"C /6LTV5H#0DQGK?&M)5:'$"AGAY4Y.VR%,T/8 MH1'.#H%S=E29LZ-6.#,$+QKA[ @B9V?S%$1E[94S?_6UX#S2>2V[5Z\' S? M,J[4'R;")A]67K!UEE9J 9ZQ:QO7:3(KP7QKQ&Z+?=L V5#-VC@^-<0R%Q=[ MBZ3GJF.@VNGJ $_W6MW,SKH M4]3 G597Q^J8>_K7P$.:/H14FD:4I?7E-M^KMO5@_2MU3G VQK$RA@PCK*@2 MA*6A\<%3I 1HZ1#9J[43D0T4&TN#"M$UQ:T1?=,Y8.J-M"OZQX2XD_3A2'\0 MWQ]B 5:7#%:B$H1Q+BK.YSN6:/:F>XHO%OU3);/N0S M6^*&G'=Q-PX;.=-E1PZA20DP5V_& I6[2/-%Z=T+$8U=FZGE9?=&Q.Z-B-T; M$>OH#_[!P093NN+!P0"F?;QR%;G*FG+MN;M&H?5WP;U8G;?5 8UA%# $8R:4 MHF@E,C07,);LDG%,QG21&N[.[SFB@:^RRW\7NI#':12P4:8!"(YB);[*@%K+ MA?C2E7T^H #__?\!4$L#!!0 ( &4_G$H@\("0:D( '2+N/^AKF9ELG,Q"_! MS*JLJJS,/_[;EW6"GG%>Q%GZIV].7[WY!N$TS*(X7?WIFVUQ$A1A''_S;__Z M/__''__7R/7FU>GW;]')227I/"@(9Y8B)O+LU6GSS44E-4M_1N]>G_WX^NS- MZ8_H],W/[[[_^?N?T/QC0_F1P%S&9M(D3G]_),]#1->T^-,W3V6Y^?GUZY>7 MEU=?'O/D59:O".>;MZ]KPF\XY<]?BKA#_?*VICU]_9\?;^[#)[P.3N*T*(,T M;+FH&!G?Z?OW[U^S;PEI$?]<,/Z;+ Q*]O:-N)"2@O[KI"8[H1^=G)Z=O#U] M]:6(OB'O *$_YEF"[_ 2,0 _E[L-_M,W1;S>)!0X^^PIQTLYBB3/7U/^URE> MT1^'/N$]?<+I#_0)?Z@^?B!VA&^"1YQ\@RCYKW?72JW>=P2*G*^=X1T%]2@H MRS["4PTLU@FE(K-PH[ A)IOEG>U M)89]0GWQS5MN@G\@'_SWAVKXZ76;YFAG__+$H\R L:S$,/)-C MR?:ZP4/ MR;X^'65R7&3;/,1#?L)ZS&9/&OF2.3 RQA%&.CO@].37^V_^M69%01HASHP$ M;O1;S?]??WS-GCBM9IU?9V*-YD,ULO&-2AVFRC(H'ID^9*9=!<&&3F _O,9) M6=2?4#?ZX>3-:366_Z'Z^+_OR4_))M>'X+$=:RK]541NG40/E;J$G.(H#B S M$]WC>T;1$*'?&)D/OST9W?$U^;,P*280 MM #[+4#AHJ.%O8@Z"S!TJ*&.W! M1E'@\-4J>WX=X9C:PSOZ!S6#=X(9D(^:T>V!B-W3I/^UVY]''B&(32A0J.V",]3FP5A@;..O.,CM+$.@A+:+ M'FBY531D@#:QA\%H$93>K3WP->8=7L5T79F6GX*U;+J0D[FW!!W_^YY8"K'_GSI=.?V#)DWN_ M;$6#.)%;=[X@0TH>)-=IA+_\.]XI3;1'!^70"L!=C]XC G!I*0*53U?$B%$C M0N[*!BZV>=Z9@=2K #6I>TLPP:Z-047GU![T('HF49%WIGG7JP)NEE=Q@O,+ M\MA5EJL'ACTJJ&%!"K8[*'1( (8$R?-5 P(C136MXQDA6Z^S]+[,PM_OGP+R M&A;;DAX=TRE*/=QIF<#F"@M5]B8.#0?$+&*$HYQ2&"=BK#/$F9' [<&YP&)Y M%:=!&L9D09P5L>: =1@K\-F!A5K2TP0-']SY@A%4?_[*TB)+XHAEQYP'"G%B>2\*'!9&.QLGPC&HN101=OI4CBW$MGC^WO;]_>7#_='.50OA72< M P R(FB+K,(^*\/LT4+:IP)XWTSW"(&L58I"&80'P+9Q$11/\S2B_[G\^S9^ M#A*"JIB7%T&>[\@L_CE(MJJT"DM>&-L9I)AH2U:,SFUK *J^K1$FEI44TC]P MRWZ4,7-3'TKIQLVCJ(."$F'R>;9$',01]2/Q2UZ":/B(5W&:TMT\HN>.+-YA M9CXG!NEPC@S#;$L0W.$0$S2/"?Z$RVJ05@WW6A:@&=-"C<[$J:%W/W\:P?1# MJXH%Y0T/2G!!'"5)LA>Z,BBHF_S+Z=O93Z??HV]IGC Z(?\^FWW__OOO@(+& M(^KY_>S]FY^HGJ<_,#W?S<[>_M#3TYU?7:?/1*LLWQ$5%:^C2P+C-S*8HI^( MWSOWB_[#>_91D\3X.)/Z,\X?,[U5'X;2G47>YG@3Q-%#\ 6K\D6[)# 6*8,I M6J3XO7.+[#^\]UM7)"A.PVR-44E)P7_TRR\;G!98/Z\K:$'-0 Y<8@]=0BC# MD*%06@CFQ+YLD-@L[KW8$#%NA,!N@*A2$;(R2%"HW?Z8)@RC#S+OW1V.UIV= M?L!+3)!$%]F:N@R[A7-+\')-%&J:F& LV4X5T;3U',YMW0:.- JRC5;RI-P M/:IDH% 0@C:$Y4@N85J9.%;*Y?R?;7!>[J@R["K(#4Q@)"$"8R'K!;9=A&N.&=T("[."_,%7P6&X76\3=B(8X0U9),?< M[-B:^.S'V4_O?A(6_V25?/K3*=#J'^HUG)W^,'MW]K;=&S@[/9V=O7\#NCE0 M$C7CQP3S 8:\@SMN_= ?@OY(MZ> MS7Y\_ZYUW;=O9V=G_>U+=YYK\$YH#]1Y&9@G&8RD_AKN4,X \)*E=:%'GG$# M>;9F 'K>G) =$ZO%ENC(7]R=&R_*)YQ7PQGQ*NT&B((6QL&UP$5OEQ(Z=WT- MBIY5,%KPK0;ME@+LUH%ZBP!H*T"[.N8[2/#[7%IXT!EJ-R0TBI.8KG ,^6E2 M2A@[U( 6C5)"YMQ"E1AZ]G!S/3^_OKE^N+X$RJ@< +6E],)R[1(L=0S@=FR1 M:JFFAK3J84F7B0^64Z=TW 8[NBZTRS7:)X;-,I)#E^47=2G!,HMD,-2Y-AM. M#3BX9.GJ >?K#_C1D(LFI00:3M2@.^-(G\S] *+"T)]K".4)F;O6B-+.4#V2 M? S*;2X=2 X#KZX*>J B-? -W6'BNTM)HUM$V(%F_>,IX'1$S[<0;$.&J/!LL(':3!M1=)50WJ8IO3 M;39+:]^G!K9U.7BII7=)X>Q:0CRE>10&P=Z^-UM SDMP*:!#DC_T*LHXS4[E&T946UNNQELV#!0E]KX M$[*J@#YTLAY)E=2 !T]VHZ:"%.;PR7J$Y,=/=<:K%SMEUK;BCYG868@'QF%M M%]U,:(U=N#G4FAZW^S1NLM 3U# >P)O98%.Y3>K(DKE5/&#IW'I _9JI=;*S M[IJ3FV#@F!K ;'D;/4)%#+_QK;=^.27H]K?13FXZFZPD\*WN^2-VT1\JP^H M%>#'?_&61;.DN$B"HF#MW*PGA %R_+GL8Z6PZ?Z/5H@75X(L$*J'Y,X-FJ.' M7&,N!SE1#VYI:I<4Z54T9E9!MT:%SI$<$KGPE:H7=B/ -J]7/%B3&A:CD*M0 M[3).D_+E?-DY%JC#VF[9>AWSBYFT4E.6EB1>PVFHME(M!U =-[,2G>IM:G+W M-=M,6"2E31L.=M.OPP-4Y^M@)4*1!WW[*2LQ.NW?OG19'S@+?W_*DHCH3F]? MECMC56 U U0M8),*W0K *FJ NK]Z*/UC[(?%Q;__>7'SX?+N_G^CR__X]?KA MKU"KS>'@!08"GK' S@=5K6]M6<\>&=S(+X.[/]R+-"!C?!^ I.+A)J9Q04$) MT0D*MN53EL?_(*N@G][,WKQA_T,%+Z+^+Z=H$^3_!\5%08_KWKZ9G;WYD1"< MU03UA=BS][.?WK^9_7#V4_4-T-58%R_AW>S=FW>SL[,WPDM@EV')-V<_OIF= MOGFG>@D.,Z*BB%4P#Y+;((ZNTTICX?VH$F0L&('RI*Q5ZJ1,&;G<9T]90NI7 M7R#D)W&*0LX 9UUWN SB%$>704YOMQ;S]LKX![R,PU@5O]@PPEB7O4JB=9FY MG%N7+:2>==6,"%><TTYF&/>1=#% >.5//V)3.\DQCG[ M<7]Z)]^\^>GM[/NS'T?-Z^$3IN;^XYNWE;&3#^1EKOAE'S(OD ^#=">;K0?R MNG6)48I1+QG$>!3'B:K.H^RQA[QSA;DQ4Z0W1;BY5?>ZT#:-Z$U[3<6R5T>) MIV7CQ!1J-@)6OT*F'^3^DO5^@C_[ M27;[2![L'PW8>D'SLLSCQVW)#*;,B&\<+WG7=)1@K0D_4?!K*TF\I9]&U@9O M9@,_&M.JHZKK(.,!+?*@!J0KH\"VZVT,S?EAVQ"%>B=PUFHYW"BJVS9<9?F' M;/M8+K=)ORV$X4+=,!E VT=C%.WL) T1X'Y3:3@ZF]X>,Z&O!^C]SG8/HZTF M2OY.,.O3F$9SH5*ALK"IZMU-)A[L!NFDKV?ORNDDLB'NJ$X(?$@E7$7M6SCW MN8K3N,0W\3.]^-JM'2J\)?%M*-[I&$$P+C%>9='XATMQ;N9C(0XL#3M3EH7U MXA29-WV>-\=XYN/!/@?XV;)*"<4Q\SXYY(FS',N _(<87&?)>IH2LT %5"95.C&5"IJ M@+!*#T4R,A8E2WNH2-$FSY[CB&XE$$M:44&(#)T1^A;7G6PZ>V>0=S1PDM#& M.CC%>9#07<-H':]F*M] E@;IHWX?9O4/??@]P/7[_X9(,'Q\V[N?1W[:\ MH>55EEOLSVOHH7+V#0IT4_45Q 9^EHD_8-3+_;#V35T.M/2XRL^4"TVF(Y< MZ4JAJ)X%L&Z 08U>Y0 %/4SM "T81?4 %B$1)E1QH88-YB;5:$6RFLJ#R9+B M+UH%U)?-]\G@U@,RN/NK )$&)/;O U!5NZ/$_(!<80QN$K@F!NUP3*^]B>\@ MW62%RHBEE$ CN!IT9^#ND[D?KU485)7NJ:;U&)<=JSNZR9RG1NVTT3(FKZ34 M+YM[5&#MDV5@]SHEBR0039'[SY=8 :>J!S2H:UG3H'5GK9^R-.NZFMYN-?0P M%FQ40+1E);%SJS8@442>O&[HZV\KL_D.G: 4 ]VI&*H!CSPRUWI8G!,<\[=P M?7!*)\HKXB"\>-"6:+1HYL1SO,QR+#2^N?Q2YD&61W$:Y+OK$J]9(3C"2=Y< MPEX&'Z:T1X='>B+D >Y17V+_$/@HCP,Z2#ZB+JK([Y&)=5 5VC0B^OP&7(]# M1+MJ$#W'*5XJRV4HJ2']7PF^[[L]4B"_4^!060PA;[;A*@:XB'D$_B-X>8.X MG [M!QS2M"I?7/,3+HV;+'LT0$&]#&@GD!<)W ?O_:?W?GI"4_WJ0.$Y/$:; MT-L"95WF9X8HWFLI7H==ZBHT=6;V>5#$H2%+T< #U)W.1I%.9SH=@_NN=&8T M2DM"A DQ+L38-%F+KAQA&G4\J0,$)'3 M$.1DD.=Q4YEQP$W%ME83F$/C<>_?JU'%-)ILX$>3O^!X]40O=1(=@Q7^M%T_ MXGRQY!<8%MNR*(.49E#J1IF!,F!&GU&*BJ/2( '.1ZL1Z/J91YP7I8R9I=CR MJG59RP_E7U/HUX:WG,V?.?Q#G&RI(%O5X^W'O#'W8^P6\BX0K@+U 8UB9$RC M=D#%84+^8U'40\,*7N'#J):BW(>2#[+VAP&4M'%8EO)*G72^J[AG;9Q-/JU$ M0,WCAZ@7%$^M5CXL'IIB"8LE!7>59"^%L16:C@6J>+59C6X9:S4]0$%K$Y@! M!2^8B3$17A2](&$W171;W3H_W_U:T'IY31[]/"R).[#ZOGJK&R,(+$M@I,I[ MJ00#I4#D&XR"*!\6NN!TK?-$+DUJJ8A@J/M B&7I0VN(9=*%4,;,K MM;I2"6Y<=B+%>'D8+PH_L+&E(! DM?\5+T'/ N,^-FJ(;J.C=^XN9C"R$O*< M!2VS'&W)")XDF S/K.IVOQ4#*8@!VTDIH?=:2O4H8=I* M*6#(6TN1R9V-1^"W9>NN:,/NN!BYH.9R*V6ZT[B6!6 &M\!C&)6:CH3'OT!F MGK?'J%-]:Z_,Z%Z>]&X:B;MOLG3U@/,U@4D;*CQCL Y1IV[> M:<,#TK?3'EC_9O934_:/AGMD4J8M,3(:!1)+>HG+)Y1RZ2@AXD^(':^I@?$' M=#M$!B]!'A5N>WD>H'K%BB@OHLRHX>YT]G3?P',"I4P_UF3C@KBN6"SO,%GD MQR$]_:23]YQ9A$1#*R[WH\( 9>I!P8(%9$RPQJ4M]T=/V_.&MVH=P/WMT6P$\#>FKV6_<:OV&9*R^N*M: M+;VC]OD\<%$5*&69B]??UD*^HP9IL<-[F%:#BHP)(?\9C9O/% M0>3JZ'VDR^.!F\@ :6UKPQF.5'3[$!^97!4?PK3;8##76<)OG-*E96"OXLAIRK2>PK^5;X? /C_$ZE02/ M_$^OI-$3Y>Q^^*0.F_K*+PN5CGSV;''=QIU&H'N&="AH4U/93HG]YHR4V1?? MTJEFV">4<'K@46I8MJMT/O#S_3!_0L0!>M7,K[^-L*5>_GC733O1CGPW'0E^ M^IE$R2'.)K![YW$];-H1G]ODL8/(41/96+6D7N=%^'CY)<1%0>;D*ON+5ARO M2[SA2$P2D5S#4+RW V4"U;69XD5TJM\<(M!]C9S#T?8KHC"9-'1#CU5N89;R M@@LGCU2L-HO(U;3JG^:.^V!*U*IO-3<7E17O;@ _8(?,(0KVVF7:,,/TSK1' MIN@\PS&!3:^3*O'ZVVV!"\#FY_9WJV4-/12OZ%"AOM^GU[V*<7?K91(]OF>O MABNMA\;NW=\*MU6_I9))2/F=] K^#+7R4?L L$8"QWDI5E=XO1L8Z!%H,45! M#:T@KP8 "Y4MG%XCQ1='-T(T%M1H)'A14.,VV%7W]N<\_XTH3'RLW-%[=ZSM M-?ETHXD3AP@ NE$[6,7._5IK;O>W;0="DY@FRQ_DQ\I17&XEY>1 MKZZRG"@28ARQCF\LL)6,(8:78BT%UL,&*BMS,TL18+XV")]B7;,%3$:94@_/ MUV<2=0Y?GUD+]3T\.W!]9BG1X[!MS%)D6_!E2-S$<.IE".C2"T!?<']OKB\= MNNS2"O+*KRU4MO!EC11?_-<(T;CL:B3XL>P2YM[Z_O8-O7*T6%[D.%+6";'@ M RM;9*?07NTB/1-$ 2,;1+)Z(8R/V]I-\=)KDIP;)F=R&J5R_)PES]2! MR#,PU2F4ZN3.B>[PIHIF%\LA3F3!!^-$U@J)3F1DMRY$3V M2Z>Q:MTV2J4>.I&P("0*DM?V%!28:-065C>O))6,X-L1!I44.Q *+LA-!RTD MM=1'BS;FRD>I4<>JN8 +6&6 M84+-R>+R"\[#N%"VK['@@U^&:152+<.D3*#+, TBPXJ%%P:M6%'#"[\(&Z\2 MKJA9>RNA[JD?)UWB9$Z/Z\K=L "@YO$J;.PJ8A$Q<@9?@D41S9 XD?-Y%B%J ME:D/@+E?%.PF9X1I19\RHU,-OVC&LG4IA5?9NK?-RK+I2&6_ E,QP;J17A69 M'\DYP!Q)!T?2G:]N)$8OZD.[S8308;;SV %SO."W\92*J+;P M>@R@VW<*-(:M.YX>T&[@448?=NULM1%W[*H+78TND407'^]TV6\Y'"C3]SM= MEAL0!PGT^$Z7_3J]NME$A**Z7OP56T91N8@)[A2\MCI2=;.X.N+K\/ZBE[BP M%,)F-M;9#P*#I<#O;PQ05K7;82$"=._#&I]ZVX"Y<#.A$4'5[.R/\TZCL/;> MFX^Y28?G(EH+]3UGZOQ=M@-JJ[ M'@M/5. M6!(BK2['_A DPC@HE'8.JQ[DJR"MNA.T?=EY:\M;\D[K3BA-LX,@:>ZBF[*% M)Y(-5"UARA?3J:0PA6#W51:F0]UOMA84<8$62R0*0K_57/\%YQT,V6)95$ZBH 0X)]% D)P2, 0DG]5H@_9/GBAP1^NKTW8?A=E\+TR"K MH??#=K0#JI(8W'I,8XS$?(X\9)KS,PY6 <[LQ7PQPV I)X4Q=AULTN(B7 E!TQ=< ,<15)46S^X9O-BV.P6"=]7S320 M6G/[4)W>J)RZ-KV2%;@RO0&7T10Y/TL?J"0+=.<="P'[4] M&JHMQVC,:-Q;-_52CMMU4'RH W+VM%U8&! M00!PG&"%3FNL)\1 0=N(3*C+ON,!'EU(+Z>8#KP,3$ '%E:J=,XJM!SNCRDL MX/0W\MD5',PMEEU7J 0C)KESC;"YCP0?\A_GK>B'!\ ["EG* MAJ4L-VWC2"F!;ARH07M:P1 M%@O:-F"5!^O"?EDP5 CL9O@P566[Y'82P+;/A\"3;TVS0@B-&$3,MA8DYFGX MD-D\B8+P9BDV1P MUBP>+3UNB4Y<([;\OB5!5-[@K&HT#)A QHL#JE)PH/J=<@4C9;FO6W 0T'X! M RX.$7E5Q8*N1%2+=#KEF(L93/L6]KT;=*99QR6__Y9&_ +W"J=AC(LA<\T0 M&6"SS7!%]^8;>P$0,\Y0=/T@$*^"A'GF'5YM$VIR._0Q**EW>#'_,( 5H'TM MC:L5.UZ@1U0*(ZRMCEU#%]G]6'X'6G\OT,F5,([B!QQ^3TH[46@8OC,HT5%$>Q)B$(=B/'9!1ZLB3UL.&1;A2V8O2K 9(QZ.:]@WC+,*$3$CUU>])98GF?Y19;GF*,S3 W#1,#XX1@U15<# MDQS/TZT_L9QG6R76BYGB R["/-[P4K:?\$N+]#;/4O)GR,$2#_TK+N=1MBF5 M34]'R@+*]S]$\4Z6_QA![G/[QZ/L9_2WLFBM6B)--/"N/#K]H!TF+L!%>C#] M3/DJ=/X-Y]2_9%GT$B<)&:^NTY+@C1\3/"\*7-JGX@R4 >/$HQ05G7>0 .=. M.P)=ST)K&3Y,-E;ZF-8F0X5X;)G:5U5J:MS1KZ+1A7"BAI4,!)09@461!^ET3[BC M;<)NPBKTJWI@]1JKCQX?ZF?2VZM%2?[_*& XBR^L=6 M$O @H=%LOZ3U=;K,\C4SXO-=]:7Q6&&L-*!#AL.4[QPYC!/E_@#B$)S:H:A? ML5V0.*/13DT!OT,T\5O ^7,$YH4^VFJ/'Y#IUO MBSBE[:6KA_@P!.P7::;=GD*BPH@8^HA:7VP+<_!REYWD@R]<[R!>C*-%MNR*,EX0CS*!S?Z&)3;G/6= M7BP[%;Z'39:V8J!=;)BZSDP'H?D, :IVQ%21Q3?_<<3*];_,X#>--D+1U MWJH=2E;3_B8+1C69DVY_7>0XBLOY*L?L5/8B2TD4'M#1Q+3Y9RN_$BU 3:Y7C6_%SM?AVG7YG&S$:_YS7R8 MN%EUED]9FG6+O=>5WH=-W\.$04_B8U273^5#) %.Z,-A:J-[&.=%.Z;@1VE>6H+3(XH^G=1.@)W:=FV=ZT MZ.",D(?TL*I^*[S0:%N9\3Y>QTF00Y_Y-EV$]/] M#,O;S$9VX(O-ENI)[S@;>.&N.UL!T]Q\9F?,E0C$9*!:B$?1^('J7@1YOJ,: M52H+%[^I-_XY)I%]'C[MJ(M[=HNZ';L>=[RZ2H!AP_F3@AIY/ MK923SZ=:5L#YU )7WU I$9U,:^;J-J=_,^D8[3JGO8K;JEZX6IV-;N]>$@YH MEU(J(7>C'CF@ZRBP:,//YM*$/[/680JMLV>^N1VGZ)#K$=,XQ^5R2>_V/F.^ M<_40?+D+2LPKLV[)U-IV=5"\C"$"8%QGN(JB)]ES.W>LH=!Z9MD(J'=L:5X> ME3%#K11-8P]7#C>AHB71D- ")AU5B9%W.,Q6:4Q1?]PF9;Q)\ ><$(@Y'>;F M>4[OX/-$$/J!XLV,%0949/@@U3O5AT=)\D:@4B M46(U;P+>@QW\$F[B%%^7>*V:<@X1^)48?N\5'&3\C33_'6 /ZF1.0.4B)AAH MB>7B3:#?$JIF+%5S]*DCF73IHI#@Y/^5W0>4G(G8L;D_81RB3GVN:,,#957#N%R!TZ0"WQGO-D7GV+Q\6V;TFD]XOHU6N+PC:]50MN8;P.?>KP@YD:/C!WE#;]3QP;1:+1_S*.(S:E!,F<5"A8O.+K*\LH7B==*-+3@<>\7 MUHK4/F%D /$'2U0]RVGYZE(3&>%$RRQ'NG'UJ)[@6!=W2[U?4S*1)3BBA<+B M9QK1%A?;/"<_JR(JUC' +-7,*HA+,36U\Z66"4K/FFJ&^JKN46OT2+S EP6! MS0+ FX!_0-@X874=^"(Z@\KF' 4M+R=TF4:J"'\ [$MV8Z_)S_A(LQ30V]/9 M$8'?ET%>3@#]'*_B-!71_]^ V \QF#[\\8N3MG:YY6!BY !8D-@IT2Q%].0P MBQ ;3/U@O;[F1@,3^9:"VX7'UZ'%>ZY%BE=!B96CS&'* +;':JL$?8AI/6E6 M5S!B?]*D35IFH.#AL"+ &20!J$76<"4[3;+LV=VWR1J*K9\$)=1XFB$NI"J% MR<7P:E!,T QQ46 -$"?3EH\:A,6'!"BK C^:X^91DJ 3I@8K?4 I*Y!3YM$8 M)RMA!7S"W%0AK^M(5YBX8!H*&+$8VD7IBUF5$I MD%;&<7S(UD&\'RPK:("L2 :T8S4B@7LKZ3]=:16_<2JHM&@+I*W=FC"/O_;+ M!7^.RZ#XB->/.-_#JR("N+ZKA-IU1P%S#5L8GY">< M'M2O1L!&+F#;N-@17KGS@$JV6KDQI(#:L8*&7U9J2:(R+1]4L&8!:EADK\W( MA-@:F:=E'-$2I_$SOL=A5?KM\DN8;",<79%?6"ADVJ^2:K=K,LU#H#=4IGQ5 M\KV6*9X N TS'7SM#HWX&-0^!]4/0O0'[-3?E98EAM^_.?!]F2:+Z<0#M1V= M^/5T6I).)-M]N]))@?=3K:;R+2^FN0-?EO98;B+97Z5KJ8_R)A'\M3F5]D"L M\9R"E0;(-L ]JS_ADE\GOM*7#EW3/4O@HX=V7W9]@F5%(I1$><8EZ6>?Q(1B2F:MVP D=5PHMXH4[Q MVJ80#./0T[T2T<,/E^K"+'<%&@%VYJP9C^T YRXKA3_1\M0%\63^Y5_B M\NDJRY#[4VC-7?E/\!+D MD0?NT^VTHMNZDU+"&+,&M&B3$C+GIJ7$<%BS'L %=%U$E$/6I M@*U%DRJT9Q;@"4%=X)^"-=;F!JG)?3"0/GRUF;2TP,:R#\1H,I0!.*GH, UF M>A5&ITH\O&0/3]FV"-+HBNA<8ISN=3M1YD[8L[I/IABJ5IU=8W6@9D+3>9R2VH=Y4'M:IB % MG@5-9UF]N,F+,RD*8K'DQGP5A.SVVN673U88:QIB%JB:=GP M.;U ]HV,V1E9UU6A5<]/F"34_X@)@PK #5+O#SUGR3!.:0J[)\(?5S.I:7(Y%;\7KJ<' M9UXZ$#D8^&+E!&HQ+>KZ-TL4$2U]B7S8M=#[38Z#:)%^#O*8;EO16L6G5A.Y MCMV'V,BLGCI84O,"1T\F8&:W8A(0%X'(M%8+8:6T?=AD&*PBUZAH-'JN-8I3 M\FA)G(V.Y%4T ME;6=RCI:187Q;:?'0(;%]YANI%(=#HD,M0)\2WI]%.F?',/EW%C ?J P_C/%C4%;IO7=X4U6'6BQO\S@- MXTV0<,>+<+Y87L5%&"1_Q<'^X<]T8N&-_I#7H7*4,3)!G6L\8(-#LC)/=6NX M&U:9??&8Q*N@RJ=K'SQ#[:/I^-T\'#5/IQ_SYR,* "@V/,YKH^>R7\7X<)U2 M+1Y>LL/?CR#*^W&@I_9(WV_D^.SO>R =^'B<,I=&Y)G>N[7I[1 ?^^EKP_838W>6= DH K? M _4ZVP?8:5U6?^F^$UGWR?U#7?H]>$HI0R'-M)-2 /["_;PYR=[V7 :8!M_60OHDZX M/U@@2";^1*@EA^)<+F+9B.C;4!"!8D'VZ\XW02,=79Y?/WR8?^>V<8_WK\-] MPO_17\D=?R6B""3*?MWYADA_5;\,NF+_^S;FEX G&R*OXB\XHLT/5O@B4^A^ M11;7%T'Q=)5D+YW/6UY9Z]'I1+L?,*=^+?6X.95]CPH35?T+B-YHZCB_L!XA ]&J[J\*/E.XX/+\HG MG#^^U %^[KH84Q&^->'H&PC@$^ZAY5+5*CNJJQX<_ ML47?**X(6W'X8MD])?36?7/4Z\+C+/S&<'58;28WZCO$ *9^%#U&V_RG+=UV MI(?*V2H/UL5%DA6]^J$Z0O<6KH=<&[:<"L2>=5#ZA<@8,4]+X.2(TSLUW9&0 M-S7D4 IY?)OV(/\=EY^#9(M_">*T6*3SHL!E\6><1-?I![S$>4Y61]F:N@K[ M&1[R;2%;2(R6!-#L_3"EFW[PX\3 M(P_!*OD;(5*0\]4'%I1>2Q'B)@F'4ZS M% 5,.'HBTFGJ3U3)ITN Y@&HI$]PW%7^&*^!B4-,'EJDB$M$5"2Z3E$M%(E2 M$1/K?AET1#,0-MH'&0#M5S7=_=C1O@:?8OY M*LCQIOW!R-$)2C&@2;/%Y*(72@;ZKLBY&D6&K_?->OQ$_K@MMUT#M8/G3SO(E> MD+QOWH'" 5OF38)<6UZ<<9\\4O;N>DQ\".LW+Q!6#T+L2?!ER(UO2?625/OM M4PH&\JS)7DG'I0Z6ZMZ7)H+<=R(+QS'XS8&;[,#.0Y=AY4[H1\#FW(>G(%WP MAC"_$!%E<:TO6NKN\5^9(XY\O9.XZ\!G?SU./4JQZ5U_ACB03C)-D.XWN /6M-]=N<*#*D#*[8X9:KORS:M^?)W0C@ B@TJ)6DBSCC#.) GB8$9> MWWZ(B^UZFP2L:6CGP%NQLSS^*FH6I 5!B^-GNBE%>W/3:U_D(1&96RZRM,R# MD(A2)@\/%0!PR724BLV-TD'<,-='1T"4' (3(:B5@J@8),A!@B"0[&1_U!SM M;7=9F=UE&1F-E&W0^B3N/48%L_:)_>]!K%X.HE\"A9"=<#J87F0#<"(7.+79 M72->:H%7;*-F\BH)4N>N2%R4-$*0D%)EE@8$5+*1O_D^S[HY2D.G] +1D\!6VEP&?3*8E#WA2S0 M,J,K-+Q&9(;:Y!EMUHXV"4%!-Y!RO GBG*4)1GD0IRA,<$!+[9.)@2VE"K?Y MV8>\65482+F1P.Y^7IY**YV53'=OB<0%5H&Z1-$!O "WFX8JUEQXLF6$N0,U M#)UB356-#!$=)>@(HQJ<-D%>QD&2[,@ $6YI1O_CCHPB]=.+;L8QREY23J*1 MZ7:$.?1U,7[;):C[H68:]=H?%%'_4?UR$P8\/+>7MB,K%BDS2>DX*B.#"&?4 M<-OHI4\#%*RH@*A3K+,4)6Q88+.,%WX[1@U&2Z]D,6J(>7\XYIQAKG^ R3R, M%KXN%DL&X2&SGM#MV-Q[X!!U:H^TX0'Q4'M@DB[$56LL1*NULYKKW'%)*,\. MA=TZZ0&:,%:T6*('$BGPF.0A\V=>/5BS:N7&?QT29"D&U0/.\N5[UO@9IUM< M# KC;9@ ]K6M56EVNHT<,'O?EK#ZP1DNZW4Y"=&X$!2491X_;DL6K>FC=[># MP6@U:T;WH;6F0>$D&DWFUK-%(C.BW#2GJQ!SN*":^DZA72AJMTEH M%'U -M54_=58V6Z:BHO3,);7:#010_5'TT'O]C^340+T-U/#D-?$Z%##7]OL M*7!CN(ZI8_#$:'HJ: WG!NQ:I F*E0'='.&D_R9>LJO]81FDX4YZ=5!-!I", MJ8';I%Q*:& 2*Y5 ^C\W(673":<]YBT2520].5J'(UM<5LT@[W%9)BSO8+[. MMLK:63H&H)'-J$)G9%-2NQ_9#% DQE,SH)9CAC@/4&/.H3K0?;"0!(]TFSO< MTKIR$W8N20C):K'99'FY3>-2/2BK22$ZB^AAMYU"Y'1 G3]T8/IK:I[T%*=5 MWA/=!,E:7KHOLHP3C((U7:7S4H-)'*0E"J*(X"_8,0EABLB2@DSI?%HGXNAG M81+$:\=]/09I7Y%W-(:X[/A5_'"CW?_R2TF6E'1]JO+Z'H5[9U> K'U\[VL0 MUY9BZ-]7JZD@ JYI(!ZP@Y^%&$?$M!_B->88KK+\)GBYW\:E[*Z6D0-BS]Y* MB7:S7DL.M$MO@4FROUMSH9*PU0FY--C?[U5)$:4&GY[K:> :7M-Q^")T6BW MU]34\,9CVEZ3&= QMM?J9@O5O?!;GN0L3UU7DL+UX5#!WN_$L4\'VHM##D9S M#Z;.:-G4'"#].*:'/3XT)+H]!07/,[DGDW."/Y.542:[<*RA!0@'3<";0%!% M"!,"ZM'THZ::GB?'%XP#/3,6Q^D7HY&S; O.@3@+2([%0/R?KQ_F]V@=T"ML MW1_A,@V3( \\BC](#$X_"%985?Y,S^))#")10QN%"/3P<4@/C$4D,D,M%U3" MQ A%6@HZ.84=M7(:8-47.NF=3P*;9E@QSWF6>C]$V7#:-G>>1O0_M)3BDM0?:'(,"#-:14,>-"TL0% M-)+;*=,9S/4L[L=S&SS](5UM8,=88]*G+,B8'N7!LKP-=M2&KTDTLHUP=)W. MPY >9!;5%Y(8:""_^ZA^E()UI#^(&23Z'X%0;G)9+01M.#$]G69BZ%E54 FJ MOW2[4 !2TOW1Y/2*%H,T=#M9"8/;O+P(\GQ'UE"LNY]F1-4QP4U59E7V9RHU M!\A$98(C-S.!:T8+O=2,O*DD3#[.>&UPRP7G&%=!G#.DO+4E"2!NXN Q3N(R MQL5''!2T;,4BO:/U*W*B%2'XE*5Y_<_SH(BUBXX)Y<.XV^0O2/3,R80[=^*) MD?&BE)?: 6=TCMI9*[_LWUN\#,QV"^Q M:E%DRPSL 5:J2KZ70;U2X#Y9:P6:%S_KO MX4-&BR68WJ"=#&"[':*HU'QM!,!9L3TZC3$C40H2/F\$H=^X*,>E6H^C[EC? M5;P" .^]3C?;LF"CU:FTPK(5![!GJI60^F&?',[K5%AT/L9Y$&<"*GT\7I'_ MV&:T!<)MS@Y&KE,T#UG1?M[8G@P:68ZNZ8WO. R2VK^^98+1Z7<'%4T^GN^< M#?:=,_]\YVR8[YQYY#MG8WSGS$/?T2MR'Z_2>$D<(RVK/B"+1WK&R#8%*]4J M5SGSU57>#G:5M_ZYRMMAKO+6(U=Y.\95WGKH*GI%1%?Y-]DL4//?<5'J18#%$J\6GUEMN!Y\/3>. U M:U/570RVRS;%ZS8QP?B(G2JBT>LYG%NQ#9R>67[J"D&),"G7P8 M%;'[5!@]DG[L0.EI:%1S(,8"?_Q-,V#*G4P=T_+6BA.H4;2]4IV6SF8V]\V7 M;3'U:SHPSAE2FIX7RT"&Y0[7]YQN\VR5!^OYMGS*4..>DS$A6&'JW+R>^ ? M%NHIG47#"^LY1F ]\_L+CE=/-,\NX"Q\=-[@G _)'GC1!#IMLB2'!H*R'4]/![G342T\ZFA [&3I2 M10OI$3FW#06"GE6TEN#%UF,-YRK+R3"77M 2ZVFX>\B#M$C8"=DO9 5+>V08 M]+81 &M ]BK*+,O,#69RMM"4MCA# @^:1W_;5GDA,//UP7I5C"BL.%&@5LF= MJPGOE0#\A%^J$@5QNKK-LY3\&?)[09J[E@-EP#C<*$5%GQLDP+G;C4#7LU!! M!BO!3*2@5@SJR@&_=/E 'K!8SJ-L0YU/FT@O)P5:H&E@=Q9C$CKW"R\EB/Y> M!2&E[;-K8N D^:'(,Q'Y 5<2I0E5K1/=ET$:!7E4_+J)@A)3TW[S7FJ[ _C< MIU4-4JC.K+)B DFN&H"L/VBV V3#C#@WXNS']015>M61='*ADK; TD%ZW?^* M/F6O$)]1U%JX//(ER*EIWH"[9;-[Y 5,J7/%]RKZ^B MY,&(KV'J^8(?M@MVF1)7'$ M1FQVK*-98*B(P3I!:*#O]8"04$)T?U#"D/5]:(D]*6/75T"[QE"3^V(PZA6& MBM8#H]$&YU*S 5U>'%$!=Y:_V&#:JB1=52-WH9WFE=0P=F\ +YJ]@M2YU6MQ M]&RFH:XGU@(X'C@:?'<63Z^.TYOC],(Y/0#1A 5R4AA;U\$6#5U&Y]S*U2 T M-_DI\0RQ,RGH>& ?OS8:4!'[82?J2$!."6XKVDFT)F;&4MD*:! P&'W?UL%C M@#O\G"7/9)B^R'$4EU=!J-Y[M.2!L7TK1407T#(X]P0+-#V3:G@09T(U%W"@ MX$87=S[RD0#:KA^([W[*2JR/DA6T,#ZA!2[Z@I30N0]H4/2K?3%:1(D1HP:V M^2'8+4"[,^[/01[3/'A:@T83#O?)8$Q:!5>TYGT:YX8L!]#OJUN1H3NVV0L< M]XJ@M3&OC!#>&-2Q;I\*U""T4>*>28"&MQ.#=KJ"B[*4%==Z#-+?%\LE)C$% M!7=S?;ZXT\[?EKQ@ZSM[Q?:6>V9&B-6?+2K9H&MTCA;H M#C@J.$A#2N%!@#!_"?+(L%FV1P-TUT$&M'.7021P?U>A__1^JB:E\6,;C%W# M/:>WUL4ZL_,\)WCY78CS74MS&^SH9PQ_JV@:W1+U/@5K?4!QG$89'4T)>C $Q.:A3.%E\&CK?(9&P>B+B;BDX)WDJHH]%]+G0F8Z. M7^+)H^$E/E8OL2+LO,29^!8#J[=X2$'?99:O ^*S3'56HX8A>\J2".=WN-SF MZ4.0K[#BZ'.T%)"2OV.5%6H #Q4!511X'$Y93=U:4N7QO(Z1( QQ::@2!W.K MY9]78VWRY5'5OC\LMK8:<2Z#G%:<*^JJ)D/'&@,__"ACI:!J?-$R>S&R6""T M,+5:"LWPK<(+KT:3KUO+02/(1*K>WGNP+K^)RWC%+/F"EL749+)("('VKY20 M.YM5/2KW.U,*"/U-FH8044KP57L7N#E]14GN@X$84E@4M,#&8DX$V3,9'Q)9 M#M-@\I7;K_>?/\=EH Z4]@G<1T)RB'6HT_T6)):10>C]DK^^NG^%GE^AS]?$:,#C"8F?*5.KS>$Q$QR9B=WXP4F?OVH.6!^+Z@P4@V2V"E@U1/M2P@4<>?9UJ:*;K- 8V7^Q,KH[> MSKH\'MB9#-! .X.^=^-,(X=G;4&"BSO\C-,M_H1+;8*"@A;HM$L'O'-<)2-T M?]ZD1M$_ZZ"TJ")&A!HXE6 \=O@8I.GH>+X3;KRS[K^:$,3(!=R!6J^,M*>T MG 6N2[0.CR3EMBU64'5N!HXY;K.GJ#F\(VKH_V5"O M'"P%:(TP3MG.DF&8"/-(5'#( $Y P 4 8VAE+3(P M,3VY_[Z:?"Y_ZD'7-.S;'?]ZZEX0>2#WC?#-=8 -YQ^GG[N M?QY,1KVSLX32A1' GI[;PR2'GP?[WUPF5#WWE][XRW#V9=@?S'J#_B_CR2^3 M\][BV[[E-SC,E/'Y[=GW_GL^6O8 MLS_ZDC;\%+?\Y2VP"ZU_C-*V@R__]^WVT7P!&^/,=H/0<,VL%R)#ZC>8S^=? M\&]AT\#^)<#];SW3"+'TF>/J45N@?YVES<[0C\X&P[/1X/-;8'V",NCU_NI[ M#EB"50\/X)=PMP6_?@KLS=9! \<_>_'!ZM=/<%!G2([]4=S]O[XF^D[_7+C6 ME1O:X>[&77G^!@_^4P^1_WUY4^#">OW^V?0V2"W]L_[\;-3_@II]X:/XI>&X M'T.((T3^TG,#S[$M!*L+PT&Z>GP!(!0;- >YUD?\8/CPMR\@M$W#D3S\ ]JM M\++_X?WJ!EJ9#9# X%FVV._-(*7:\?[$<@=?HYL4PXR.PP-K1W6.\]=SU$_ W7\&SH.FET9 WMGMH^/S[+? AJMWUU=L6N &H MK6$:-!GT VXX'N/;4GT15).6-_,:U M *1NQ48[] TS]%+->O5'SR0KTZJ&MH\7F$;R+I&1:!? VG#@%G )UI%C0$'L MOAEA"(\DM8T$G:"\44.]F0"I#FGL?K6T@^]UQTLD)7&D<%MQ#X]XEF^LP@#* M!?W@ZE^1_6HX3=8Q-EUY/%S;+MRHVH9S P];?M1H_273DBGOK1T:#K902["- M?/,%VBDT;:"*H:$R&YD.7NHR+0A"Y\(TO]PGX]FIO].@TY._WVTVTD,J[>U]FXV31JV=?7"SL9(HM;S';#;@ M2I+OMFMKQ@,G\=9V<$T-!I%8NRMULR%747SO5;L9)V+?D+\2-AO](956?51W MAH\FU"OX"D+#=FH/FHMTF^N[+$9X*+?)![KLL"('W*^^ V"($CZ-I2 S!&TM[.4-9?9=-OC(8^LS38* M$Z?#83/)'(I^M9W=MBS]5=-L9^SHO_LH1%?-Z')>(@<>"(^VAO;,7S\L\:; M_'<=Y#O#Y Z+MQT]\U9%[H$PEGVYQ#]A8RDK"#*$L,(<[+#;R%:"]B[7]JA^A; M_7Y_WN^=]5)"^;]"HKV8:B]/%G, >7 \L_ %!T5R>SY#-? '_Z@:]>(YP%NE ME(QC/ ,'T^'J]H_I:#P=3.>#Z6@PF)W/YO-9*G3>(2?BQQ'F 3 _K[W7+Q:P MD0[&Z"^(G_%9?Y#$E_\7_-%^:$^0[,'(#W\-1S@=GI^?3V>3V7 X&X^FT]P( M\\!8^,710DN:TH9_+6&E&!*?M/BRQ7'-9^:+[>QUO_*]34.1)N/R./GS? OX MOWX:?.I% 1RUMT4?R.*LVU3- @[,0H.[=HPU03>%WQ<'?]X)Y; 93+0S5*"= ME,<'X-L>9-/Z:H15,ZC0KHO:XF/8>@J\+ONZ@D-H.)=F;*)M0E=EHYR&W[]K]@1YU1 M!^VZJ"U^1A.MG2O0VF7D^P5C3=\]TIIV47="O";JFRN;=->V _Q+.+RUY].G M7*%5%Y7&RV9ZCNZKLY+>9N.YV'.'8U:"7.P$W616=.JN.H6Y3K5+YY@+Z'8BTG6QNO*")ZQ7J/@;&T86\3.] MP MPB#]"4+O-(?>Y,?_R"6;[Z\C'KS KO [BG3- V,X.9\/QO,F\[(^GXL@ &' MX*C8J(C'N;I9V%C@V4P4X)3JGX2RCD&'M%5:@2W2Z7+YD78>&NE:):KKZ:JII':V6- MU^>XA9F?86>JR S$J:4!2C2%LGAV4!!=(EB:-:CHTBFD"#-*O1PY8H# .'7GY2DX)D1OWC M5CF3,>I%C/)M0#+T)$BRVH83VW91D1P<4J]GQ":QC.="#F> ML[(^E&T_NVLWD%*;TXK-XM$BAH&*;FF>1[M--XZTTY^BM0(G2B4X]URS?^FHV7\:D6JV$EMW3*2^3K?IS5/EX3=./@!47/\%W%?<4+<2IK(M#G8P"]G)QFP)* MZZ*T!AW A0BCDGQ%)?>?HJMD;C"< @[$(%#.;.M 2 '<0N>DP+P18'73&2." MX*C%:JNG444'CD*17Q9 R(T[! L!!EL.'U4$!U+,S;X._:5C! %^BYC;E'#3 MZ1"(Y/#>ZC%6Y?6TR(I$[] AO @RV5;(J_JK3?9FM4-:9W'5:JBK(EVC3&D[ MQ#5!41:7AY_% ZY)UWU%CPYA091+62$..JT-.'_^Q7,@9P&*Y@QWS%1M6@?M MD"$QX$&0ZU9VJ:I,1U)DH3(E]J"9AE 0TA_95C Y;#7;555PA&79,1L/AFW= MN$EQX9P\:+=DS([=0TE-GBL\'*GV!VJTOT25E5U@I6\I+4PSVD3XB@>>MVS3 MIBT3[([=TWY-GB4M%J63A:(=Q9,/C"#R=\Q%H]RP*)YA!R#!R6-3K\,\AH + MUOCR]1 )PD6ZR77%28EA<708M'3PAX:[(RT(0GV[ X'F;$MR.6AU>UH6)_GT.%XIY#N-J#9EU,++*/7!!B5EA^#6?D4!S\7D]9P0\LQ28"5.J,L DB2- M%IYCD>(5CTL/+Z+P!>Z._IWM.^@.\L,>75:^*-LM/-DB1L3T3*3Y1;>AI'DH(Z'SN.ACEMV M6:.\[#+>DGE7MT"._3A_D=,=,*PNII_]XG[52P@K*36%OKP?#./<3VE="'$8 M(64J\OD]&@Z Q]!7X$: 7D7MH%41@2/U$TY$R@27+P=WDL((')5A(P&X":P./A$$8 M/]J=%)NEV0*NSAV#2 .FY882J,F$R)Q,U"2'K$G'5,]D35)Z@D(%+ZQ_1@$. MNKWV? YO&K5]QU0OQJ=61V6<28$6-N3PC:W3_18@:U5ZM(RG2\<4*\QJ"TGS MJO: 0<8S/=6@V*QCVN=BKX7K>B5V((5U++);+Z IG="R8WKGY;"%/'A%-;$! M5%%8O9T_:-4QE?-P1WT1MDF@IPJ%WWFN5X1XM>JI[3L& C$^Z0_.'ENB4&;F MKJ$TXURZ",H@L8.>&UR E>>#7)&YJSUO9?ZK'8@ M9.YI"VTZIG4V;ZFN&Y<%53SGT]RM-%#AP@ALDW'O5MFG8T@0YS5%1E.?I?H] M#I%W$4QHAP5Q;7(BHLU[3:WRF?X$]OH%!3!">!IK2O!0J%]M)T+R$5N(#GII!QVY2Q$/MZD)DIE3 MJ1$^Q'"A'1[J:)0;%^^_)"D*LZ(8TT0,)9LJMBC1J'042S*DT,77-'+!OU_M M5]L"KI5)&I@._(,C5)K:M2C'<5?05)OUEJN>[BN%J K=O32"EVO'^['WK3"B M=T<"T;N(=B\FKC:-=\\D?_INJ8LV:;MW($2#>_ ]A&/K8O=[@!*\]M>>"S.$ M".=X.4^;#"EHE;W;T&FJ@6(E:47(G\K29,/SK*K7M_;1;<&3 MMP2FYYJV PIB>/+D&)0V/G4ZR'PWZ;6Z*U94^HPG0YXCJ)G653L4OAM8RCBM M+:\N.J&Q> /(!Z'L!P5O55T^<-9 3ARU/%66>K['XT'E.1B9-\3&'\BH):&* MX[MBRY$6*!0+=6'T^D!),U&U^@:)L+^ 6 L418-!>:4/]T#NH'#M5Y O='D M'MYN'^AI**M6RX;*@4]^EW:_6@(H%-O$+D%H4Q<_#-\ZW+=P]OH 3S-128/_S DV M*?W/+MG!2> #>]*D)BOG2J<')RCZGB" 6^TU]X+*??6@+.@\^V!JVQ4H.K>YVB@#BD$#3 MT! &AA0]64BWQLGS&<)K6=+O%%'$(P*]?$XM@LB/B M+Z_Q$] .$I+T28@T;2:3EJ^A%!FC5"C7G@_%80)@X1IF>/]!$#D#;IQ43@]S M3033S4LL?I$WW\QQ$CT=6+8@)TD9U%J]H4T1TSX6J^E.K8*0=EAL;Z/I *JF+$XE:BA7 MF^GR!9C? X+$^2]0.8@5I3WM,/(DRD=2\)%FD2'YC4,N632X>@.^:0?4 EG, M?J>#L7JBT"L!KM7%$OD$PYW8.AGW.2$0"8NAY9@BQ1!"Y0N3XG/\>RURI],# MD8 F1SY]@L)\X/<9\!<\\!\!2G]/!D+@8FF:JZ1FRPQ_:Q+];;T3S M=" H7TQ-H\JTW&SEMIVYW0.>L_R0%*1R.B"4(1A9,61:X8Y?XLTO'3F)G@XJ M6Y!3N_%A0T6EOZ&0%JZ%_D!'J%?#0?/W VO' M [<%U('O[Z"X_S"<2 QG!WU/'6 \XI#UNML6@_DQ-/Q0EZCM=\;7[ -?!''( M>B,NQM>56S[J[M'5UA,'7^W =+P@BA_ @B?\AQS!3P6]4IXU&$"*@]Y9+Z,$ M_X&)H6<,"N14Y-GX:\--ZCUECRW$17?S8]O7@C**[K43_2=9]_07=DKMM+,4[>FE;#SXI"$IK(;TEF3[AF$)7H$; M 93VLG9M ;LP+-N%A%8O3TR)-_B0)<94IW> ^IX,)Z,99'<^'YU/YD/AT%]B MK1$4VLU2(764U\6Z+!_U?#U\ M;HUSWH[+\S:EU(.D>C$M#9[K%'S'M13(/AO-AY/QL#]6%&AW.$#6O*6VUVZV M"HF><+\FQ&@+0>+O-4-)M_Z,V3DISTY$Y0R1Z6$Z"I"GJ*JL2UP4 J4^)R-A^9$8G=37ISD<'&NJ4D:,TR->1W." M2EB] [P+ZHPVA6-Z7WY**/X,?X&H*I[&_'.WL.<:PV/2>#883:#15Q3S6$0S M_E5UR&DYW8=478O]ERN&(E_9;L#8<++]UY" ,[[X9(1H( MIV$@A(IADCU(LY<1[:54U1B)C1W7>D51@3AH?@U@L ^41O^/I)S-S2#KYSSG9" %B!& H0Q>14 MA(#![R(M_@['XX>&[7(4G&/T41('GI\X: MPN3T($8YUF=-(GLT-@6O/V MUVYN\ZF0G;IQ OOP?>#ZC0NE$PE$B0X(T69[:KT\.078OS9L'Z?;9,-C3>'J M+BHF,&E$K$E;V4>[B?NR!=?_-@7ON[*2C?A>OB^X0902/QN\ $A M_"RA']^G];(O8,?:4_X3NE7\8LQEKK[QG]A7%@R/QOW@. M1&H0#_'."P6NUKG[%V?(7/W\KZ^GLFUH)H4C7L+1^^QNF"6.92EHG):!$ H7 MT^QE1'LYJ@JF2#:0RQ?#70-T$KGR?<^_]*!N8B/%L EB))1TI*)@4Z;>AYF^@.-RU_>R ^#U<;B^Z( T5S MX70@7.&'F&_]#5BV:>##6_JL\@Y+K"KMFMU)N]DJ*-ELMC;@M[55N)'&'^'_ MK,C!,7L!>H#GQ4!%5RY1_AM+\=Q]NZ7_9FPW?0]$BUQ\(=,\*IOFE(Y2>RPO M-1_72)GT^_W!$&+F7-&S=QDN#X=ZXZX\?X/U?[%+?LETS-2CIMU4%U(;P3,C M40Q'? XKY4:+&(!QV0"44_N5F@*I.?YC"*KA9#:9]\^GB@HO9J@]'"HJU63" M,\97VXE"8%6N\0VI:6<*A-1690J:B^&(34$A05O$#$S*9J!80T"I"9!43. < M;ASAGG$XF*LJT+-'*1I>[BJ;?Y;3.A:0/.ZKG]#^*H\ M9\\NX* INY(>M598O>2P\H'09F!6W@Q4U3]0NC605PAA/)E-"UA78O/Q*.\\ MURM6[$C+=8A9?A%BVLU[7GU5F?_& CCJ:QM&FK.039B7;0(SV5FI87C7K&>& M^YZH"/:*+49 NPG,2&"6Q.$1G]8/4I=%YN.@3[I3+28P*YY^G<]DSL +-T%) MBBVNI"&X2E?VUG!6-\I3;L+V$4]U4CJ$T'PG^.F)21%*)WVWLB,N=A<&M*,F M>'P!(/S-]Z*MC8ZBG(D2C.[:3>S:.1-U&#WJ?35?^H30]";XW[F3*)1.^1/* MIMBO7$_HJ;C(W\4UZ':7CA$(>/ K>VMG%:1F4C20P1&O_6GTJ)!!(/C@4CI* MY_N)A$UG4-UKCWN"EWH4 3U0/ZD;!T2+,GO4RSWAW;D[PT<^KE?P%82&[?!- MZC'W.W2]G_8?^+GW4_(-->YUW5^G4Y59F8P#6V*:12@TTLX(2%5M,6&2R7>% M/5#\+.["^F<4A.F6IR*U:_%FTUX&%Z*A'2XXU%?6>7.6]87$$_S _0HG\<$A M?0.;9^!3-$]JJIV"F^NJK']NQI4'Z1"O:@I)SJYE^%;P^Q9:0X @T9\3=<[= M3SL <"NK>%E3GUGE2I>\ZL/])+B!?Z4M .6&VF&@EI7GY(L:.:5":?&-_Y/Q MEESZ)W<.%,U16NNKOFI-E%4HPF#3:3N/IZT+RH_2*WIPY&JU0MG]KV OAB64 M8UPG,X*&K5P#_C"[@)M =R#3D.=6DNH(#]"KS4K!:0:<*2FX;8?PPT[C* M"H.B"0R2+!-.("2MNPN%*@83,(S;!(.*T@@U?8.$4L3$(@FZ> 8E5DQ0,W7+ MX_D6.:&]=:#B'"A?'VV,%U#8[AID\1K1X)__!.>:H#U#4DVHCB;02QM+ AT&$"33!J,:NL49W/%'HH3(XYD5DK4&X M!%94K.V=PPE7O],"2GV15)@3N49A85EV3'NQ0;=S]S^ =>WY":0AHDFWEJP^ M19:&'==R/7%4^#(5'U]^=Z$)RMC):3N%)Z16O-S:&DS=H6GV@?0\,/Y?DA2JMI/P+_U393TX#>FWDT'/SG8A4"'P7D);$3%[N+*("GEB!( M^HI9",*+J%E%[V04J6(FJA*3* M/OI!0)(.*X(3N.6@<9!"LCA4!B;DV^BG9V%M$#3*Y%#Y/3.Y-EP\[C_LT BH M@0;E1OKID"G_XAF0DZ46E)9-V(%,#2Z]T%MZ'OP22XV'+;NB2RZ^6KU>%U:H MK!)W/ER7H VK3 D]:'746A?A29(/1W5\3R$S'E\D5>RSR(WU4WEK&RP! ;1Q M0]Z6RBLW6;3FVJE=0#D\FM5YSR6I^$E:-3K=F%8:>DKKHH!&.L) R/:+L-D1 M'%18R5M6)CA'5^T0TN(!O*XXJ+L))7A #M/$A7H'J(['8BO]M%Q7%P2UC.="*KF&DX'5-0\2LN=E09?=8TKA;9V M1H&E[D+IK]8D(&G)<-0^QYJ/_:B0@ZCY*,5@DLQ',0QD_W7TSW+S;I@8?%%X M/AGT)[/Y9#H<]:>*W(/'OS40$G&#[4 ;D1T*=;UXA7,(OV;AP3FW\5Q>O@(U__]5^ MM2VXNVT$+,Y/G"3$FL@F =M$YM%+B\4SV3:4E@"QY9-&I6LXD\%^ J7ID6_& M)!=\/'YL\#.9(&!V])NH%JH]=@\'' >S\Z-,Y<@_1%_3ZS\I>_T1U3-$MH?H MZN/QSW/+<,61FB+P3,_'_>%X.!],IH/12-&S;6A0V?N85>D3A);:S55N49?G M*2][^H:\%SFHB,,K-]1.D;S:8.F1RAR'&A4YQHL,W!D;4!E?1VM>Y'JLFTJI MBF%IE,&A\I@J6F'%IQ=8K.4+>;B-,UC7T/$V%<2ILW*65=_"<5W@HC(W:M6'2*^IR]=$>#ER6OSZK'<$%J@ 3;=#YY_]T S M !Q=-==WM=8(1J NRZTZ=125*B()XYOQ9F^BS87G^]X/= 0RMO WI9*8=4B< M )2$6._FPYM%H>+:@8^0(<.Z=_-+]X!KV:%W[QB8&K'=0BF/#$;"Y;$EV280 MHO&D$RP7Q%29[L7JUC'8U&*WZ<.>E7!1E.=+,L9+@$X'*'R\P6)&)](U*#5G M7E)0*FU!FZ@))4+_Y2:6:$!1*0_P,* (_S_W@>..*])AT]$HB$B#B5RE J&( M(?;91?7A]=2NE;DO(5G.YR-0YL>U\L>U\L>U\L>ULNQKY/*"7LF:+'.=RZ13[L[-,UW]2B6A M98O!MU[2W MAI.^#WB_0HUN/<,5]9J57E$[])KM*V=YJ][^N[WTP^BGX0OHX0[H^Q].-:5. M-0UFN32G&GNQU\P/T\BIIH'F>#52QZG&K\R1'LIL[%330*'<:JGG5).\&_]P MGBAPGE !(.P\.7;]GZCSA J 3CA/OAEA4H=W";;[S?)^'QO?NUNHE,\UW 0; MSM^!41'%W8BLYM!H. "4>$\Q4N.%O+9= P+><+!S MWGL%\)]A(.IVG+#?^BX_8L0)>/I8-0_G_=GY\/Q8#B?Z'#8:>)R MG [43V-N48M[(5/V]/5"+E&UY K7X_[WVJF-5_:$")]*GO2M^(7'71VFE;70 M3E_54J=HJ8*7CCB.OMDNRD6K=ACFV^BIV(JQ$;R#3'ZZ6)PKR3JLUG2^313G(WB.'UUU@1#B7Y?XD5%6]!7'-]B<26O=D+K!MXMGB&?[H@"/(_ M7UC_C((0#?KJV0XMXT"#4FAJKN=J;66Z;D\6>IE_(K"N[3=@7;X8_AJ@XR51 M!M<^ )=&\'+M>#\*/\_Z'EH(F:0[!+-61=*J,U?X7$=$V\)U(\/9/QI^"XP MH"=+;#R3"!BJ[M A9-1@M%5?ZO#]'&OWX0OP]YQ?O6V!&X"@9DW]:;FF/J;? MVW^@EWY!G^KZ>(3Q2W<+UTK'QW"M57>"B)D,S@?#^:P_&,WGT_'L7,H,)BN+ MY#MCM-9N[M:09W$*BS*K;QC8(Q0\KCM]$04VVODDSX('%1ZVRC[:*+N.GLJG M G%>]?6<)D.OC/0KM"GR-U0_<<6U0= HDT/E?CJB.4[&_8<=&N1@/7(C_73( ME'_1UG*RI*?2R :(YFSAZ*&-.IN9U[J>ALD1XR>)S\*2(ZLFI2TL06BPB_: )G<*]_3R<$[DL.M%T!1/!IQ.JL' MK6RX>W ,-[SZ5V1O"2Y1L[ M%KSCRDX0=Y[KI5NPPN:A:H6D=NH0&&HPVD(]6A6X$(7$*:"A%A":UH\MOT3? M_B'C,?3,[Q=&4-PRH;6P[K79>?E0@3]RAK_2RW^FA[^CS^59^MQ\41B,,T1U MIP1OT_Z\?SZ>#F?3L:)"T]G!D3)@J )WC9W?P<4N:Y-4)EG\,'RK*JY=&GWM MK$@-!1-N!5H5C[[W?_' JXMY%-KHI_Y6-5=&"EL:&M\ UI90QK5KH56!^7IW M&Y_2#GML+! LS7L)1KGWA.AG>P#^RO,WAFO&##ZA317F]\5SX("7((Q\]PG% MOH7T>\X:5+0#S[L!H>B@DR6ZXX#7E>&C=R8"^'/,HRBP*OM_0$J6T#KBN6/* MGR9^6D2 /,+Z8?6=]VTMB5"K4D"U>41^]7"7Q3,'V#7S]&*X]YBAX#.FYV-'LI;%S7NVK MF7GY:B;WH5[VI5[V*7UN9[+AL?*9B"UEI$Y[AAM A +[%1T,KN&,(RJ*FL0D M1J"(\)%ZHU*A@7WV!Q:>J&W]#Q(E7K=>=A$/_TQ95\\WW QI%?9 M?:+N& X&VGVA2%=M="W=%#>6 M5-U99F@S_M\.4Q>G9L$V==\JKUL)]6.FVD M @YM5,<]N%]A'IX\[GG/TZVKZJ_->PL)84K*Z#%D MF456D64C>BDUK'$IE:]$0&ZN^FD+]==52_ *W @$0@L^NU,1^F/U9SB.:ZF: M7$G:W!4?OI81A>Q#8+\]^-[*#H6TR]?Q<@#-)FS22EMNWU4L0VC[V0.%D MRLPVIP5VKCT_UP;+!X56H&@EU.'JS01!< %< '^!?[)P+1QK\6AO;,?P\<^$ M3/J@7XXSR(:0)GWF+?B^CBH<;*[I7WKQ>,^2 <==_]*+Q]Q+!IT0A,-.:M(D M X]_KGP5R$7?N%;&6R8=YNH@0$%-H?\5W%Q9>);9SU&:/XQB>K)H'@IS7'TU M-$?"2BV^!%"7Z1;7HW=X]0RL#0>+:QTY"(R[;T:(]KKUHID&@[*5P9_ EB#[ M2"_YBDZ!3&DQ;F1K$0R@;0.N:8- Q"J(T%#SF"%^YR ;6%7Z.+FQCC-?7'7% M-PZY^=0WS??6#NUU'+AI!%4!4>6&VFE40"$$;?+Q=RR:1/EYE7>QM.;Z:95/ M,2R-,CC4\UKV]\<_JHLX%QMHKCN&"HJ'0 [.E.NLI<65=F/+[J ? !J99#$^ MVRCX3(X=MU>XAI09&JZY(Z8YTIKIKZ!J&1?G*#>'DF8JO82OJJ7V$83P"(,S M;C9>1*W,2>_0'4#4Y+75:U4YK]MX7;D=5-.^T**(M#TSS<'I/.4V8J79.L;OKK MG$=M/-KGX+LC3C#T@$.0A/;<@; R19#8]@A P:'-,BCXF>T*$MK-(]01&2)+ MA#BK^CZ$US!G4 -5BFN#H%$FA\IG=GNOC.J@0Z;\BZ=I3I:4*ZVE/1SK=HK> M03O-R]VK5_/99IY@^IAB4KCKP?=>;?@U8A(8I:G^NJD6;W&*"G&IS>44V;49 M^>:+$<3Q[H^VNW; '\"U/)*QI;;MEG;%V&PE)%SY%61)@ _ 1S\PUH!67+2J M2W< 4IM;2?=4-)RH>K3%--'5:_!@[-#:=AGY2/(4A) ;=P\; GQ6W'LIR.:[ M-(*7>X@PRS=6<=@J_ &JU_QJ..C44?-Z8T2XWH"$>]FG<" V_EGN:_K<=J"1 ME:7!BKMF=)*P>!?TE:#MQC6="&KAQCV (6%!%^JOWSSETDJZJC?GM2LGK@-Y MA9=PENW@-@>_E%P!9GJG(X9& P9;*ZS6OJ&_MEW#-6W#R97A+S!\;=@^_@N4 MXM]LX$/1O^SN5Z1^8FO!N+P6[(GV%Q_*6'AA3_':\6^U&ARW$B M"<6+QEZ$&;.L):.ZBPICD>$ /YT.!7]K&\^V8Z-+Y6_ 0$.T[MTE,.$F!RH+ M-KCS7#_]YX41V)7)/-+H:V>">-2?-T#M2D+?9Q_W?%_L]G_=S^U;\ J"^>$B;=[?)M@4B]] ?/^NU]N^>@;U/3@^5A7X9XMPDFS MTK@(4- 7.P*Z+".BJ00ZLH%)/6Q+@!+M@!6G48K"29"*=I!J"@:2+[FY1#H" ML9KO8&D B_=>I:HE4;'!4;P>-7@F2P,M5TN=HJ7N3]N&+RGIHE@AJ\WFIRO* M;?8&VG$JE\E/UWP-#9:M6T8(MM1O: _@N$\AI[Y M?0FV2>8(JM$=^H8;&";Z1-VXZ0DI;AI_KX<_V,N^B"O8/^4^J4_P](.QBU,@#BNOA!;D_/^^70XF$]&L_%X.E+U1ND!"GQO[1N;112^ M0&#^._4#TO)G.'MK9VSJZZB\XC2104=.YV01+ &Z/46F>B^+K$T=7/$0/$&H MU18+=?^CUTJ4/?I";B\8S3TIO\@EL$+EWW6A=5,=Q?T>J]=X.AA-YX/A:#Z$ M>!WVU1B>)Q]O#'=8 _'NT80C]='S(T'X#<#Y0'N;A:?KT1J3LG;*QJ2V #1X M-JP%]*!'F$"0BH '-,4>15'-.HP5#KX[XI@NL)TRO(# -=8 31)XAL3"X$%+ M1??3@8ZH$%J+D6M_;_.;YUD_;,?)=B_?O%<<^7/CIK\3V[C,RD?KE%!N7^*M M>IOD0SW;W;=0O"5)A[%PK1LH7G=M/SN)IX?[42A!&DH.0GMEIX.M2B2CM-;. M'-127N'<(L"HOJ4[6Z["IX&B1?1$.IV*\LJAZ_%1EN'309?"VB!HE,FA<@=6 M>V7X=- A4_[%.PU.EO14VM(+O:7G0:I4E1TV.7J%<3'4D<-4NJ2P(G5*[?33 MH8&M-.47RBIJNH3>NYQ??/<)7VPU+D@*)-3\HV//8#>^W& M-<#,'7: .UAOOT&SAIY=80"!3:!S4*G)W'E M6G1K071J_?4+&N^S$8#__O]02P$"% ,4 " !E/YQ*+X<[%4J- !R#@L M$ @ $ 8VAE+3(P,3'-D4$L! A0#% @ 93^<2EY#1>75#0 5\< !0 M ( !WIL &-H92TR,#$W,#,S,5]C86PN>&UL4$L! A0#% @ 93^<2L7] MUIR@$P +20! !0 ( !Y:D &-H92TR,#$W,#,S,5]D968N M>&UL4$L! A0#% @ 93^<2B#P@)!J0@ =)P# !0 ( ! MM[T &-H92TR,#$W,#,S,5]L86(N>&UL4$L! A0#% @ 93^<2AIXTA4< M,@ 3D# !0 ( !4P ! &-H92TR,#$W,#,S,5]P&UL 64$L%!@ & 8 A $ *$R 0 $! end

Three months ended March 31,

Pretax profits